Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 3/20 | 0.52 |
| ▸ | MAPT | P10636 | 4/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.48 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.48 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.48 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.48 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.48 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.48 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.48 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.48 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.48 |
| ▸ | GPR3 | P46089 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 2/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lithium SCHEMBL31322481 | 0.97 | CYP2A6 (0.50) | CYP2A6MAPTHDAC3HDAC4HDAC1 | |
| SCHEMBL28744583 | 0.93 | CYP2A6 (0.50) | CYP2A6MAPTHDAC3HDAC4HDAC1 | |
| SCHEMBL8786726 | 0.81 | CYP2A6 (0.48) | CYP2A6MAPTHDAC3HDAC4HDAC1 | |
| SCHEMBL9380333 | 0.81 | CA2 (0.39) | CYP2A6MAPTHDAC3HDAC4HDAC1 | |
| SCHEMBL20174709 | 0.78 | CYP2A6 (0.42) | CYP2A6MAPTHDAC3HDAC4HDAC1 | |
| SCHEMBL30003342 | 0.77 | CYP2A6 (0.67) | CYP2A6MAPTCHRNA7SMN1; SMN2CA1 | |
| SCHEMBL2792315 | 0.77 | CYP2A6 (0.67) | CYP2A6MAPTCHRNA7SMN1; SMN2CA1 | |
| SCHEMBL13319555 | 0.77 | ERN1 (0.42) | CYP2A6MAPTHDAC3HDAC4HDAC1 | |
| SCHEMBL4381193 | 0.76 | CYP2A6 (0.54) | CYP2A6MAPTHDAC3HDAC4HDAC1 | |
| SCHEMBL15113957 | 0.74 | PKM (0.47) | CYP2A6MAPTHDAC3HDAC4HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1080 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118930515-A | Reversible photochromic compound and preparation method and application thereof | 东北林业大学 | 2024-11-12 | — | — | CN | claimed |
| CN-115490702-B | Method for synthesizing BTBF aromatic amine derivative | 广东阿格蕾雅光电材料有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-118108767-A | Synthesis method of bis (3-benzothienyl) phosphorus chloride | 浙江九洲药业股份有限公司 | 2024-05-31 | — | — | CN | claimed |
| CN-115490703-B | BTBF synthesis method | 广东阿格蕾雅光电材料有限公司 | 2024-05-31 | — | — | CN | claimed |
| CN-116704872-A | Preparation method of surface-enhanced Raman label | 南京工业大学 | 2023-09-05 | — | — | CN | claimed |
| WO-2022262310-A1 | METHOD FOR SYNTHESIZING BTBF AROMATIC AMINE DERIVATIVES | 广东阿格蕾雅光电材料有限公司 | 2022-12-22 | — | — | WO | claimed |
| CN-115490702-A | Synthetic method of BTBF arylamine derivative | 广东阿格蕾雅光电材料有限公司 | 2022-12-20 | — | — | CN | claimed |
| CN-115490703-A | Synthetic method of BTBF | 广东阿格蕾雅光电材料有限公司 | 2022-12-20 | — | — | CN | claimed |
| CN-110734451-B | Semiconductor material, preparation method thereof and organic light-emitting diode | 北京大学深圳研究生院 | 2022-07-22 | — | — | CN | claimed |
| US-10858334-B2 | Method for aerobic oxidative coupling of thiophenes with a ligand-supported palladium catalyst | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2020-12-08 | — | — | US | claimed |
| CN-111138452-A | 1, 8-dialkyl-1, 4,5, 8-naphthalimide compound and preparation method thereof | 杭州师范大学 | 2020-05-12 | — | — | CN | claimed |
| CN-110734451-A | semiconductor materials, preparation method thereof and organic light emitting diode | 北京大学深圳研究生院 | 2020-01-31 | — | — | CN | claimed |
| CN-110734452-A | semiconductor materials, and preparation method and application thereof | 北京大学深圳研究生院 | 2020-01-31 | — | — | CN | claimed |
| CN-110734453-A | amine derivatives, preparation method thereof and organic light emitting diode | 北京大学深圳研究生院 | 2020-01-31 | — | — | CN | claimed |
| US-20190210993-A1 | Method for Aerobic Oxidative Coupling of Thiophenes with a Ligand-Supported Palladium Catalyst | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2019-07-11 | — | — | US | claimed |
| EP-3004120-B1 | SPIRO-1,1'-BIINDANE-7,7-BISPHOSPHINE OXIDES AS HIGHLY ACTIVE SUPPORTING LIGANDS FOR PALLADIUM-CATALYZED ASYMMETRIC HECK REACTION | UNIV NANYANG TECH (SG) | 2018-08-29 | — | — | EP | claimed |
| US-20160136629-A1 | SPIRO-1,1'-BINDANE-7,7-BISPHOSPHINE OXIDES AS HIGHLY ACTIVE SUPPORTING LIGANDS FOR PALADIUM-CATALYZED ASYMMETRIC HECK REACTION | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2016-05-19 | — | — | US | claimed |
| EP-3004120-A1 | SPIRO-1,1'-BIINDANE-7,7-BISPHOSPHINE OXIDES AS HIGHLY ACTIVE SUPPORTING LIGANDS FOR PALLADIUM-CATALYZED ASYMMETRIC HECK REACTION | Nanyang Technological University (SG) | 2016-04-13 | — | — | EP | claimed |
| WO-2014196930-A1 | SPIRO-1,1'-BIINDANE-7,7-BISPHOSPHINE OXIDES AS HIGHLY ACTIVE SUPPORTING LIGANDS FOR PALLADIUM-CATALYZED ASYMMETRIC HECK REACTION | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2014-12-11 | — | — | WO | claimed |
| US-20250289817-A1 | SEROTONIN RECEPTOR MODULATORS AND METHODS OF MAKING AND USING THE SAME | KULEON LLC (US) | 2025-09-18 | — | — | US | disclosed |
| EP-4108667-B1 | POLYCYCLIC AROMATIC DERIVATIVE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | SFC CO LTD (KR) | 2025-08-13 | — | — | EP | disclosed |
| CN-120201863-A | Organic electroluminescent device | SFC株式会社 | 2025-06-24 | — | — | CN | disclosed |
| US-12338230-B2 | Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders | ACHILLION PHARMACEUTICALS, INC. (US) | 2025-06-24 | — | — | US | disclosed |
| EP-3915979-B1 | DEUTERATED COMPOUNDS FOR ORGANIC LIGHT EMITTING ELEMENTS, AND ORGANIC LIGHT EMITTING ELEMENTS COMPRISING SAME AND HAVING LONG LIFESPAN | SFC CO LTD (KR) | 2025-06-18 | — | — | EP | disclosed |
| CN-120136771-A | Benzocarbazole derivative and organic electroluminescent device | 海宁奕诺炜特科技有限公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-120040478-A | Boron-nitrogen compound and organic electroluminescent device using same | 海宁奕诺炜特科技有限公司 | 2025-05-27 | — | — | CN | disclosed |
| US-20250163078-A1 | IMIDAZOPYRIDAZINE DERIVATIVE, AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | Shanghai Simr Biotechnology Co., Ltd. (CN) | 2025-05-22 | — | — | US | disclosed |
| US-12284917-B2 | Compound for organic light-emitting diode and organic light-emitting diode comprising same | SFC CO., LTD. (KR) | 2025-04-22 | — | — | US | disclosed |
| CN-119775239-A | Polycyclic aromatic organic electroluminescent compound and preparation method and application thereof | 奥来德(上海)光电材料科技有限公司 | 2025-04-08 | — | — | CN | disclosed |
| EP-4524139-A1 | IMIDAZOPYRIDAZINE SUBSTITUTED BENZENE RING DERIVATIVE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE | Shanghai Simr Biotechnology Co., Ltd. (CN) | 2025-03-19 | — | — | EP | disclosed |
| CN-119613361-A | Organic electroluminescent device and deuterated mixture | 阜阳欣奕华新材料科技股份有限公司 | 2025-03-14 | — | — | CN | disclosed |
| CN-119431422-A | Boron-nitrogen-containing compound and application thereof | 阜阳欣奕华新材料科技股份有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-119390716-A | Boron-nitrogen-containing compound and application thereof | 阜阳欣奕华新材料科技股份有限公司 | 2025-02-07 | — | — | CN | disclosed |
| US-20250042934-A1 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | SAGE THERAPEUTICS, INC. | 2025-02-06 | — | — | US | disclosed |
| EP-4484433-A1 | IMIDAZOPYRIDAZINE DERIVATIVE, AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | Shanghai Simr Biotechnology Co., Ltd. (CN) | 2025-01-01 | — | — | EP | disclosed |
| WO-2024259241-A1 | 5-HT2A RECEPTOR MODULATORS AND METHODS OF USE THEREOF | Transneural Therapeutics, Inc. (US) | 2024-12-19 | — | — | WO | disclosed |
| CN-119143789-A | Multiple resonance thermal activation delay fluorescent material based on peripheral heavy atom substitution and application thereof in organic electroluminescent device | 吉林大学 | 2024-12-17 | — | — | CN | disclosed |
| US-12171143-B2 | Compound, organic optoelectronic diode, and display device | LT MATERIALS CO., LTD. (KR) | 2024-12-17 | — | — | US | disclosed |
| CN-119039494-A | Metal catalyst, catalyst composition and application thereof | 万华化学集团股份有限公司 | 2024-11-29 | — | — | CN | disclosed |
| CN-119053611-A | Compound, material for organic electroluminescent element, and electronic device | 出光兴产株式会社 | 2024-11-29 | — | — | CN | disclosed |
| CN-119039540-A | Catalyst composition and application thereof, and preparation method of olefin block copolymer | 万华化学集团股份有限公司 | 2024-11-29 | — | — | CN | disclosed |
| CN-119019431-A | Polycyclic aromatic compound, material for organic device, organic electroluminescent element, display device, and lighting device | 爱思开新材料捷恩智株式会社 | 2024-11-26 | — | — | CN | disclosed |
| CN-118930515-A | Reversible photochromic compound and preparation method and application thereof | 东北林业大学 | 2024-11-12 | — | — | CN | disclosed |
| US-12127470-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2024-10-22 | — | — | US | disclosed |
| US-20240341188-A1 | CONDENSED CYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-10-10 | — | — | US | disclosed |
| US-12114562-B2 | Compound for organic light-emitting diode and long lifespan organic light-emitting diode comprising same | SFC CO., LTD. (KR) | 2024-10-08 | — | — | US | disclosed |
| CN-118702657-A | Anthracene compound and organic light-emitting element comprising same | SFC株式会社 | 2024-09-27 | — | — | CN | disclosed |
| CN-118684695-A | Condensed-cyclic compound, light-emitting device, electronic apparatus, and electronic device | 三星显示有限公司 | 2024-09-24 | — | — | CN | disclosed |
| CN-118561851-A | Preparation method of polysubstituted indolo [2,3-b ] carbazole compound | 湖南师范大学 | 2024-08-30 | — | — | CN | disclosed |
| EP-3919500-B1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEMICAL LTD (KR) | 2024-08-28 | — | — | EP | disclosed |
| CN-115443270-B | Anthracene compound and organic light-emitting element comprising same | SFC株式会社 | 2024-07-09 | — | — | CN | disclosed |
| CN-113861043-B | Compound and application thereof | 北京鼎材科技有限公司 | 2024-07-05 | — | — | CN | disclosed |
| US-20240224780-A1 | Organic Compound, Light-Emitting Element, and Display Panel | SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2024-07-04 | — | — | US | disclosed |
| US-20240224780-A1 | Organic Compound, Light-Emitting Element, and Display Panel | SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) | 2024-07-04 | — | — | US | disclosed |
| US-20240199583-A1 | ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS | ACHILLION PHARMACEUTICALS, INC. | 2024-06-20 | — | — | US | disclosed |
| CN-115490702-B | Method for synthesizing BTBF aromatic amine derivative | 广东阿格蕾雅光电材料有限公司 | 2024-06-14 | — | — | CN | disclosed |
| CN-114989200-B | Boron-containing nitrogen compounds and their use in organic electronic devices | 广州追光科技有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-115490703-B | BTBF synthesis method | 广东阿格蕾雅光电材料有限公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-118108767-A | Synthesis method of bis (3-benzothienyl) phosphorus chloride | 浙江九洲药业股份有限公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-118108767-A | Synthesis method of bis (3-benzothienyl) phosphorus chloride | 浙江九洲药业股份有限公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-118063326-A | Method for promoting nickel catalysis to synthesize arylamine compound by red light | 陕西师范大学 | 2024-05-24 | — | — | CN | disclosed |
| US-11985891-B2 | Polycyclic aromatic compounds and organic electroluminescent devices using the same | SFC CO., LTD. (KR) | 2024-05-14 | — | — | US | disclosed |
| WO-2024097355-A1 | DEUBIQUITINASE-TARGETING CHIMERAS AND RELATED METHODS | VICINITAS THERAPEUTICS, INC. (US) | 2024-05-10 | — | — | WO | disclosed |
| WO-2024077203-A1 | SEROTONIN RECEPTOR MODULATORS AND METHODS OF MAKING AND USING THE SAME | KULEON LLC (US) | 2024-04-11 | — | — | WO | disclosed |
| US-11945836-B2 | Compositions and methods for treating CNS disorders | SAGE THERAPEUTICS, INC. (US) | 2024-04-02 | — | — | US | disclosed |
| CN-114605314-B | Indene derivative and application thereof | 上海八亿时空先进材料有限公司 | 2024-04-02 | — | — | CN | disclosed |
| CN-114605411-B | Acridine derivative and application thereof | 上海八亿时空先进材料有限公司 | 2024-03-19 | — | — | CN | disclosed |
| CN-113227066-B | Compound for organic light-emitting element and long-life organic light-emitting element comprising same | SFC株式会社 | 2024-03-19 | — | — | CN | disclosed |
| US-11926617-B2 | Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders | ACHILLION PHARMACEUTICALS, INC. (US) | 2024-03-12 | — | — | US | disclosed |
| US-20240057471-A1 | ORGANIC LIGHT-EMITTING DEVICE COMPRISING NOVEL ORGANIC COMPOUND IN EMISSION LAYER | SFC CO., LTD. (KR) | 2024-02-15 | — | — | US | disclosed |
| US-20240023359-A1 | ORGANIC LIGHT-EMITTING DEVICE COMPRISING NOVEL ORGANIC COMPOUND IN EMISSION LAYER | SFC CO., LTD. (KR) | 2024-01-18 | — | — | US | disclosed |
| US-20240023359-A1 | ORGANIC LIGHT-EMITTING DEVICE COMPRISING NOVEL ORGANIC COMPOUND IN EMISSION LAYER | SFC CO., LTD. (KR) | 2024-01-18 | — | — | US | disclosed |
| US-20240023359-A1 | ORGANIC LIGHT-EMITTING DEVICE COMPRISING NOVEL ORGANIC COMPOUND IN EMISSION LAYER | SFC CO., LTD. (KR) | 2024-01-18 | — | — | US | disclosed |
| CN-113748106-B | Compound for organic light-emitting element and organic light-emitting element comprising same | SFC株式会社 | 2024-01-02 | — | — | CN | disclosed |
| CN-111378295-B | Xanthene dye, coloring composition containing the same, colorant for color filter, and color filter | 保土谷化学工业株式会社 | 2023-11-24 | — | — | CN | disclosed |
| EP-3889236-B1 | ORGANIC LIGHT-EMITTING ELEMENT USING POLYCYCLIC AROMATIC DERIVATIVE COMPOUND | SFC CO LTD (KR) | 2023-11-22 | — | — | EP | disclosed |
| WO-2023216753-A1 | IMIDAZOPYRIDAZINE SUBSTITUTED BENZENE RING DERIVATIVE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE | 上海赛默罗生物科技有限公司 | 2023-11-16 | — | — | WO | disclosed |
| EP-4273946-A1 | ORGANIC LIGHT-EMITTING DEVICE COMPRISING NOVEL ORGANIC COMPOUND IN EMISSION LAYER | SFC Co., Ltd. (KR) | 2023-11-08 | — | — | EP | disclosed |
| EP-4273946-A1 | ORGANIC LIGHT-EMITTING DEVICE COMPRISING NOVEL ORGANIC COMPOUND IN EMISSION LAYER | SFC Co., Ltd. (KR) | 2023-11-08 | — | — | EP | disclosed |
| EP-3688000-B1 | HYDROCARBON-SOLUBLE HALOGEN AND THIOLATE/MAGNESIUM EXCHANGE REAGENTS | ALBEMARLE GERMANY GMBH (DE) | 2023-11-08 | — | — | EP | disclosed |
| WO-2023210737-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | 出光興産株式会社 | 2023-11-02 | — | — | WO | disclosed |
| CN-112250708-B | Anthracene-containing dimer skeleton ligand, preparation method thereof and application thereof in metal catalytic reaction | 中国科学院理化技术研究所 | 2023-10-13 | — | — | CN | disclosed |
| US-11780856-B2 | Compound and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2023-10-10 | — | — | US | disclosed |
| US-11780856-B2 | Compound and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2023-10-10 | — | — | US | disclosed |
| US-11780807-B2 | Benzoselenophene, benzothiophene, and benzofuran analogs and methods of modulating the serotonin 5-HT2C receptor | Kuleon, LLC (US) | 2023-10-10 | — | — | US | disclosed |
| US-11780856-B2 | Compound and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2023-10-10 | — | — | US | disclosed |
| EP-4254526-A1 | ORGANIC LIGHT-EMITTING DEVICE COMPRISING NOVEL ORGANIC COMPOUND IN EMISSION LAYER | SFC Co., Ltd. (KR) | 2023-10-04 | — | — | EP | disclosed |
| EP-3340983-B1 | ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS | ACHILLION PHARMACEUTICALS INC (US) | 2023-10-04 | — | — | EP | disclosed |
| EP-3340983-B1 | ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS | ACHILLION PHARMACEUTICALS INC (US) | 2023-10-04 | — | — | EP | disclosed |
| EP-4254526-A1 | ORGANIC LIGHT-EMITTING DEVICE COMPRISING NOVEL ORGANIC COMPOUND IN EMISSION LAYER | SFC Co., Ltd. (KR) | 2023-10-04 | — | — | EP | disclosed |
| US-11773074-B2 | Method for aerobic oxidative coupling of thiophenes with a ligand-supported palladium catalyst | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2023-10-03 | — | — | US | disclosed |
| US-11773074-B2 | Method for aerobic oxidative coupling of thiophenes with a ligand-supported palladium catalyst | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2023-10-03 | — | — | US | disclosed |
| US-11773074-B2 | Method for aerobic oxidative coupling of thiophenes with a ligand-supported palladium catalyst | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2023-10-03 | — | — | US | disclosed |
| US-20230287010-A1 | POLYCYCLIC AROMATIC DERIVATIVE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | SFC CO., LTD (KR) | 2023-09-14 | — | — | US | disclosed |
| US-20230287010-A1 | POLYCYCLIC AROMATIC DERIVATIVE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | SFC CO., LTD (KR) | 2023-09-14 | — | — | US | disclosed |
| US-20230279043-A1 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | SAGE THERAPEUTICS, INC. | 2023-09-07 | — | — | US | disclosed |
| US-20230279043-A1 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | SAGE THERAPEUTICS, INC. | 2023-09-07 | — | — | US | disclosed |
| US-20230279043-A1 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | SAGE THERAPEUTICS, INC. | 2023-09-07 | — | — | US | disclosed |
| CN-116704872-A | Preparation method of surface-enhanced Raman label | 南京工业大学 | 2023-09-05 | — | — | CN | disclosed |
| WO-2023160475-A1 | IMIDAZOPYRIDAZINE DERIVATIVE, AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | 上海赛默罗生物科技有限公司 | 2023-08-31 | — | — | WO | disclosed |
| CN-116655589-A | Preparation method of dibenzothiophene derivative | 湖北尚赛光电材料有限公司 | 2023-08-29 | — | — | CN | disclosed |
| EP-3162806-B1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | LT MATERIALS CO LTD (KR) | 2023-08-23 | — | — | EP | disclosed |
| EP-3162806-B1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | LT MATERIALS CO LTD (KR) | 2023-08-23 | — | — | EP | disclosed |
| CN-112110884-B | Organic light-emitting compound and organic light-emitting element comprising same | SFC株式会社 | 2023-08-22 | — | — | CN | disclosed |
| US-20230263058-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2023-08-17 | — | — | US | disclosed |
| US-20230263058-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2023-08-17 | — | — | US | disclosed |
| US-20230257346-A1 | BENZOSELENOPHENE AND SELENOPHENOPYRIDINE ANALOGS AND METHODS OF MODULATING THE SEROTONIN 5-HT2C RECEPTOR | Kuleon, LLC (US) | 2023-08-17 | — | — | US | disclosed |
| EP-3754737-B1 | ORGANIC COMPOUND FOR ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DIODE INCLUDING SAME | SFC CO LTD (KR) | 2023-08-16 | — | — | EP | disclosed |
| EP-3754737-B1 | ORGANIC COMPOUND FOR ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DIODE INCLUDING SAME | SFC CO LTD (KR) | 2023-08-16 | — | — | EP | disclosed |
| EP-4223854-A2 | PHOSPHORESCENT MATERIALS | Universal Display Corporation (US) | 2023-08-09 | — | — | EP | disclosed |
| EP-4223854-A2 | PHOSPHORESCENT MATERIALS | Universal Display Corporation (US) | 2023-08-09 | — | — | EP | disclosed |
| CN-116491242-A | Organic light-emitting element comprising novel organic compound in light-emitting layer | SFC株式会社 | 2023-07-25 | — | — | CN | disclosed |
| US-20230232650-A1 | ORGANOELECTROLUMINESCENT DEVICE USING POLYCYCLIC AROMATIC COMPOUNDS | SFC CO., LTD (KR) | 2023-07-20 | — | — | US | disclosed |
| US-20230232650-A1 | ORGANOELECTROLUMINESCENT DEVICE USING POLYCYCLIC AROMATIC COMPOUNDS | SFC CO., LTD (KR) | 2023-07-20 | — | — | US | disclosed |
| US-20230217818-A1 | ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THEREOF | LG DISPLAY CO., LTD. (KR) | 2023-07-06 | — | — | US | disclosed |
| US-20230217818-A1 | ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THEREOF | LG DISPLAY CO., LTD. (KR) | 2023-07-06 | — | — | US | disclosed |
| US-20230217818-A1 | ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THEREOF | LG DISPLAY CO., LTD. (KR) | 2023-07-06 | — | — | US | disclosed |
| EP-4206206-A1 | ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THEREOF | LG Display Co., Ltd. (KR) | 2023-07-05 | — | — | EP | disclosed |
| CN-116375731-A | Organic compound, organic light emitting diode including the same, and organic light emitting device | 乐金显示有限公司 | 2023-07-04 | — | — | CN | disclosed |
| US-11685751-B2 | Compound and organic light-emitting element comprising same | LG CHEM, LTD. (KR) | 2023-06-27 | — | — | US | disclosed |
| US-11685751-B2 | Compound and organic light-emitting element comprising same | LG CHEM, LTD. (KR) | 2023-06-27 | — | — | US | disclosed |
| US-20230200099-A1 | ORGANIC LIGHT-EMITTING DIODE WITH HIGH EFFICIENCY AND LONG LIFESPAN | SFC CO., LTD. (KR) | 2023-06-22 | — | — | US | disclosed |
| US-20230200099-A1 | ORGANIC LIGHT-EMITTING DIODE WITH HIGH EFFICIENCY AND LONG LIFESPAN | SFC CO., LTD. (KR) | 2023-06-22 | — | — | US | disclosed |
| CN-114874247-B | Boron nitrogen compound and organic electronic device comprising same | 广州追光科技有限公司 | 2023-06-16 | — | — | CN | disclosed |
| US-20230183200-A1 | ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SFC CO., LTD (KR) | 2023-06-15 | — | — | US | disclosed |
| US-20230183200-A1 | ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SFC CO., LTD (KR) | 2023-06-15 | — | — | US | disclosed |
| US-20230167139-A1 | PHOTOCHROMIC GERMOLE-FUSED DIARYLETHENES AND PRODUCTION THEREOF | THE UNIVERSITY OF HONG KONG (CN) | 2023-06-01 | — | — | US | disclosed |
| US-20230167139-A1 | PHOTOCHROMIC GERMOLE-FUSED DIARYLETHENES AND PRODUCTION THEREOF | THE UNIVERSITY OF HONG KONG (CN) | 2023-06-01 | — | — | US | disclosed |
| EP-3399005-B1 | PHOSPHORESCENT MATERIALS | UNIVERSAL DISPLAY CORP (US) | 2023-05-31 | — | — | EP | disclosed |
| US-20230165032-A1 | ORGANOELECTROLUMINESCENT DEVICE USING POLYCYCLIC AROMATIC DERIVATIVE COMPOUNDS | SFC CO., LTD (KR) | 2023-05-25 | — | — | US | disclosed |
| US-20230165032-A1 | ORGANOELECTROLUMINESCENT DEVICE USING POLYCYCLIC AROMATIC DERIVATIVE COMPOUNDS | SFC CO., LTD (KR) | 2023-05-25 | — | — | US | disclosed |
| US-20230143961-A1 | NOVEL ANTHRACENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SFC CO., LTD. (KR) | 2023-05-11 | — | — | US | disclosed |
| US-20230143961-A1 | NOVEL ANTHRACENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SFC CO., LTD. (KR) | 2023-05-11 | — | — | US | disclosed |
| US-20230143961-A1 | NOVEL ANTHRACENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SFC CO., LTD. (KR) | 2023-05-11 | — | — | US | disclosed |
| US-20230137925-A1 | HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND | IDEMITSU KOSAN CO.,LTD (JP) | 2023-05-04 | — | — | US | disclosed |
| US-20230137925-A1 | HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND | IDEMITSU KOSAN CO.,LTD (JP) | 2023-05-04 | — | — | US | disclosed |
| US-20230137925-A1 | HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND | IDEMITSU KOSAN CO.,LTD (JP) | 2023-05-04 | — | — | US | disclosed |
| US-20230135152-A1 | PIKFYVE KINASE INHIBITORS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-05-04 | — | — | US | disclosed |
| US-20230135152-A1 | PIKFYVE KINASE INHIBITORS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-05-04 | — | — | US | disclosed |
| US-20230135152-A1 | PIKFYVE KINASE INHIBITORS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-05-04 | — | — | US | disclosed |
| EP-4168417-A1 | HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND | Idemitsu Kosan Co., Ltd (JP) | 2023-04-26 | — | — | EP | disclosed |
| CN-114031631-B | Organic compound, composition, electroluminescent diode and display device | 广东聚华印刷显示技术有限公司 | 2023-04-25 | — | — | CN | disclosed |
| US-11631821-B2 | Polycyclic aromatic compounds containing a 1,11-dioxa-,1,11-dithia-, or 1-oxa-11-thia-4,8-diaza-11b-boradicyclopenta[a,j]phenalene core and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2023-04-18 | — | — | US | disclosed |
| CN-111303149-B | Benzo five-membered fused heterocycle organic compound and application thereof | 烟台显华化工科技有限公司 | 2023-04-07 | — | — | CN | disclosed |
| US-20230075017-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2023-03-09 | — | — | US | disclosed |
| CN-115715293-A | Heterocyclic compound and organic electroluminescent device comprising the same | 出光兴产株式会社 | 2023-02-24 | — | — | CN | disclosed |
| US-20230053347-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-02-23 | — | — | US | disclosed |
| US-20230053347-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-02-23 | — | — | US | disclosed |
| EP-4137486-A1 | NOVEL ANTHRACENE COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | SFC Co., Ltd. (KR) | 2023-02-22 | — | — | EP | disclosed |
| EP-3750971-B1 | ORGANIC ELECTROLUMINESCENT DEVICE | SFC CO LTD (KR) | 2023-02-22 | — | — | EP | disclosed |
| EP-4137486-A1 | NOVEL ANTHRACENE COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | SFC Co., Ltd. (KR) | 2023-02-22 | — | — | EP | disclosed |
| WO-2023018864-A1 | HALLUCINOGENIC AND NON-HALLUCINOGENIC SEROTONIN RECEPTOR AGONISTS AND METHODS OF MAKING AND USING THE SAME | PSILOSTERICS, LLC (US) | 2023-02-16 | — | — | WO | disclosed |
| EP-4123738-A1 | HIGHLY EFFICIENT AND LONG-LASTING ORGANIC LIGHT-EMITTING DIODE | SFC Co., Ltd. (KR) | 2023-01-25 | — | — | EP | disclosed |
| EP-4123738-A1 | HIGHLY EFFICIENT AND LONG-LASTING ORGANIC LIGHT-EMITTING DIODE | SFC Co., Ltd. (KR) | 2023-01-25 | — | — | EP | disclosed |
| US-20230019844-A1 | LIGHT EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-01-19 | — | — | US | disclosed |
| CN-109206417-B | Opioid receptor agonists and uses thereof | 四川海思科制药有限公司 | 2023-01-03 | — | — | CN | disclosed |
| EP-4108667-A1 | POLYCYCLIC AROMATIC DERIVATIVE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | SFC Co., Ltd. (KR) | 2022-12-28 | — | — | EP | disclosed |
| WO-2022262310-A1 | METHOD FOR SYNTHESIZING BTBF AROMATIC AMINE DERIVATIVES | 广东阿格蕾雅光电材料有限公司 | 2022-12-22 | — | — | WO | disclosed |
| WO-2022262310-A1 | METHOD FOR SYNTHESIZING BTBF AROMATIC AMINE DERIVATIVES | 广东阿格蕾雅光电材料有限公司 | 2022-12-22 | — | — | WO | disclosed |
| EP-4103281-A1 | PIKFYVE KINASE INHIBITORS | Acurastem Inc. (US) | 2022-12-21 | — | — | EP | disclosed |
| CN-115498122-A | Light emitting device | 三星显示有限公司 | 2022-12-20 | — | — | CN | disclosed |
| CN-115490703-A | Synthetic method of BTBF | 广东阿格蕾雅光电材料有限公司 | 2022-12-20 | — | — | CN | disclosed |
| CN-115490702-A | Synthetic method of BTBF arylamine derivative | 广东阿格蕾雅光电材料有限公司 | 2022-12-20 | — | — | CN | disclosed |
| US-20220396581-A1 | COMPOUNDS FOR THE TREATMENT OF PARAMYXOVIRUS VIRAL INFECTIONS | Janssen Biopharma, Inc. (US) | 2022-12-15 | — | — | US | disclosed |
| CN-115449056-A | Polymer, solid-state battery, and electric device | 欣旺达电子股份有限公司 | 2022-12-09 | — | — | CN | disclosed |
| CN-115443270-A | Novel anthracene compound and organic light-emitting element including same | SFC株式会社 | 2022-12-06 | — | — | CN | disclosed |
| US-11482685-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2022-10-25 | — | — | US | disclosed |
| CN-115210893-A | Organic light emitting element with high efficiency and long lifetime | SFC株式会社 | 2022-10-18 | — | — | CN | disclosed |
| CN-113348172-B | Compound and organic light emitting device including the same | 株式会社LG化学 | 2022-10-11 | — | — | CN | disclosed |
| US-20220315562-A1 | ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS | ACHILLION PHARMACEUTICALS, INC. | 2022-10-06 | — | — | US | disclosed |
| WO-2022205592-A1 | BENZOTHIOPHENE BENZO FIVE-MEMBERED HETEROCYCLE MATERIAL, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | 北京大学深圳研究生院 | 2022-10-06 | — | — | WO | disclosed |
| CN-115141209-A | Compound with fused heterocyclic biaryl amine or carbazole parent structure | 烟台显华科技集团股份有限公司 | 2022-10-04 | — | — | CN | disclosed |
| CN-115135660-A | Polycyclic aromatic derivative compound and organic light-emitting device using same | SFC株式会社 | 2022-09-30 | — | — | CN | disclosed |
| CN-115124520-A | Opioid receptor agonists and uses thereof | 四川海思科制药有限公司 | 2022-09-30 | — | — | CN | disclosed |
| CN-115109070-A | Compound containing indolo-heterocyclic structure and application thereof | 烟台显华科技集团股份有限公司 | 2022-09-27 | — | — | CN | disclosed |
| CN-115073426-A | Pyrimidine heterocyclic compound and preparation method and application thereof | 上海科州药物研发有限公司 | 2022-09-20 | — | — | CN | disclosed |
| US-20220289753-A1 | SHP2 INHIBITORS | IRBM S.P.A. (IT) | 2022-09-15 | — | — | US | disclosed |
| EP-4053124-A1 | FIVE-MEMBERED HETEROCYCLIC OXOCARBOXYLIC ACID COMPOUND AND MEDICAL USE THEREOF | Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) | 2022-09-07 | — | — | EP | disclosed |
| CN-114989200-A | Boron-containing nitrogen compounds and their use in organic electronic devices | 广州追光科技有限公司 | 2022-09-02 | — | — | CN | disclosed |
| CN-106883205-B | Novel compound and organic light-emitting device comprising same | 东进世美肯株式会社 | 2022-08-30 | — | — | CN | disclosed |
| CN-114874247-A | Boron-nitrogen compound and organic electronic device comprising same | 广州追光科技有限公司 | 2022-08-09 | — | — | CN | disclosed |
| US-11407738-B2 | Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders | ACHILLION PHARMACEUTICALS, INC. (US) | 2022-08-09 | — | — | US | disclosed |
| US-11404647-B2 | Organic compound for organic light emitting diode and organic light emitting diode including same | SFC CO., LTD. (KR) | 2022-08-02 | — | — | US | disclosed |
| CN-110621681-B | Novel transition metal compound and method for producing same | LG化学株式会社 | 2022-07-29 | — | — | CN | disclosed |
| CN-110734451-B | Semiconductor material, preparation method thereof and organic light-emitting diode | 北京大学深圳研究生院 | 2022-07-22 | — | — | CN | disclosed |
| US-20220227773-A1 | FUSED RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2022-07-21 | — | — | US | disclosed |
| CN-112010859-B | Fused ring compound, preparation method and application thereof | 中国科学院上海药物研究所 | 2022-07-19 | — | — | CN | disclosed |
| CN-110467597-B | Aralkyl cyclamine derivatives and application thereof in multi-target anti-depression drugs | 上海医药工业研究院 | 2022-07-12 | — | — | CN | disclosed |
| US-20220216431-A1 | COMPOUND FOR ORGANIC LIGHT-EMITTING DIODE AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME | SFC CO., LTD. (KR) | 2022-07-07 | — | — | US | disclosed |
| WO-2022145938-A1 | ORGANIC LIGHT-EMITTING DEVICE COMPRISING NOVEL ORGANIC COMPOUND IN EMISSION LAYER | 에스에프씨 주식회사 | 2022-07-07 | — | — | WO | disclosed |
| US-20220190249-A1 | LIGHT EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-06-16 | — | — | US | disclosed |
| CN-114605314-A | Indene derivative and application thereof | 上海八亿时空先进材料有限公司 | 2022-06-10 | — | — | CN | disclosed |
| CN-114605411-A | Acridine derivative and application thereof | 上海八亿时空先进材料有限公司 | 2022-06-10 | — | — | CN | disclosed |
| CN-114616228-A | Compound, polymerizable composition, polymer, hologram recording medium, optical material, and optical member | 三菱化学株式会社 | 2022-06-10 | — | — | CN | disclosed |
| EP-3757110-B1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEMICAL LTD (KR) | 2022-06-08 | — | — | EP | disclosed |
| CN-114573551-A | Preparation method of benzo-cyclopentenothiophene compound | 浙大宁波理工学院 | 2022-06-03 | — | — | CN | disclosed |
| WO-2022114448-A1 | ORGANIC LIGHT-EMITTING DEVICE COMPRISING NOVEL ORGANIC COMPOUND IN EMISSION LAYER | 에스에프씨 주식회사 | 2022-06-02 | — | — | WO | disclosed |
| CN-112331922-B | Electrolyte and lithium ion battery comprising same | 湖北亿纬动力有限公司 | 2022-05-17 | — | — | CN | disclosed |
| US-20220123219-A1 | COMPOUND FOR ORGANIC LIGHT EMITTING ELEMENT, AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME AND HAVING LONG LIFESPAN | SFC CO., LTD. (KR) | 2022-04-21 | — | — | US | disclosed |
| EP-3981855-A1 | COMPOUND FOR ORGANIC LIGHT-EMITTING ELEMENT AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | SFC Co., Ltd. (KR) | 2022-04-13 | — | — | EP | disclosed |
| EP-3978497-A1 | FUSED RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) | 2022-04-06 | — | — | EP | disclosed |
| CN-112574242-B | Preparation method of benzo-heterocycle-3-boric acid | 沧州普瑞东方科技有限公司 | 2022-03-25 | — | — | CN | disclosed |
| CN-114213467-A | Phosphorescent light-emitting material based on iridium complex and organic electroluminescent device | 北京大学深圳研究生院 | 2022-03-22 | — | — | CN | disclosed |
| US-20220085298-A1 | COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE | LT MATERIALS CO., LTD. (KR) | 2022-03-17 | — | — | US | disclosed |
| CN-114031631-A | Organic compound, composition, electroluminescent diode and display device | 广东聚华印刷显示技术有限公司 | 2022-02-11 | — | — | CN | disclosed |
| US-11236113-B2 | Hydrocarbon-soluble halogen and thiolate/magnesium exchange reagents | ALBEMARLE GERMANY GMBH (DE) | 2022-02-01 | — | — | US | disclosed |
| US-11225495-B2 | Transition metal compound and method for preparing the same | LG CHEM, LTD. | 2022-01-18 | — | — | US | disclosed |
| CN-109952300-B | 5-or 8-substituted imidazo [1,5-a ] pyridines | 百济神州有限公司 | 2022-01-18 | — | — | CN | disclosed |
| US-20220006013-A1 | ORGANOELECTROLUMINESCENT DEVICE USING POLYCYCLIC AROMATIC COMPOUNDS | SFC CO., LTD. (KR) | 2022-01-06 | — | — | US | disclosed |
| CN-113861043-A | Compound and application thereof | 北京鼎材科技有限公司 | 2021-12-31 | — | — | CN | disclosed |
| WO-2021255698-A1 | HETEROCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE HETEROCYCLIC COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2021-12-23 | — | — | WO | disclosed |
| EP-3919500-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2021-12-08 | — | — | EP | disclosed |
| EP-3919500-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2021-12-08 | — | — | EP | disclosed |
| CN-113748106-A | Compound for organic light-emitting element and organic light-emitting element comprising same | SFC株式会社 | 2021-12-03 | — | — | CN | disclosed |
| EP-3915979-A1 | COMPOUND FOR ORGANIC LIGHT EMITTING ELEMENT, AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME AND HAVING LONG LIFESPAN | SFC Co., Ltd. (KR) | 2021-12-01 | — | — | EP | disclosed |
| EP-3907228-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG Chem, Ltd. (KR) | 2021-11-10 | — | — | EP | disclosed |
| US-11161824-B2 | Heterocyclic lipoxin analogs and uses thereof | UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN (IE) | 2021-11-02 | — | — | US | disclosed |
| EP-3889236-A1 | ORGANIC LIGHT-EMITTING ELEMENT USING POLYCYCLIC AROMATIC DERIVATIVE COMPOUND | SFC Co., Ltd. (KR) | 2021-10-06 | — | — | EP | disclosed |
| CN-113348172-A | Compound and organic light emitting device including the same | 株式会社LG化学 | 2021-09-03 | — | — | CN | disclosed |
| CN-113330016-A | Compound, organic photoelectric device, and display device | LT素材株式会社 | 2021-08-31 | — | — | CN | disclosed |
| CN-109317202-B | Polycarbazole loaded nano-palladium material and preparation method and application thereof | 苏州大学 | 2021-08-27 | — | — | CN | disclosed |
| WO-2021163727-A1 | PIKFYVE KINASE INHIBITORS | AcuraStem Incorporated (US) | 2021-08-19 | — | — | WO | disclosed |
| WO-2021163727-A1 | PIKFYVE KINASE INHIBITORS | AcuraStem Incorporated (US) | 2021-08-19 | — | — | WO | disclosed |
| CN-113227066-A | Compound for organic light-emitting element and long-life organic light-emitting element comprising same | SFC株式会社 | 2021-08-06 | — | — | CN | disclosed |
| WO-2021150080-A1 | POLYCYCLIC AROMATIC DERIVATIVE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | 에스에프씨 주식회사 | 2021-07-29 | — | — | WO | disclosed |
| CN-113121560-A | Benzothienobenzo five-membered heterocyclic material and preparation method and application thereof | 北京大学深圳研究生院 | 2021-07-16 | — | — | CN | disclosed |
| WO-2021123237-A1 | 2-AMINO-N-(AMINO-OXO-ARYL-LAMBDA6-SULFANYLIDENE)ACETAMIDE COMPOUNDS AND THEIR THERAPEUTIC USE | Oxford Drug Design Limited (GB) | 2021-06-24 | — | — | WO | disclosed |
| WO-2021125622-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND DISPLAY DEVICE | 에스케이머티리얼즈 주식회사 | 2021-06-24 | — | — | WO | disclosed |
| US-20210184121-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2021-06-17 | — | — | US | disclosed |
| EP-3500559-B1 | HETEROCYCLIC LIPOXIN ANALOGS AND USES THEROF | UNIV COLLEGE DUBLIN NAT UNIV IRELAND DUBLIN (IE) | 2021-06-16 | — | — | EP | disclosed |
| EP-3500559-B1 | HETEROCYCLIC LIPOXIN ANALOGS AND USES THEROF | UNIV COLLEGE DUBLIN NAT UNIV IRELAND DUBLIN (IE) | 2021-06-16 | — | — | EP | disclosed |
| US-20210167293-A1 | POLYCYCLIC AROMATIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME | SFC CO., LTD. (KR) | 2021-06-03 | — | — | US | disclosed |
| WO-2021107680-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | 주식회사 엘지화학 | 2021-06-03 | — | — | WO | disclosed |
| WO-2021107681-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2021-06-03 | — | — | WO | disclosed |
| CN-108373476-B | Kinase inhibitor and preparation and application thereof | 成都地奥制药集团有限公司 | 2021-06-01 | — | — | CN | disclosed |
| US-11014935-B2 | Compounds for the treatment of paramyxovirus viral infections | Janssen Biopharma, Inc. (US) | 2021-05-25 | — | — | US | disclosed |
| EP-3611177-B1 | NOVEL TRANSITION METAL COMPOUND AND METHOD FOR PREPARING SAME | LG CHEMICAL LTD (KR) | 2021-05-19 | — | — | EP | disclosed |
| EP-3611177-B1 | NOVEL TRANSITION METAL COMPOUND AND METHOD FOR PREPARING SAME | LG CHEMICAL LTD (KR) | 2021-05-19 | — | — | EP | disclosed |
| WO-2021083060-A1 | FIVE-MEMBERED HETEROCYCLIC OXOCARBOXYLIC ACID COMPOUND AND MEDICAL USE THEREOF | 中国科学院上海药物研究所 | 2021-05-06 | — | — | WO | disclosed |
| EP-3660024-B1 | POLYCYCLIC AROMATIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME | SFC CO LTD (KR) | 2021-05-05 | — | — | EP | disclosed |
| WO-2021060277-A1 | AMINATING AGENT AND METHOD FOR PRODUCING AMINATED PRODUCT | ＡＧＣ株式会社 | 2021-04-01 | — | — | WO | disclosed |
| CN-112574242-A | Preparation method of benzo-heterocycle-3-boric acid | 沧州普瑞东方科技有限公司 | 2021-03-30 | — | — | CN | disclosed |
| EP-3792989-A1 | ORGANIC LIGHT EMITTING DIODE INCLUDING BORON COMPOUNDS | SFC Co., Ltd. (KR) | 2021-03-17 | — | — | EP | disclosed |
| US-20210074931-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2021-03-11 | — | — | US | disclosed |
| US-20210074931-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2021-03-11 | — | — | US | disclosed |
| US-20210053927-A1 | Heterocyclic Lipoxin Analogs and Uses Thereof | UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN (IE) | 2021-02-25 | — | — | US | disclosed |
| US-20210047285-A1 | Method for Aerobic Oxidative Coupling of Thiophenes with a Ligand-Supported Palladium Catalyst | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2021-02-18 | — | — | US | disclosed |
| CN-112331922-A | Electrolyte and lithium ion battery comprising same | 湖北亿纬动力有限公司 | 2021-02-05 | — | — | CN | disclosed |
| US-20210032274-A1 | Novel Transition Metal Compound and Method for Preparing the Same | LG CHEM, LTD. (KR) | 2021-02-04 | — | — | US | disclosed |
| CN-112250708-A | Anthracene dimer-containing framework ligand, preparation method thereof and application thereof in metal catalytic reaction | 中国科学院理化技术研究所 | 2021-01-22 | — | — | CN | disclosed |
| US-20210017218-A1 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | SAGE THERAPEUTICS INC (US) | 2021-01-21 | — | — | US | disclosed |
| US-10892426-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2021-01-12 | — | — | US | disclosed |
| US-10882856-B2 | 5 or 8-substituted imidazo [1,5-a] pyridines as selective inhibitors of indoleamine and/or tryptophane 2,3-dioxygenases | BEIGENE, LTD. (KY) | 2021-01-05 | — | — | US | disclosed |
| EP-3757110-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2020-12-30 | — | — | EP | disclosed |
| US-20200403165-A1 | ORGANIC COMPOUND FOR ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DIODE INCLUDING SAME | SFC CO., LTD. (KR) | 2020-12-24 | — | — | US | disclosed |
| EP-3754737-A1 | ORGANIC COMPOUND FOR ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DIODE INCLUDING SAME | SFC Co., Ltd. (KR) | 2020-12-23 | — | — | EP | disclosed |
| EP-3754737-A1 | ORGANIC COMPOUND FOR ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DIODE INCLUDING SAME | SFC Co., Ltd. (KR) | 2020-12-23 | — | — | EP | disclosed |
| CN-112110884-A | Organic light-emitting compound and organic light-emitting element including same | SFC株式会社 | 2020-12-22 | — | — | CN | disclosed |
| WO-2020251183-A1 | COMPOUND FOR ORGANIC LIGHT-EMITTING ELEMENT AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | 에스에프씨 주식회사 | 2020-12-17 | — | — | WO | disclosed |
| US-20200395553-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | SFC CO., LTD. (KR) | 2020-12-17 | — | — | US | disclosed |
| EP-3750971-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | SFC Co., Ltd. (KR) | 2020-12-16 | — | — | EP | disclosed |
| US-10858334-B2 | Method for aerobic oxidative coupling of thiophenes with a ligand-supported palladium catalyst | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2020-12-08 | — | — | US | disclosed |
| WO-2020239073-A1 | FUSED RING COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | 中国科学院上海药物研究所 | 2020-12-03 | — | — | WO | disclosed |
| CN-112010859-A | Fused ring compound, preparation method and application thereof | 中国科学院上海药物研究所 | 2020-12-01 | — | — | CN | disclosed |
| WO-2020218079-A1 | CYCLOALKANE-CONDENSED POLYCYCLIC AROMATIC COMPOUND | 学校法人関西学院 | 2020-10-29 | — | — | WO | disclosed |
| EP-3719029-A1 | COMPOSITIONS FOR INDUCING SEDATION | Sage Therapeutics, Inc. (US) | 2020-10-07 | — | — | EP | disclosed |
| US-10774108-B2 | Compositions and methods for treating CNS disorders | SAGE THERAPEUTICS, INC. (US) | 2020-09-15 | — | — | US | disclosed |
| US-20200262818-A1 | ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS | ACHILLION PHARMACEUTICALS, INC. (US) | 2020-08-20 | — | — | US | disclosed |
| US-10749118-B2 | Heterocyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-08-18 | — | — | US | disclosed |
| US-10749117-B2 | Materials for electronic devices | MERCK PATENT GMBH (DE) | 2020-08-18 | — | — | US | disclosed |
| US-10749117-B2 | Materials for electronic devices | MERCK PATENT GMBH (DE) | 2020-08-18 | — | — | US | disclosed |
| WO-2020153758-A1 | COMPOSITION, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE | 엘티소재주식회사 | 2020-07-30 | — | — | WO | disclosed |
| US-20200239496-A1 | Hydrocarbon-Soluble Halogen and Thiolate/Magnesium Exchange Reagents | Ludwig-Maximilians-Universitat München (DE) | 2020-07-30 | — | — | US | disclosed |
| WO-2020153758-A1 | COMPOSITION, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE | 엘티소재주식회사 | 2020-07-30 | — | — | WO | disclosed |
| CN-111378295-A | Xanthene dye, coloring composition containing the dye, coloring agent for color filter, and color filter | 保土谷化学工业株式会社 | 2020-07-07 | — | — | CN | disclosed |
| CN-111303149-A | Benzo five-membered fused heterocycle organic compound and application thereof | 烟台显华化工科技有限公司 | 2020-06-19 | — | — | CN | disclosed |
| EP-3660024-A1 | POLYCYCLIC AROMATIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME | SFC Co., Ltd. (KR) | 2020-06-03 | — | — | EP | disclosed |
| US-10662175-B2 | Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders | ACHILLION PHARMACEUTICALS, INC. (US) | 2020-05-26 | — | — | US | disclosed |
| US-20200152890-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2020-05-14 | — | — | US | disclosed |
| CN-111138452-A | 1, 8-dialkyl-1, 4,5, 8-naphthalimide compound and preparation method thereof | 杭州师范大学 | 2020-05-12 | — | — | CN | disclosed |
| CN-111138452-A | 1, 8-dialkyl-1, 4,5, 8-naphthalimide compound and preparation method thereof | 杭州师范大学 | 2020-05-12 | — | — | CN | disclosed |
| US-10651397-B2 | Organic light emitting compound and organic light emitting device comprising the same | SFC CO., LTD. (KR) | 2020-05-12 | — | — | US | disclosed |
| US-10644244-B2 | Heterocyclic compound and organic light emitting device using same | LT MATERIALS CO., LTD. (KR) | 2020-05-05 | — | — | US | disclosed |
| US-10593896-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-03-17 | — | — | US | disclosed |
| US-10593896-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-03-17 | — | — | US | disclosed |
| EP-3224269-B1 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | SAGE THERAPEUTICS INC (US) | 2020-02-26 | — | — | EP | disclosed |
| EP-3224269-B1 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | SAGE THERAPEUTICS INC (US) | 2020-02-26 | — | — | EP | disclosed |
| EP-3611177-A1 | NOVEL TRANSITION METAL COMPOUND AND METHOD FOR PREPARING SAME | LG Chem, Ltd. (KR) | 2020-02-19 | — | — | EP | disclosed |
| EP-3611177-A1 | NOVEL TRANSITION METAL COMPOUND AND METHOD FOR PREPARING SAME | LG Chem, Ltd. (KR) | 2020-02-19 | — | — | EP | disclosed |
| CN-110734451-A | semiconductor materials, preparation method thereof and organic light emitting diode | 北京大学深圳研究生院 | 2020-01-31 | — | — | CN | disclosed |
| CN-110734452-A | semiconductor materials, and preparation method and application thereof | 北京大学深圳研究生院 | 2020-01-31 | — | — | CN | disclosed |
| CN-110734453-A | amine derivatives, preparation method thereof and organic light emitting diode | 北京大学深圳研究生院 | 2020-01-31 | — | — | CN | disclosed |
| CN-110621681-A | Novel transition metal compound and method for producing same | LG化学株式会社 | 2019-12-27 | — | — | CN | disclosed |
| CN-110467597-A | Aralkyl cyclammonium analog derivative and its application in multiple target point anti-depression drug | SHANGHAI INST PHARMACEUTICAL IND | 2019-11-19 | — | — | CN | disclosed |
| US-10463391-B2 | Magnetic ferrocenyl-functionalized nanoparticle | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2019-11-05 | — | — | US | disclosed |
| EP-3154990-B1 | ROBUST PHOTOCHROMIC COMPOUNDS WITH SILICON- OR PHOSPHORUS-CONTAINING HETEROCYCLIC RING | UNIV HONG KONG (CN) | 2019-09-11 | — | — | EP | disclosed |
| WO-2019164331-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2019-08-29 | — | — | WO | disclosed |
| CN-108373461-B | A kind of method that light/nickel concerted catalysis prepares fluoro biaryl | 陕西师范大学 | 2019-08-20 | — | — | CN | disclosed |
| US-10370397-B2 | Phosphine substituted ferrocenyl complex | Kind Fahd University of Petroleum and Minerals (SA) | 2019-08-06 | — | — | US | disclosed |
| US-10367143-B2 | Organic semiconducting compounds | MERCK PATENT GMBH (DE) | 2019-07-30 | — | — | US | disclosed |
| WO-2019141229-A1 | COMPOUND AS PPAR AGONIST AND APPLICATION THEREOF | 上海怡立舍生物技术有限公司 | 2019-07-25 | — | — | WO | disclosed |
| WO-2019141229-A1 | COMPOUND AS PPAR AGONIST AND APPLICATION THEREOF | 上海怡立舍生物技术有限公司 | 2019-07-25 | — | — | WO | disclosed |
| US-20190210993-A1 | Method for Aerobic Oxidative Coupling of Thiophenes with a Ligand-Supported Palladium Catalyst | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2019-07-11 | — | — | US | disclosed |
| EP-3500559-A1 | HETEROCYCLIC LIPOXON ANALOGS AND USES THEROF | University College Dublin (IE) | 2019-06-26 | — | — | EP | disclosed |
| US-20190161451-A1 | HERBICIDAL PYRIMIDINE COMPOUNDS | BASF SE (DE) | 2019-05-30 | — | — | US | disclosed |
| EP-3487301-A1 | HERBICIDAL PYRIMIDINE COMPOUNDS | BASF SE (DE) | 2019-05-29 | — | — | EP | disclosed |
| US-10294212-B2 | Inhibitors of the kynurenine pathway | CURADEV PHARMA, PVT. LTD. (IN) | 2019-05-21 | — | — | US | disclosed |
| US-10294212-B2 | Inhibitors of the kynurenine pathway | CURADEV PHARMA, PVT. LTD. (IN) | 2019-05-21 | — | — | US | disclosed |
| US-20190148651-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2019-05-16 | — | — | US | disclosed |
| US-20190148651-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2019-05-16 | — | — | US | disclosed |
| WO-2019076709-A1 | NEW SUBSTITUTED BENZONAPHTHATHIOPHENE COMPOUNDS FOR ORGANIC ELECTRONICS | BASF SE (DE) | 2019-04-25 | — | — | WO | disclosed |
| WO-2019063418-A1 | HYDROCARBON-SOLUBLE HALOGEN AND THIOLATE/MAGNESIUM EXCHANGE REAGENTS | ALBEMARLE GERMANY GMBH (DE) | 2019-04-04 | — | — | WO | disclosed |
| US-10249824-B2 | Condensed-cyclic compound and organic light-emitting diode comprising the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-04-02 | — | — | US | disclosed |
| CN-109561685-A | The pyrimidine compound of weeding | 巴斯夫欧洲公司 | 2019-04-02 | — | — | CN | disclosed |
| EP-3444247-A1 | PYRIDONE DERIVATIVE COMPRISING HETEROATOMIC RING BUTANE SUBSTITUENT, FOR TREATING FIBROSIS AND INFLAMMATORY DISEASES | Shijiazhuang Sagacity New Drug Development Co., Ltd. (CN) | 2019-02-20 | — | — | EP | disclosed |
| CN-109317202-A | A kind of polycarbazole load nano palladium material and the preparation method and application thereof | 苏州大学 | 2019-02-12 | — | — | CN | disclosed |
| CN-105209449-B | Inhibitors of the kynurenine pathway | 库拉德夫制药私人有限公司 | 2019-02-01 | — | — | CN | disclosed |
| WO-2019022569-A1 | NOVEL TRANSITION METAL COMPOUND AND METHOD FOR PREPARING SAME | 주식회사 엘지화학 | 2019-01-31 | — | — | WO | disclosed |
| US-20190029718-A1 | MAGNETIC FERROCENYL-FUNCTIONALIZED NANOPARTICLE | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2019-01-31 | — | — | US | disclosed |
| US-20190031697-A1 | PHOSPHINE SUBSTITUTED FERROCENYL COMPLEX | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2019-01-31 | — | — | US | disclosed |
| CN-103709153-B | Benzothiophene derivative and its application in field of organic electroluminescence | 昆山维信诺显示技术有限公司 | 2019-01-29 | — | — | CN | disclosed |
| US-10186672-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-01-22 | — | — | US | disclosed |
| US-10186672-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-01-22 | — | — | US | disclosed |
| US-10150109-B2 | Palladium(II)-silica supported catalyst | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2018-12-11 | — | — | US | disclosed |
| US-10150111-B2 | Method for catalytic synthesis of cinnamic acid with catalyst recycle | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2018-12-11 | — | — | US | disclosed |
| US-10150110-B2 | Method for making and using a solid-supported catalyst | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2018-12-11 | — | — | US | disclosed |
| CN-103382178-B | Fused ring compound and Organic Light Emitting Diode comprising it | 三星显示有限公司 | 2018-11-16 | — | — | CN | disclosed |
| US-20180326410-A1 | METHOD FOR CATALYTIC SYNTHESIS OF CINNAMIC ACID WITH CATALYST RECYCLE | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2018-11-15 | — | — | US | disclosed |
| US-20180326409-A1 | METHOD FOR MAKING AND USING A SOLID-SUPPORTED CATALYST | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2018-11-15 | — | — | US | disclosed |
| US-10125159-B2 | Functionalized magnetic nanoparticle, a catalyst, a method for forming C—C bonds | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2018-11-13 | — | — | US | disclosed |
| EP-3399005-A1 | PHOSPHORESCENT MATERIALS | Universal Display Corporation (US) | 2018-11-07 | — | — | EP | disclosed |
| WO-2018033642-A9 | HETEROCYCLIC LIPOXIN ANALOGS AND USES THEREOF | UNIVERSITY COLLEGE DUBLIN (IE) | 2018-10-18 | — | — | WO | disclosed |
| EP-2699571-B1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2018-09-05 | — | — | EP | disclosed |
| EP-3004120-B1 | SPIRO-1,1'-BIINDANE-7,7-BISPHOSPHINE OXIDES AS HIGHLY ACTIVE SUPPORTING LIGANDS FOR PALLADIUM-CATALYZED ASYMMETRIC HECK REACTION | UNIV NANYANG TECH (SG) | 2018-08-29 | — | — | EP | disclosed |
| US-10058856-B2 | Method for palladium-catalyzed cinammic acid formation | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2018-08-28 | — | — | US | disclosed |
| CN-105612238-B | Organic luminescent compounds and organic luminescent device comprising the organic luminescent compounds | SFC有限责任公司 | 2018-08-17 | — | — | CN | disclosed |
| CN-108373461-A | A kind of method that light/nickel concerted catalysis prepares fluoro biaryl | 陕西师范大学 | 2018-08-07 | — | — | CN | disclosed |
| US-20180200706-A1 | PALLADIUM(II)-SILICA SUPPORTED CATALYST | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2018-07-19 | — | — | US | disclosed |
| US-20180200705-A1 | METHOD FOR PALLADIUM-CATALYZED CINAMMIC ACID FORMATION | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2018-07-19 | — | — | US | disclosed |
| EP-3340983-A1 | ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS | Achillion Pharmaceuticals, Inc. (US) | 2018-07-04 | — | — | EP | disclosed |
| US-20180179186-A1 | ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS | ACHILLION PHARMACEUTICALS, INC. (US) | 2018-06-28 | — | — | US | disclosed |
| WO-2018114777-A1 | NITROGEN-CONTAINING BIOPOLYMER-BASED CATALYSTS, THEIR PREPARATION AND USES IN HYDROGENATION PROCESSES, REDUCTIVE DEHALOGENATION AND OXIDATION | F. HOFFMANN-LA ROCHE AG (CH) | 2018-06-28 | — | — | WO | disclosed |
| EP-2970173-B1 | INHIBITORS OF THE KYNURENINE PATHWAY | CURADEV PHARMA PRIVATE LTD (IN) | 2018-05-09 | — | — | EP | disclosed |
| EP-2970173-B1 | INHIBITORS OF THE KYNURENINE PATHWAY | CURADEV PHARMA PRIVATE LTD (IN) | 2018-05-09 | — | — | EP | disclosed |
| US-9957259-B2 | Selective HDAC1 and HDAC2 inhibitors | REGENACY PHARMACEUTICALS, LLC (US) | 2018-05-01 | — | — | US | disclosed |
| US-9956550-B2 | Solid-supported palladium(II) complex for catalyzing Mizoroki-Heck coupling reactions and a method thereof | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2018-05-01 | — | — | US | disclosed |
| US-20180099987-A1 | FUNCTIONALIZED MAGNETIC NANOPARTICLE, A CATALYST, A METHOD FOR FORMING C-C BONDS | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2018-04-12 | — | — | US | disclosed |
| WO-2018054365-A1 | NOVEL 5 or 8-SUBSTITUTED IMIDAZO [1, 5-a] PYRIDINES AS SELECTIVE INHIBITORS OF INDOLEAMINE AND/OR TRYPTOPHANE 2, 3-DIOXYGENASES | BEIGENE, LTD. (KY) | 2018-03-29 | — | — | WO | disclosed |
| WO-2018056619-A1 | ORGANIC LUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME | 주식회사 두산 | 2018-03-29 | — | — | WO | disclosed |
| US-20180065117-A1 | SOLID-SUPPORTED PALLADIUM(II) COMPLEX FOR CATALYZING MIZOROKI-HECK COUPLING REACTIONS AND A METHOD THEREOF | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2018-03-08 | — | — | US | disclosed |
| WO-2018033642-A1 | HETEROCYCLIC LIPXON ANALOGS AND USES THEROF | UNIVERSITY COLLEGE DUBLIN (IE) | 2018-02-22 | — | — | WO | disclosed |
| WO-2018033642-A1 | HETEROCYCLIC LIPXON ANALOGS AND USES THEROF | UNIVERSITY COLLEGE DUBLIN (IE) | 2018-02-22 | — | — | WO | disclosed |
| EP-2618394-B1 | ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL & SUMIKIN CHEM CO (JP) | 2018-02-21 | — | — | EP | disclosed |
| US-9893297-B2 | Materials for electronic devices | MERCK PATENT GMBH (DE) | 2018-02-13 | — | — | US | disclosed |
| US-9893297-B2 | Materials for electronic devices | MERCK PATENT GMBH (DE) | 2018-02-13 | — | — | US | disclosed |
| US-9893297-B2 | Materials for electronic devices | MERCK PATENT GMBH (DE) | 2018-02-13 | — | — | US | disclosed |
| WO-2018019554-A1 | HERBICIDAL PYRIMIDINE COMPOUNDS | BASF SE (DE) | 2018-02-01 | — | — | WO | disclosed |
| US-20180030026-A1 | INHIBITORS OF THE KYNURENINE PATHWAY | CURADEV PHARMA PVT LTD | 2018-02-01 | — | — | US | disclosed |
| US-20180030026-A1 | INHIBITORS OF THE KYNURENINE PATHWAY | CURADEV PHARMA PVT LTD | 2018-02-01 | — | — | US | disclosed |
| US-20180030026-A1 | INHIBITORS OF THE KYNURENINE PATHWAY | CURADEV PHARMA PVT LTD | 2018-02-01 | — | — | US | disclosed |
| US-20180030040-A1 | SELECTIVE HDAC1 AND HDAC2 INHIBITORS | ACETYLON PHARMACEUTICALS, INC. | 2018-02-01 | — | — | US | disclosed |
| CN-105669730-B | A kind of purification process of organic boron acid compounds | 沧州普瑞东方科技有限公司 | 2018-01-16 | — | — | CN | disclosed |
| EP-2629345-B1 | ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL & SUMIKIN CHEM CO (JP) | 2017-12-06 | — | — | EP | disclosed |
| US-20170342102-A1 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | SAGE THERAPEUTICS, INC. (US) | 2017-11-30 | — | — | US | disclosed |
| US-20170342102-A1 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | SAGE THERAPEUTICS, INC. (US) | 2017-11-30 | — | — | US | disclosed |
| US-20170342102-A1 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | SAGE THERAPEUTICS, INC. (US) | 2017-11-30 | — | — | US | disclosed |
| US-9815811-B2 | Inhibitors of the kynurenine pathway | CURADEV PHARMA, PVT. LTD. (IN) | 2017-11-14 | — | — | US | disclosed |
| US-9815811-B2 | Inhibitors of the kynurenine pathway | CURADEV PHARMA, PVT. LTD. (IN) | 2017-11-14 | — | — | US | disclosed |
| US-9815811-B2 | Inhibitors of the kynurenine pathway | CURADEV PHARMA, PVT. LTD. (IN) | 2017-11-14 | — | — | US | disclosed |
| US-20170283429-A1 | COMPOUNDS FOR THE TREATMENT OF PARAMYXOVIRUS VIRAL INFECTIONS | Janssen Biopharma, Inc. | 2017-10-05 | — | — | US | disclosed |
| US-20170283429-A1 | COMPOUNDS FOR THE TREATMENT OF PARAMYXOVIRUS VIRAL INFECTIONS | Janssen Biopharma, Inc. | 2017-10-05 | — | — | US | disclosed |
| US-20170283429-A1 | COMPOUNDS FOR THE TREATMENT OF PARAMYXOVIRUS VIRAL INFECTIONS | Janssen Biopharma, Inc. | 2017-10-05 | — | — | US | disclosed |
| US-9765066-B2 | Selective HDAC1 and HDAC2 inhibitors | REGENACY PHARMACEUTICALS, LLC (US) | 2017-09-19 | — | — | US | disclosed |
| US-9765066-B2 | Selective HDAC1 and HDAC2 inhibitors | REGENACY PHARMACEUTICALS, LLC (US) | 2017-09-19 | — | — | US | disclosed |
| US-9761808-B2 | Heterocyclic compound and organic light-emitting device comprising the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-09-12 | — | — | US | disclosed |
| US-9761808-B2 | Heterocyclic compound and organic light-emitting device comprising the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-09-12 | — | — | US | disclosed |
| US-9724351-B2 | Compounds for the treatment of paramoxyvirus viral infections | ALIOS BIOPHARMA, INC. (US) | 2017-08-08 | — | — | US | disclosed |
| US-9724351-B2 | Compounds for the treatment of paramoxyvirus viral infections | ALIOS BIOPHARMA, INC. (US) | 2017-08-08 | — | — | US | disclosed |
| US-9724351-B2 | Compounds for the treatment of paramoxyvirus viral infections | ALIOS BIOPHARMA, INC. (US) | 2017-08-08 | — | — | US | disclosed |
| US-9722182-B2 | Heterocyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-08-01 | — | — | US | disclosed |
| US-9722182-B2 | Heterocyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-08-01 | — | — | US | disclosed |
| US-9708528-B2 | Robust photochromic compounds with silicon- or phosphorus-containing heterocyclic ring and the production thereof | THE UNIVERSITY OF HONG KONG (HK) | 2017-07-18 | — | — | US | disclosed |
| US-9708528-B2 | Robust photochromic compounds with silicon- or phosphorus-containing heterocyclic ring and the production thereof | THE UNIVERSITY OF HONG KONG (HK) | 2017-07-18 | — | — | US | disclosed |
| US-20170194577-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2017-07-06 | — | — | US | disclosed |
| US-20170194577-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2017-07-06 | — | — | US | disclosed |
| US-20170194577-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2017-07-06 | — | — | US | disclosed |
| EP-2617724-B1 | ORGANIC ELECTROLUMINESCENT DEVICE | NIPPON STEEL & SUMIKIN CHEM CO (JP) | 2017-07-05 | — | — | EP | disclosed |
| EP-2617724-B1 | ORGANIC ELECTROLUMINESCENT DEVICE | NIPPON STEEL & SUMIKIN CHEM CO (JP) | 2017-07-05 | — | — | EP | disclosed |
| US-20170141325-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | HEESUNG MATERIAL LTD. (KR) | 2017-05-18 | — | — | US | disclosed |
| US-20170141325-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | HEESUNG MATERIAL LTD. (KR) | 2017-05-18 | — | — | US | disclosed |
| US-20170141325-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | HEESUNG MATERIAL LTD. (KR) | 2017-05-18 | — | — | US | disclosed |
| EP-3162806-A2 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | Heesung Material Ltd. (KR) | 2017-05-03 | — | — | EP | disclosed |
| US-9630983-B2 | Organic electroluminescent material and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2017-04-25 | — | — | US | disclosed |
| US-9630983-B2 | Organic electroluminescent material and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2017-04-25 | — | — | US | disclosed |
| US-9630983-B2 | Organic electroluminescent material and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2017-04-25 | — | — | US | disclosed |
| US-20170104165-A1 | MATERIALS FOR ELECTRONIC DEVICES | UDC IRELAND LIMITED (IE) | 2017-04-13 | — | — | US | disclosed |
| US-20170104165-A1 | MATERIALS FOR ELECTRONIC DEVICES | UDC IRELAND LIMITED (IE) | 2017-04-13 | — | — | US | disclosed |
| US-20170104165-A1 | MATERIALS FOR ELECTRONIC DEVICES | UDC IRELAND LIMITED (IE) | 2017-04-13 | — | — | US | disclosed |
| US-9620722-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2017-04-11 | — | — | US | disclosed |
| US-9620722-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2017-04-11 | — | — | US | disclosed |
| US-9620722-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2017-04-11 | — | — | US | disclosed |
| US-20170084839-A1 | ORGANIC SEMICONDUCTING COMPOUNDS | MERCK PATENT GMBH (DE) | 2017-03-23 | — | — | US | disclosed |
| US-20170084839-A1 | ORGANIC SEMICONDUCTING COMPOUNDS | MERCK PATENT GMBH (DE) | 2017-03-23 | — | — | US | disclosed |
| US-20170084839-A1 | ORGANIC SEMICONDUCTING COMPOUNDS | MERCK PATENT GMBH (DE) | 2017-03-23 | — | — | US | disclosed |
| WO-2017035409-A1 | ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS | ACHILLION PHARMACEUTICALS, INC. (US) | 2017-03-02 | — | — | WO | disclosed |
| WO-2017035409-A1 | ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS | ACHILLION PHARMACEUTICALS, INC. (US) | 2017-03-02 | — | — | WO | disclosed |
| EP-1390340-B1 | COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS | MASSACHUSETTS INST TECHNOLOGY (US) | 2017-03-01 | — | — | EP | disclosed |
| EP-1390340-B1 | COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS | MASSACHUSETTS INST TECHNOLOGY (US) | 2017-03-01 | — | — | EP | disclosed |
| CN-106432180-A | Compound containing benzo[b]thiophene structure, and derivative, preparation method and application | 华东师范大学 | 2017-02-22 | — | — | CN | disclosed |
| US-20170044144-A1 | SELECTIVE HDAC1 AND HDAC2 INHIBITORS | REGENACY PHARMACEUTICALS, LLC | 2017-02-16 | — | — | US | disclosed |
| US-20170044144-A1 | SELECTIVE HDAC1 AND HDAC2 INHIBITORS | REGENACY PHARMACEUTICALS, LLC | 2017-02-16 | — | — | US | disclosed |
| EP-3119776-A1 | ORGANIC SEMICONDUCTING COMPOUNDS | Merck Patent GmbH (DE) | 2017-01-25 | — | — | EP | disclosed |
| EP-2666768-B1 | Condensed-cyclic compound and organic light-emitting diode comprising the same | SAMSUNG DISPLAY CO LTD (KR) | 2016-12-21 | — | — | EP | disclosed |
| EP-2940018-B1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING THE SAME | SAMSUNG DISPLAY CO LTD (KR) | 2016-11-23 | — | — | EP | disclosed |
| US-9499531-B2 | Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin | ALBANY MOLECULAR RESEARCH, INC. (US) | 2016-11-22 | — | — | US | disclosed |
| US-9447113-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2016-09-20 | — | — | US | disclosed |
| US-9447113-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2016-09-20 | — | — | US | disclosed |
| US-20160248024-A1 | ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | SFC CO., LTD. (KR) | 2016-08-25 | — | — | US | disclosed |
| US-20160248024-A1 | ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | SFC CO., LTD. (KR) | 2016-08-25 | — | — | US | disclosed |
| US-20160248024-A1 | ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | SFC CO., LTD. (KR) | 2016-08-25 | — | — | US | disclosed |
| US-9421212-B2 | Selective HDAC1 and HDAC2 inhibitors | ACETYLON PHARMACEUTICALS, INC. (US) | 2016-08-23 | — | — | US | disclosed |
| US-9421212-B2 | Selective HDAC1 and HDAC2 inhibitors | ACETYLON PHARMACEUTICALS, INC. (US) | 2016-08-23 | — | — | US | disclosed |
| EP-1951684-B1 | BI-ARYL META-PYRIMIDINE INHIBITORS OF KINASES | TARGEGEN INC (US) | 2016-07-13 | — | — | EP | disclosed |
| US-9385327-B2 | Heterocyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-07-05 | — | — | US | disclosed |
| CN-105669730-A | Purification method of organic boric acid compound | 沧州普瑞东方科技有限公司 | 2016-06-15 | — | — | CN | disclosed |
| WO-2016082789-A1 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | SAGE THERAPEUTICS, INC. (US) | 2016-06-02 | — | — | WO | disclosed |
| US-9349966-B2 | — | — | 2016-05-24 | — | — | US | disclosed |
| US-20160136629-A1 | SPIRO-1,1'-BINDANE-7,7-BISPHOSPHINE OXIDES AS HIGHLY ACTIVE SUPPORTING LIGANDS FOR PALADIUM-CATALYZED ASYMMETRIC HECK REACTION | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2016-05-19 | — | — | US | disclosed |
| WO-2016072691-A1 | ORGANIC ELECTRONIC DEVICE AND DISPLAY DEVICE USING COMPOSITION FOR ORGANIC ELECTRONIC DEVICE | 덕산네오룩스 주식회사 | 2016-05-12 | — | — | WO | disclosed |
| US-9318713-B2 | Asymmetric fused polyheteroaromatic compound, organic thin film including the asymmetric fused polyheteroaromatic compound, and electronic device including the organic thin film | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-04-19 | — | — | US | disclosed |
| US-9318713-B2 | Asymmetric fused polyheteroaromatic compound, organic thin film including the asymmetric fused polyheteroaromatic compound, and electronic device including the organic thin film | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-04-19 | — | — | US | disclosed |
| US-9318713-B2 | Asymmetric fused polyheteroaromatic compound, organic thin film including the asymmetric fused polyheteroaromatic compound, and electronic device including the organic thin film | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-04-19 | — | — | US | disclosed |
| EP-3004120-A1 | SPIRO-1,1'-BIINDANE-7,7-BISPHOSPHINE OXIDES AS HIGHLY ACTIVE SUPPORTING LIGANDS FOR PALLADIUM-CATALYZED ASYMMETRIC HECK REACTION | Nanyang Technological University (SG) | 2016-04-13 | — | — | EP | disclosed |
| CN-103108875-B | Nitrogen-containing aromatic compound, organic semiconductor material and organic electronic devices | NIPPON STEEL & SUMIKIN CHEMICAL CO.,LTD. (JP) | 2016-04-13 | — | — | CN | disclosed |
| US-9312496-B2 | Organic electroluminescent element | NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD. (JP) | 2016-04-12 | — | — | US | disclosed |
| US-20160067259-A1 | SELECTIVE HDAC1 AND HDAC2 INHIBITORS | ACETYLON PHARMACEUTICALS, INC. (US) | 2016-03-10 | — | — | US | disclosed |
| US-20160067259-A1 | SELECTIVE HDAC1 AND HDAC2 INHIBITORS | ACETYLON PHARMACEUTICALS, INC. (US) | 2016-03-10 | — | — | US | disclosed |
| EP-2628743-B1 | NITROGENATED AROMATIC COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC ELECTRONIC DEVICE | NIPPON STEEL & SUMIKIN CHEM CO (JP) | 2016-02-24 | — | — | EP | disclosed |
| EP-2628743-B1 | NITROGENATED AROMATIC COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC ELECTRONIC DEVICE | NIPPON STEEL & SUMIKIN CHEM CO (JP) | 2016-02-24 | — | — | EP | disclosed |
| US-20160046596-A1 | INHIBITORS OF THE KYNURENINE PATHWAY | CURADEV PHARMA PRIVATE LTD. (IN) | 2016-02-18 | — | — | US | disclosed |
| US-20160046596-A1 | INHIBITORS OF THE KYNURENINE PATHWAY | CURADEV PHARMA PRIVATE LTD. (IN) | 2016-02-18 | — | — | US | disclosed |
| US-20160046596-A1 | INHIBITORS OF THE KYNURENINE PATHWAY | CURADEV PHARMA PRIVATE LTD. (IN) | 2016-02-18 | — | — | US | disclosed |
| US-9255084-B2 | Heterocyclic compound and organic light-emitting device containing the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-02-09 | — | — | US | disclosed |
| CN-104119311-B | A kind of 2,6-diaryl naphthalene compounds and preparation method thereof | HANGZHOU NORMAL UNIVERSITY (CN) | 2016-02-03 | — | — | CN | disclosed |
| EP-2970173-A1 | INHIBITORS OF THE KYNURENINE PATHWAY | Curadev Pharma Private Ltd. (IN) | 2016-01-20 | — | — | EP | disclosed |
| US-20150380663-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-12-31 | — | — | US | disclosed |
| US-20150380663-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-12-31 | — | — | US | disclosed |
| CN-105209449-A | Inhibitors of the kynurenine pathway | CURADEV PHARMA PRIVATE LTD | 2015-12-30 | — | — | CN | disclosed |
| WO-2015188790-A1 | ROBUST PHOTOCHROMIC COMPOUNDS WITH SILICON- OR PHOSPHORUS-CONTAINING HETEROCYCLIC RING AND PRODUCTION THEREOF | THE UNIVERSITY OF HONG KONG (CN) | 2015-12-17 | — | — | WO | disclosed |
| US-20150361332-A1 | ROBUST PHOTOCHROMIC COMPOUNDS WITH SILICON- OR PHOSPHORUS-CONTAINING HETEROCYCLIC RING AND THE PRODUCTION THEREOF | THE UNIVERSITY OF HONG KONG (HK) | 2015-12-17 | — | — | US | disclosed |
| US-20150361332-A1 | ROBUST PHOTOCHROMIC COMPOUNDS WITH SILICON- OR PHOSPHORUS-CONTAINING HETEROCYCLIC RING AND THE PRODUCTION THEREOF | THE UNIVERSITY OF HONG KONG (HK) | 2015-12-17 | — | — | US | disclosed |
| EP-2940018-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING THE SAME | Samsung Display Co., Ltd. (KR) | 2015-11-04 | — | — | EP | disclosed |
| US-20150307535-A1 | PHOSPHORESCENT MATERIALS | UNIVERSAL DISPLAY CORPORATION (US) | 2015-10-29 | — | — | US | disclosed |
| US-20150307535-A1 | PHOSPHORESCENT MATERIALS | UNIVERSAL DISPLAY CORPORATION (US) | 2015-10-29 | — | — | US | disclosed |
| US-20150307535-A1 | PHOSPHORESCENT MATERIALS | UNIVERSAL DISPLAY CORPORATION (US) | 2015-10-29 | — | — | US | disclosed |
| US-20150274713-A1 | ARYL- AND HETEROARYL-SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN | CURIA GLOBAL, INC. | 2015-10-01 | — | — | US | disclosed |
| US-9145412-B2 | Selective HDAC1 and HDAC2 inhibitors | ACETYLON PHARMACEUTICALS, INC. (US) | 2015-09-29 | — | — | US | disclosed |
| US-9145412-B2 | Selective HDAC1 and HDAC2 inhibitors | ACETYLON PHARMACEUTICALS, INC. (US) | 2015-09-29 | — | — | US | disclosed |
| WO-2015139802-A1 | ORGANIC SEMICONDUCTING COMPOUNDS | MERCK PATENT GMBH (DE) | 2015-09-24 | — | — | WO | disclosed |
| WO-2015139802-A1 | ORGANIC SEMICONDUCTING COMPOUNDS | MERCK PATENT GMBH (DE) | 2015-09-24 | — | — | WO | disclosed |
| EP-2283000-B1 | 3- OR 4-SUBSTITUTED PIPERIDINE COMPOUNDS | SK BIOPHARMACEUTICALS CO LTD (KR) | 2015-09-23 | — | — | EP | disclosed |
| EP-1778639-B1 | ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN | ALBANY MOLECULAR RES INC (US) | 2015-09-02 | — | — | EP | disclosed |
| US-20150238498-A1 | COMPOUNDS FOR THE TREATMENT OF PARAMOXYVIRUS VIRAL INFECTIONS | JANSSEN PHARMACEUTICA NV (BE) | 2015-08-27 | — | — | US | disclosed |
| US-20150238498-A1 | COMPOUNDS FOR THE TREATMENT OF PARAMOXYVIRUS VIRAL INFECTIONS | JANSSEN PHARMACEUTICA NV (BE) | 2015-08-27 | — | — | US | disclosed |
| US-20150238498-A1 | COMPOUNDS FOR THE TREATMENT OF PARAMOXYVIRUS VIRAL INFECTIONS | JANSSEN PHARMACEUTICA NV (BE) | 2015-08-27 | — | — | US | disclosed |
| US-9118021-B2 | Heterocyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-08-25 | — | — | US | disclosed |
| US-9118021-B2 | Heterocyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-08-25 | — | — | US | disclosed |
| US-9118028-B2 | Organic electroluminescent device | NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD. (JP) | 2015-08-25 | — | — | US | disclosed |
| US-9112157-B2 | Hole transport materials including OLED applications | SOLVAY USA, INC. (US) | 2015-08-18 | — | — | US | disclosed |
| US-9112157-B2 | Hole transport materials including OLED applications | SOLVAY USA, INC. (US) | 2015-08-18 | — | — | US | disclosed |
| US-9112157-B2 | Hole transport materials including OLED applications | SOLVAY USA, INC. (US) | 2015-08-18 | — | — | US | disclosed |
| US-9085531-B2 | Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin | ALBANY MOLECULAR RESEARCH, INC. (US) | 2015-07-21 | — | — | US | disclosed |
| US-9076973-B2 | Phosphorescent materials | UNIVERSAL DISPLAY CORPORATION (US) | 2015-07-07 | — | — | US | disclosed |
| US-9076973-B2 | Phosphorescent materials | UNIVERSAL DISPLAY CORPORATION (US) | 2015-07-07 | — | — | US | disclosed |
| US-9076973-B2 | Phosphorescent materials | UNIVERSAL DISPLAY CORPORATION (US) | 2015-07-07 | — | — | US | disclosed |
| US-9067955-B2 | Copper-catalyzed formation of carbon-heteroatom and carbon—carbon bonds | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2015-06-30 | — | — | US | disclosed |
| US-9067955-B2 | Copper-catalyzed formation of carbon-heteroatom and carbon—carbon bonds | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2015-06-30 | — | — | US | disclosed |
| US-20150171345-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2015-06-18 | — | — | US | disclosed |
| US-20150171345-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2015-06-18 | — | — | US | disclosed |
| US-9059412-B2 | Transition metal complexes containing substituted imidazole carbene as ligands and their application in OLEDs | UNIVERSAL DISPLAY CORPORATION (US) | 2015-06-16 | — | — | US | disclosed |
| US-9059412-B2 | Transition metal complexes containing substituted imidazole carbene as ligands and their application in OLEDs | UNIVERSAL DISPLAY CORPORATION (US) | 2015-06-16 | — | — | US | disclosed |
| US-9059412-B2 | Transition metal complexes containing substituted imidazole carbene as ligands and their application in OLEDs | UNIVERSAL DISPLAY CORPORATION (US) | 2015-06-16 | — | — | US | disclosed |
| US-20150133679-A1 | ASYMMETRIC FUSED POLYHETEROAROMATIC COMPOUND, ORGANIC THIN FILM INCLUDING THE ASYMMETRIC FUSED POLYHETEROAROMATIC COMPOUND, AND ELECTRONIC DEVICE INCLUDING THE ORGANIC THIN FILM | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-05-14 | — | — | US | disclosed |
| US-20150133679-A1 | ASYMMETRIC FUSED POLYHETEROAROMATIC COMPOUND, ORGANIC THIN FILM INCLUDING THE ASYMMETRIC FUSED POLYHETEROAROMATIC COMPOUND, AND ELECTRONIC DEVICE INCLUDING THE ORGANIC THIN FILM | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-05-14 | — | — | US | disclosed |
| US-20150133679-A1 | ASYMMETRIC FUSED POLYHETEROAROMATIC COMPOUND, ORGANIC THIN FILM INCLUDING THE ASYMMETRIC FUSED POLYHETEROAROMATIC COMPOUND, AND ELECTRONIC DEVICE INCLUDING THE ORGANIC THIN FILM | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-05-14 | — | — | US | disclosed |
| EP-2850668-A2 | HOLE TRANSPORT MATERIALS INCLUDING OLED APPLICATIONS | Solvay USA Inc. (US) | 2015-03-25 | — | — | EP | disclosed |
| US-8969592-B2 | Heterocyclic host materials | UNIVERSAL DISPLAY CORPORATION (US) | 2015-03-03 | — | — | US | disclosed |
| US-8969592-B2 | Heterocyclic host materials | UNIVERSAL DISPLAY CORPORATION (US) | 2015-03-03 | — | — | US | disclosed |
| US-20150053934-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT- EMITTING DEVICE COMPRISING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-02-26 | — | — | US | disclosed |
| US-20150053934-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT- EMITTING DEVICE COMPRISING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-02-26 | — | — | US | disclosed |
| EP-1731505-B1 | ALKOXYPHENYLPROPANOIC ACID DERIVATIVES | TAKEDA PHARMACEUTICAL (JP) | 2015-01-14 | — | — | EP | disclosed |
| WO-2014196930-A1 | SPIRO-1,1'-BIINDANE-7,7-BISPHOSPHINE OXIDES AS HIGHLY ACTIVE SUPPORTING LIGANDS FOR PALLADIUM-CATALYZED ASYMMETRIC HECK REACTION | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2014-12-11 | — | — | WO | disclosed |
| WO-2014186035-A1 | INHIBITORS OF THE KYNURENINE PATHWAY | CURADEV PHARMA PRIVATE LTD. (IN) | 2014-11-20 | — | — | WO | disclosed |
| WO-2014186035-A1 | INHIBITORS OF THE KYNURENINE PATHWAY | CURADEV PHARMA PRIVATE LTD. (IN) | 2014-11-20 | — | — | WO | disclosed |
| CN-104119356-A | I-shaped benzothiophene compound and preparation method thereof | UNIV HANGZHOU NORMAL | 2014-10-29 | — | — | CN | disclosed |
| EP-2172450-B9 | NOVEL MALONIC ACID SULFONAMIDE DERIVATIVE AND PHARMACEUTICAL USE THEREOF | MITSUBISHI TANABE PHARMA CORP (JP) | 2014-10-08 | — | — | EP | disclosed |
| US-RE45173-E1 | Inhibitors of CYP 17 | NOVARTIS AG (CH) | 2014-09-30 | — | — | US | disclosed |
| US-20140243524-A1 | ARYL- AND HETEROARYL-SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN | ALBANY MOLECULAR RESEARCH, INC. (US) | 2014-08-28 | — | — | US | disclosed |
| US-20140228394-A1 | INHIBITORS OF CYP 17 | NOVARTIS AG (CH) | 2014-08-14 | — | — | US | disclosed |
| US-8766248-B2 | Nitrogen-containing aromatic compound, organic semiconductor material, and organic electronic device | NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD. (JP) | 2014-07-01 | — | — | US | disclosed |
| US-8766248-B2 | Nitrogen-containing aromatic compound, organic semiconductor material, and organic electronic device | NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD. (JP) | 2014-07-01 | — | — | US | disclosed |
| US-8766248-B2 | Nitrogen-containing aromatic compound, organic semiconductor material, and organic electronic device | NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD. (JP) | 2014-07-01 | — | — | US | disclosed |
| US-8766249-B2 | Nitrogenated aromatic compound, organic semiconductor material, and organic electronic device | NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD. (JP) | 2014-07-01 | — | — | US | disclosed |
| US-8766249-B2 | Nitrogenated aromatic compound, organic semiconductor material, and organic electronic device | NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD. (JP) | 2014-07-01 | — | — | US | disclosed |
| US-8766249-B2 | Nitrogenated aromatic compound, organic semiconductor material, and organic electronic device | NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD. (JP) | 2014-07-01 | — | — | US | disclosed |
| US-8741901-B2 | Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin | ALBANY MOLECULAR RESEARCH, INC. (US) | 2014-06-03 | — | — | US | disclosed |
| US-20140128391-A1 | SELECTIVE HDAC1 AND HDAC2 INHIBITORS | REGENACY PHARMACEUTICALS, LLC | 2014-05-08 | — | — | US | disclosed |
| US-20140128391-A1 | SELECTIVE HDAC1 AND HDAC2 INHIBITORS | REGENACY PHARMACEUTICALS, LLC | 2014-05-08 | — | — | US | disclosed |
| US-20140103300-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2014-04-17 | — | — | US | disclosed |
| US-20140103300-A1 | NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2014-04-17 | — | — | US | disclosed |
| EP-2445903-B1 | 1,3-DISUBSTITUTED IMIDAZOLIDIN-2-ONE DERIVATIVES AS INHIBITORS OF CYP 17 | NOVARTIS AG (CH) | 2014-03-26 | — | — | EP | disclosed |
| WO-2014031784-A1 | COMPOUNDS FOR THE TREATMENT OF PARAMOXYVIRUS VIRAL INFECTIONS | ALIOS BIOPHARMA, INC. (US) | 2014-02-27 | — | — | WO | disclosed |
| EP-2699571-A2 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | Merck Patent GmbH (DE) | 2014-02-26 | — | — | EP | disclosed |
| US-20140042370-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2014-02-13 | — | — | US | disclosed |
| US-20140042370-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2014-02-13 | — | — | US | disclosed |
| US-20140042370-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2014-02-13 | — | — | US | disclosed |
| US-20140034915-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO. LTD. (KR) | 2014-02-06 | — | — | US | disclosed |
| US-20140027733-A1 | TRANSITION METAL COMPLEXES CONTAINING SUBSTITUTED IMIDAZOLE CARBENE AS LIGANDS AND THEIR APPLICATION IN OLEDS | UNIVERSAL DISPLAY CORPORATION (US) | 2014-01-30 | — | — | US | disclosed |
| US-20140027733-A1 | TRANSITION METAL COMPLEXES CONTAINING SUBSTITUTED IMIDAZOLE CARBENE AS LIGANDS AND THEIR APPLICATION IN OLEDS | UNIVERSAL DISPLAY CORPORATION (US) | 2014-01-30 | — | — | US | disclosed |
| US-20140027733-A1 | TRANSITION METAL COMPLEXES CONTAINING SUBSTITUTED IMIDAZOLE CARBENE AS LIGANDS AND THEIR APPLICATION IN OLEDS | UNIVERSAL DISPLAY CORPORATION (US) | 2014-01-30 | — | — | US | disclosed |
| US-20140021449-A1 | PHOSPHORESCENT MATERIALS | UNIVERSAL DISPLAY CORPORATION (US) | 2014-01-23 | — | — | US | disclosed |
| US-20140021449-A1 | PHOSPHORESCENT MATERIALS | UNIVERSAL DISPLAY CORPORATION (US) | 2014-01-23 | — | — | US | disclosed |
| US-20140021449-A1 | PHOSPHORESCENT MATERIALS | UNIVERSAL DISPLAY CORPORATION (US) | 2014-01-23 | — | — | US | disclosed |
| US-8604042-B2 | Bi-aryl meta-pyrimidine inhibitors of kinases | TARGEGEN, INC. (US) | 2013-12-10 | — | — | US | disclosed |
| US-20130324716-A1 | HOLE TRANSPORT MATERIALS INCLUDING OLED APPLICATIONS | PLEXTRONICS, INC. (US) | 2013-12-05 | — | — | US | disclosed |
| EP-2666768-A2 | Condensed-cyclic compound and organic light-emitting diode comprising the same | Samsung Display Co., Ltd. (KR) | 2013-11-27 | — | — | EP | disclosed |
| WO-2013173396-A2 | HOLE TRANSPORT MATERIALS INCLUDING OLED APPLICATIONS | PLEXTRONICS, INC. (US) | 2013-11-21 | — | — | WO | disclosed |
| US-20130292653-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING THE SAME | SAMSUNG DISPLAY CO. LTD. (KR) | 2013-11-07 | — | — | US | disclosed |
| US-8575183-B2 | Heterocyclic compounds and their uses | AMGEN INC. (US) | 2013-11-05 | — | — | US | disclosed |
| US-8575183-B2 | Heterocyclic compounds and their uses | AMGEN INC. (US) | 2013-11-05 | — | — | US | disclosed |
| US-8575183-B2 | Heterocyclic compounds and their uses | AMGEN INC. (US) | 2013-11-05 | — | — | US | disclosed |
| EP-2172450-B1 | NOVEL MALONIC ACID SULFONAMIDE DERIVATIVE AND PHARMACEUTICAL USE THEREOF | MITSUBISHI TANABE PHARMA CORP (JP) | 2013-10-16 | — | — | EP | disclosed |
| US-8546576-B2 | 3 or 4-substituted piperidine compounds | SK BIOPHARMACEUTICALS CO., LTD. (KR) | 2013-10-01 | — | — | US | disclosed |
| WO-2013135552-A2 | PHOSPHINITES AND AMIDOPHOSPHINITES AS LIGANDS IN CATALYTIC REACTIONS | EVONIK INDUSTRIES AG (DE) | 2013-09-19 | — | — | WO | disclosed |
| US-8519384-B2 | Phosphorescent materials | UNIVERSAL DISPLAY CORPORATION (US) | 2013-08-27 | — | — | US | disclosed |
| US-8519384-B2 | Phosphorescent materials | UNIVERSAL DISPLAY CORPORATION (US) | 2013-08-27 | — | — | US | disclosed |
| US-8519384-B2 | Phosphorescent materials | UNIVERSAL DISPLAY CORPORATION (US) | 2013-08-27 | — | — | US | disclosed |
| EP-2628743-A1 | NITROGENATED AROMATIC COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC ELECTRONIC DEVICE | Nippon Steel & Sumikin Chemical Co., Ltd. (JP) | 2013-08-21 | — | — | EP | disclosed |
| EP-2628743-A1 | NITROGENATED AROMATIC COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC ELECTRONIC DEVICE | Nippon Steel & Sumikin Chemical Co., Ltd. (JP) | 2013-08-21 | — | — | EP | disclosed |
| US-8513285-B2 | 3 or 4-substituted piperidine compounds | SK BIOPHARMACEUTICALS CO., LTD. (KR) | 2013-08-20 | — | — | US | disclosed |
| US-20130200350-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2013-08-08 | — | — | US | disclosed |
| US-20130193429-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2013-08-01 | — | — | US | disclosed |
| EP-2617724-A1 | NITROGENATED AROMATIC COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC ELECTRONIC DEVICE | Nippon Steel & Sumikin Chemical Co., Ltd. (JP) | 2013-07-24 | — | — | EP | disclosed |
| EP-2617724-A1 | NITROGENATED AROMATIC COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC ELECTRONIC DEVICE | Nippon Steel & Sumikin Chemical Co., Ltd. (JP) | 2013-07-24 | — | — | EP | disclosed |
| US-20130184458-A1 | NITROGENATED AROMATIC COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC ELECTRONIC DEVICE | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2013-07-18 | — | — | US | disclosed |
| US-20130184458-A1 | NITROGENATED AROMATIC COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC ELECTRONIC DEVICE | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2013-07-18 | — | — | US | disclosed |
| US-20130184458-A1 | NITROGENATED AROMATIC COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC ELECTRONIC DEVICE | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2013-07-18 | — | — | US | disclosed |
| US-20130175507-A1 | Novel Heterocyclic Host Materials | UNIVERSAL DISPLAY CORPORATION (US) | 2013-07-11 | — | — | US | disclosed |
| US-20130175507-A1 | Novel Heterocyclic Host Materials | UNIVERSAL DISPLAY CORPORATION (US) | 2013-07-11 | — | — | US | disclosed |
| CN-102036971-B | 3- or 4-substituted piperidine compounds | SK HOLDINGS CO LTD | 2013-07-03 | — | — | CN | disclosed |
| US-20130150576-A1 | NITROGEN-CONTAINING AROMATIC COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC ELECTRONIC DEVICE | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2013-06-13 | — | — | US | disclosed |
| US-20130150576-A1 | NITROGEN-CONTAINING AROMATIC COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC ELECTRONIC DEVICE | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2013-06-13 | — | — | US | disclosed |
| US-20130150576-A1 | NITROGEN-CONTAINING AROMATIC COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC ELECTRONIC DEVICE | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2013-06-13 | — | — | US | disclosed |
| US-8461209-B2 | Malonic acid sulfonamide derivative and pharmaceutical use thereof | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2013-06-11 | — | — | US | disclosed |
| US-20130126792-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2013-05-23 | — | — | US | disclosed |
| EP-2108649-B1 | Novel indol carboxylic acid bispyridyl carboxamide derivatives as 5-HT2c receptor antagonists | KOREA RES INST CHEM TECH (KR) | 2013-04-24 | — | — | EP | disclosed |
| US-20130048955-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2013-02-28 | — | — | US | disclosed |
| US-20130048955-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2013-02-28 | — | — | US | disclosed |
| US-8372312-B1 | Non-symmetrical dibenzodithienothiophene compounds | XEROX CORPORATION (US) | 2013-02-12 | — | — | US | disclosed |
| EP-2552908-A2 | HETEROCYCLIC COMPOUNDS AND THEIR USES | Amgen Inc. (US) | 2013-02-06 | — | — | EP | disclosed |
| US-8350256-B2 | Organic semiconductor compounds | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2013-01-08 | — | — | US | disclosed |
| US-20130005965-A1 | ARYL- AND HETEROARYL-SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-01-03 | — | — | US | disclosed |
| US-8324246-B2 | Indol carboxylic acid bispyridyl carboxamide derivatives, pharmaceutically acceptable salt thereof, preparation method and composition containing the same as an active ingredient | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2012-12-04 | — | — | US | disclosed |
| US-20120302546-A1 | NOVEL SULFAMIDES EXHIBITING NEUROPROTECTIVE ACTION AND METHODS FOR USE THEREOF | FOX CHASE CHEMICAL DIVERSITY CENTER, INC. (US) | 2012-11-29 | — | — | US | disclosed |
| WO-2012143080-A2 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2012-10-26 | — | — | WO | disclosed |
| WO-2012143080-A2 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2012-10-26 | — | — | WO | disclosed |
| US-8263635-B2 | Inhibitors of CYP 17 | NOVARTIS AG (CH) | 2012-09-11 | — | — | US | disclosed |
| US-8252781-B2 | 1,2-diazetidin-3-one derivatives and drugs containing same | KOWA COMPANY, LTD. (JP) | 2012-08-28 | — | — | US | disclosed |
| US-8242116-B2 | Fused thiazole derivatives as kinase inhibitors | UCB PHARMA S.A. (BE) | 2012-08-14 | — | — | US | disclosed |
| US-8236796-B2 | Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin | ALBANY MOLECULAR RESEARCH, INC. (US) | 2012-08-07 | — | — | US | disclosed |
| US-8227486-B2 | Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin | ALBANY MOLECULAR RESEARCH, INC. (US) | 2012-07-24 | — | — | US | disclosed |
| US-8197763-B2 | oxidation of fossil fuel containing suflide impurities ( such as benzothiophene ) with hydrogen peroxide or tert-butyl hydroperoxide ( a hydroperoxide oxidizer) in presence of phase transfer catalyst ( quaternary ammonium fluoride) and sonic waves, to sulfone; solvent extraction to remove the sulfone | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2012-06-12 | — | — | US | disclosed |
| US-8197763-B2 | oxidation of fossil fuel containing suflide impurities ( such as benzothiophene ) with hydrogen peroxide or tert-butyl hydroperoxide ( a hydroperoxide oxidizer) in presence of phase transfer catalyst ( quaternary ammonium fluoride) and sonic waves, to sulfone; solvent extraction to remove the sulfone | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2012-06-12 | — | — | US | disclosed |
| US-20120122927-A1 | 3 OR 4-SUBSTITUTED PIPERIDINE COMPOUNDS | LEE KI-HO (KR) | 2012-05-17 | — | — | US | disclosed |
| WO-2012052395-A1 | ISOXAZOLE DERIVATIVES USED AS OESTROGEN MODULATORS | N. V. ORGANON (NL) | 2012-04-26 | — | — | WO | disclosed |
| EP-1432707-B1 | AZABICYCLIC-SUBSTITUTED FUSED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE | PHARMACIA & UPJOHN CO LLC (US) | 2012-03-28 | — | — | EP | disclosed |
| US-8138199-B2 | Use of bi-aryl meta-pyrimidine inhibitors of kinases | TARGEGEN, INC. (US) | 2012-03-20 | — | — | US | disclosed |
| US-8133900-B2 | Use of bi-aryl meta-pyrimidine inhibitors of kinases | TARGEGEN, INC. (US) | 2012-03-13 | — | — | US | disclosed |
| EP-1871782-B1 | DIPHOSPHINES AND METAL COMPLEXES | UMICORE AG & CO KG (DE) | 2012-02-29 | — | — | EP | disclosed |
| EP-1871782-B1 | DIPHOSPHINES AND METAL COMPLEXES | UMICORE AG & CO KG (DE) | 2012-02-29 | — | — | EP | disclosed |
| US-8124584-B2 | Macrocyclic hepatitis C serine protease inhibitors | ENANTA PHARMACEUTICALS, INC. (US) | 2012-02-28 | — | — | US | disclosed |
| US-8124584-B2 | Macrocyclic hepatitis C serine protease inhibitors | ENANTA PHARMACEUTICALS, INC. (US) | 2012-02-28 | — | — | US | disclosed |
| WO-2012016630-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2012-02-09 | — | — | WO | disclosed |
| WO-2012016630-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2012-02-09 | — | — | WO | disclosed |
| US-8110530-B2 | For use in paddy fields; post-/pre- emergence | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2012-02-07 | — | — | US | disclosed |
| US-20120012819-A1 | ORGANIC SEMICONDUCTOR COMPOUNDS | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2012-01-19 | — | — | US | disclosed |
| EP-2159216-B1 | 3-BUTENYL-1-AMINE DERIVATIVES AND THEIR USE AS Ih MODULORS FOR THE TREATMENT OF PSYCHIATIRC DISORDERS | ORGANON NV (NL) | 2011-10-12 | — | — | EP | disclosed |
| WO-2011123751-A2 | HETEROCYCLIC COMPOUNDS AND THEIR USES | AMGEN INC. (US) | 2011-10-06 | — | — | WO | disclosed |
| WO-2011123751-A2 | HETEROCYCLIC COMPOUNDS AND THEIR USES | AMGEN INC. (US) | 2011-10-06 | — | — | WO | disclosed |
| US-20110245257-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USES | AMGEN INC. (US) | 2011-10-06 | — | — | US | disclosed |
| US-20110245257-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USES | AMGEN INC. (US) | 2011-10-06 | — | — | US | disclosed |
| US-20110245257-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USES | AMGEN INC. (US) | 2011-10-06 | — | — | US | disclosed |
| CN-102209720-A | Novel compound and organic semiconductor material | SUMITOMO CHEMICAL CO | 2011-10-05 | — | — | CN | disclosed |
| US-20110227049-A1 | PHOSPHORESCENT MATERIALS | UNIVERSAL DISPLAY CORPORATION (US) | 2011-09-22 | — | — | US | disclosed |
| US-20110227049-A1 | PHOSPHORESCENT MATERIALS | UNIVERSAL DISPLAY CORPORATION (US) | 2011-09-22 | — | — | US | disclosed |
| US-20110227049-A1 | PHOSPHORESCENT MATERIALS | UNIVERSAL DISPLAY CORPORATION (US) | 2011-09-22 | — | — | US | disclosed |
| US-20110218225-A1 | NON-STEROIDAL LIGANDS FOR THE GLUCOCORTICOID RECEPTOR, COMPOSITIONS AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-09-08 | — | — | US | disclosed |
| US-20110212077-A1 | BI-ARYL META-PYRIMIDINE INHIBITORS OF KINASES | TARGEGEN, INC. (US) | 2011-09-01 | — | — | US | disclosed |
| WO-2011097337-A1 | NOVEL SULFAMIDES EXHIBITING NEUROPROTECTIVE ACTION AND METHODS FOR USE THEREOF | ADVANCED NEURAL DYNAMICS, INC. (US) | 2011-08-11 | — | — | WO | disclosed |
| EP-2348019-A1 | 1,2-DIAZETIDIN-3-ONE DERIVATIVE AND PHARMACEUTICAL AGENT COMPRISING SAME | Kowa Company, Ltd. (JP) | 2011-07-27 | — | — | EP | disclosed |
| US-7960571-B2 | Silicon-based cross-coupling reagent and production method of organic compound using the same | KYOTO UNIVERSITY (JP) | 2011-06-14 | — | — | US | disclosed |
| US-7960571-B2 | Silicon-based cross-coupling reagent and production method of organic compound using the same | KYOTO UNIVERSITY (JP) | 2011-06-14 | — | — | US | disclosed |
| US-7951962-B2 | Condensed ring compounds formed by edge sharing between the connecting ring and each of the electron-conjugated aromatic rings, which means bonding between the two atoms; pi-electron conjugated systems; improved solvent solubility allows use in ink jet printing | SEIKO EPSON CORPORATION (JP) | 2011-05-31 | — | — | US | disclosed |
| US-7951962-B2 | Condensed ring compounds formed by edge sharing between the connecting ring and each of the electron-conjugated aromatic rings, which means bonding between the two atoms; pi-electron conjugated systems; improved solvent solubility allows use in ink jet printing | SEIKO EPSON CORPORATION (JP) | 2011-05-31 | — | — | US | disclosed |
| US-7951962-B2 | Condensed ring compounds formed by edge sharing between the connecting ring and each of the electron-conjugated aromatic rings, which means bonding between the two atoms; pi-electron conjugated systems; improved solvent solubility allows use in ink jet printing | SEIKO EPSON CORPORATION (JP) | 2011-05-31 | — | — | US | disclosed |
| EP-2035436-B1 | FUSED THIAZOLE DERIVATIVES AS KINASE INHIBITORS | UCB PHARMA SA (BE) | 2011-05-25 | — | — | EP | disclosed |
| US-7947726-B2 | Non-steroidal ligands for the glucocorticoid receptor, and compositions thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-05-24 | — | — | US | disclosed |
| CN-102036971-A | 3- or 4-substituted piperidine compounds | SK HOLDINGS CO LTD | 2011-04-27 | — | — | CN | disclosed |
| WO-2011025799-A1 | CATHEPSIN C INHIBITORS | GLAXO GROUP LIMITED (GB) | 2011-03-03 | — | — | WO | disclosed |
| WO-2011025799-A1 | CATHEPSIN C INHIBITORS | GLAXO GROUP LIMITED (GB) | 2011-03-03 | — | — | WO | disclosed |
| EP-2283000-A2 | 3- OR 4-SUBSTITUTED PIPERIDINE COMPOUNDS | SK Holdings Co., Ltd. (KR) | 2011-02-16 | — | — | EP | disclosed |
| CN-101977505-A | Farnesoid x receptor agonists | SMITHKLINE BEECHAM CORP | 2011-02-16 | — | — | CN | disclosed |
| EP-1496892-B1 | 1H-BENZO(F)INDAZOL-5-YL DERIVATIVES AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS | MERCK SHARP & DOHME (US) | 2011-01-26 | — | — | EP | disclosed |
| US-7863447-B2 | Diphosphines and metal complexes | UMICORE AG & CO., KG (DE) | 2011-01-04 | — | — | US | disclosed |
| US-7863447-B2 | Diphosphines and metal complexes | UMICORE AG & CO., KG (DE) | 2011-01-04 | — | — | US | disclosed |
| US-7863447-B2 | Diphosphines and metal complexes | UMICORE AG & CO., KG (DE) | 2011-01-04 | — | — | US | disclosed |
| US-20100331326-A1 | Inhibitors of CYP 17 | NOVARTIS AG | 2010-12-30 | — | — | US | disclosed |
| US-7855203-B2 | Indazolyl-substituted pyrroline compounds as kinase inhibitors | ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC. (US) | 2010-12-21 | — | — | US | disclosed |
| US-7842715-B2 | N-benzoyl- and N-benzylpyrrolidin-3-ylamines as histamine-3 antagonists | WYETH LLC (US) | 2010-11-30 | — | — | US | disclosed |
| US-7842715-B2 | N-benzoyl- and N-benzylpyrrolidin-3-ylamines as histamine-3 antagonists | WYETH LLC (US) | 2010-11-30 | — | — | US | disclosed |
| EP-2253315-A1 | Alkoxyphenylpropanoic acid derivatives | Takeda Pharmaceutical Company Limited (JP) | 2010-11-24 | — | — | EP | disclosed |
| US-7825246-B2 | Bi-aryl meta-pyrimidine inhibitors of kinases | TARGEGEN, INC. (US) | 2010-11-02 | — | — | US | disclosed |
| US-7820837-B2 | ethyl {6-[(3-phenoxybenzyl)oxy]-3,4-dihydronaphthalen-1-yl}acetate; having a GPR40 receptor function modulating action and being useful as an insulin secretagogue or a pharmaceutical agent for the prophylaxis or treatment of diabetes | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-10-26 | — | — | US | disclosed |
| US-20100228026-A1 | NOVEL MALONIC ACID SULFONAMIDE DERIVATIVE AND PHARMACEUTICAL USE THEREOF | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2010-09-09 | — | — | US | disclosed |
| EP-1300430-B1 | Mono-, oligo- and polymers of benzo(b)thiophene and 2,2'-bisbenzo(b)thiophene and their use as charge transport materials | MERCK PATENT GMBH (DE) | 2010-07-07 | — | — | EP | disclosed |
| EP-1300430-B1 | Mono-, oligo- and polymers of benzo(b)thiophene and 2,2'-bisbenzo(b)thiophene and their use as charge transport materials | MERCK PATENT GMBH (DE) | 2010-07-07 | — | — | EP | disclosed |
| US-20100144694-A1 | 1,2-DIAZETIDIN-3-ONE DERIVATIVES AND DRUGS CONTAINING SAME | KOWA COMPANY, LTD. (JP) | 2010-06-10 | — | — | US | disclosed |
| US-20100137302-A1 | Fused Thiazole Derivatives as Kinase Inhibitors | UCB PHARMA S.A. (BE) | 2010-06-03 | — | — | US | disclosed |
| EP-1599201-B1 | SELECTIVE NON-STEROIDAL GLUCOCORTICOID RECEPTOR MODULATORS | MERCK SHARP & DOHME (US) | 2010-04-14 | — | — | EP | disclosed |
| EP-2172450-A1 | NOVEL MALONIC ACID SULFONAMIDE DERIVATIVE AND PHARMACEUTICAL USE THEREOF | Mitsubishi Tanabe Pharma Corporation (JP) | 2010-04-07 | — | — | EP | disclosed |
| US-7678834-B2 | Substituted 4-aminocyclohexanol compounds | GRUENENTHAL GMBH (DE) | 2010-03-16 | — | — | US | disclosed |
| WO-2010027583-A1 | PHOSPHORESCENT MATERIALS | UNIVERSAL DISPLAY CORPORATION (US) | 2010-03-11 | — | — | WO | disclosed |
| WO-2010028151-A1 | PHOSPHORESCENT MATERIALS | UNIVERSAL DISPLAY CORPORATION (US) | 2010-03-11 | — | — | WO | disclosed |
| EP-2159216-A1 | Ih - Modulators | N.V. Organon (NL) | 2010-03-03 | — | — | EP | disclosed |
| US-7671056-B2 | Piperazine-piperidine antagonists and agonists of the 5-HT1A receptor | WYETH LLC (US) | 2010-03-02 | — | — | US | disclosed |
| US-7671056-B2 | Piperazine-piperidine antagonists and agonists of the 5-HT1A receptor | WYETH LLC (US) | 2010-03-02 | — | — | US | disclosed |
| US-7671056-B2 | Piperazine-piperidine antagonists and agonists of the 5-HT1A receptor | WYETH LLC (US) | 2010-03-02 | — | — | US | disclosed |
| US-7635711-B2 | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof | BOEHRINGER-INGELHEIM PHARMACEUTICALS, INC. (US) | 2009-12-22 | — | — | US | disclosed |
| US-7635711-B2 | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof | BOEHRINGER-INGELHEIM PHARMACEUTICALS, INC. (US) | 2009-12-22 | — | — | US | disclosed |
| US-7635711-B2 | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof | BOEHRINGER-INGELHEIM PHARMACEUTICALS, INC. (US) | 2009-12-22 | — | — | US | disclosed |
| US-20090304629-A1 | MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS | MIAO ZHENWEI | 2009-12-10 | — | — | US | disclosed |
| US-20090304629-A1 | MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS | MIAO ZHENWEI | 2009-12-10 | — | — | US | disclosed |
| US-20090306140-A1 | 3 or 4-Substituted Piperidine Compounds | SK BIOPHARMACEUTICALS CO., LTD. (KR) | 2009-12-10 | — | — | US | disclosed |
| WO-2009148291-A2 | 3- OR 4-SUBSTITUTED PIPERIDINE COMPOUNDS | SK HOLDINGS CO., LTD. (KR) | 2009-12-10 | — | — | WO | disclosed |
| US-7625937-B2 | 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators | MERCK & CO., INC. (US) | 2009-12-01 | — | — | US | disclosed |
| US-7625937-B2 | 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators | MERCK & CO., INC. (US) | 2009-12-01 | — | — | US | disclosed |
| US-7625937-B2 | 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators | MERCK & CO., INC. (US) | 2009-12-01 | — | — | US | disclosed |
| US-20090286789-A1 | Bi-Aryl Meta-Pyrimidine Inhibitors of Kinases | TARGEGEN, INC. (US) | 2009-11-19 | — | — | US | disclosed |
| EP-1606255-B1 | CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL MYERS SQUIBB CO (US) | 2009-11-11 | — | — | EP | disclosed |
| US-20090275582-A1 | Bi-Aryl Meta-Pyrimidine Inhibitors of Kinases | IMPACT BIOMEDICINES, INC. | 2009-11-05 | — | — | US | disclosed |
| US-20090270622-A1 | Diphosphines and Metal Complexes | UMICORE AG & CO., KG (DE) | 2009-10-29 | — | — | US | disclosed |
| US-20090270622-A1 | Diphosphines and Metal Complexes | UMICORE AG & CO., KG (DE) | 2009-10-29 | — | — | US | disclosed |
| US-20090270622-A1 | Diphosphines and Metal Complexes | UMICORE AG & CO., KG (DE) | 2009-10-29 | — | — | US | disclosed |
| US-20090258876-A1 | NOVEL INDOL CARBOXYLIC ACID BISPYRIDYL CARBOXAMIDE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD AND COMPOSITION CONTAINING THE SAME AS AN ACTIVE INGREDIENT | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2009-10-15 | — | — | US | disclosed |
| WO-2009125923-A2 | NOVEL INDOL CARBOXYLIC ACID BISPYRIDYL CARBOXAMIDE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD AND COMPOSITION CONTAINING THE SAME AS AN ACTIVE INGREDIENT | KOREA RESERACH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2009-10-15 | — | — | WO | disclosed |
| EP-2108649-A1 | Novel indol carboxylic acid bispyridyl carboxamide derivatives as 5-HT2c receptor antagonists | Korea Research Institute of Chemical Technology (KR) | 2009-10-14 | — | — | EP | disclosed |
| US-7601709-B2 | Macrocyclic hepatitis C serine protease inhibitors | ENANTA PHARMACEUTICALS, INC. (US) | 2009-10-13 | — | — | US | disclosed |
| US-7601709-B2 | Macrocyclic hepatitis C serine protease inhibitors | ENANTA PHARMACEUTICALS, INC. (US) | 2009-10-13 | — | — | US | disclosed |
| US-20090253906-A1 | ARYL- AND HETEROARYL-SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN | AMR TECHNOLOGY, INC. (US) | 2009-10-08 | — | — | US | disclosed |
| EP-2098508-A1 | Cyclic derivatives as modulators of chemokine receptor activity | Bristol-Myers Squibb Company (US) | 2009-09-09 | — | — | EP | disclosed |
| US-20090192213-A1 | Benzo[b]furane And Benzo[b]thiophene Derivatives | H. LUNDBECK A/S (DK) | 2009-07-30 | — | — | US | disclosed |
| US-7557103-B2 | Imidazopyridazine compounds | ELI LILLY AND COMPANY (US) | 2009-07-07 | — | — | US | disclosed |
| EP-1836166-B1 | GLUCOCORTICOID MIMETICS, METHODS OF MAKING THEM, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | BOEHRINGER INGELHEIM PHARMA (US) | 2009-06-17 | — | — | EP | disclosed |
| US-7541357-B2 | Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin | AMR TECHNOLOGY, INC. (US) | 2009-06-02 | — | — | US | disclosed |
| US-20090137655-A1 | Non-Steroidal Ligands for the Glucocorticoid Receptor, Compositions and Uses Thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-05-28 | — | — | US | disclosed |
| US-7534794-B2 | Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases | BIOVITRUM AB (SE) | 2009-05-19 | — | — | US | disclosed |
| US-7534791-B2 | Benzo[b]furane and benzo[b]thiophene derivatives | H. LUNDBECK A/S (DK) | 2009-05-19 | — | — | US | disclosed |
| US-7531697-B2 | Process for the preparation of aromatic aldehydes | DEGUSSA GMBH (DE) | 2009-05-12 | — | — | US | disclosed |
| US-7531697-B2 | Process for the preparation of aromatic aldehydes | DEGUSSA GMBH (DE) | 2009-05-12 | — | — | US | disclosed |
| US-7528143-B2 | Bi-aryl meta-pyrimidine inhibitors of kinases | TARGEGEN, INC. (US) | 2009-05-05 | — | — | US | disclosed |
| WO-2009050235-A1 | CGRP ANTAGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-04-23 | — | — | WO | disclosed |
| US-7517910-B2 | Alkoxyphenylpropanoic acid derivatives | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-04-14 | — | — | US | disclosed |
| US-20090069577-A1 | Silicon-Based Cross-Coupling Reagent and Production Method of Organic Compound Using the Same | KYOTO UNIVERSITY (JP) | 2009-03-12 | — | — | US | disclosed |
| US-20090069577-A1 | Silicon-Based Cross-Coupling Reagent and Production Method of Organic Compound Using the Same | KYOTO UNIVERSITY (JP) | 2009-03-12 | — | — | US | disclosed |
| US-20090054454-A1 | BENZOFURANYL- AND BENZOTHIENYL- PIPERAZINYL QUINOLINES AND METHODS OF THEIR USE | VENKATESAN ARANAPAKAM MUDUMBAI | 2009-02-26 | — | — | US | disclosed |
| US-20090048443-A1 | ARYL- AND HETEROARYL-SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN | AMR TECHNOLOGY, INC. (US) | 2009-02-19 | — | — | US | disclosed |
| US-20090042888-A1 | Prostaglandin endoperoxide H synthase biosynthesis inhibitors | BLACK LAWRENCE A | 2009-02-12 | — | — | US | disclosed |
| US-7485660-B2 | Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-02-03 | — | — | US | disclosed |
| EP-1483273-B1 | LIGANDS FOR ASYMMETRIC REACTIONS | SOLVIAS AG (CH) | 2009-01-07 | — | — | EP | disclosed |
| US-7416682-B2 | Photochromic liquid crystals | CHI MEI OPTOELECTRONICS CORPORATION (TW) | 2008-08-26 | — | — | US | disclosed |
| EP-1582524-B1 | Method of preparing organomagnesium compounds | UNIV MUENCHEN L MAXIMILIANS (DE) | 2008-08-13 | — | — | EP | disclosed |
| US-7411073-B2 | Selective non-steroidal glucocorticoid receptor modulators | MERCK & CO., INC. (US) | 2008-08-12 | — | — | US | disclosed |
| US-20080188691-A1 | Process For The Preparation Of Aromatic Aldehydes | DEGUSSA GMBH (DE) | 2008-08-07 | — | — | US | disclosed |
| US-20080188691-A1 | Process For The Preparation Of Aromatic Aldehydes | DEGUSSA GMBH (DE) | 2008-08-07 | — | — | US | disclosed |
| US-7407910-B2 | Ligands for asymmetric reactions | SOLVIAS AG (CH) | 2008-08-05 | — | — | US | disclosed |
| US-20080173571-A1 | Ultrasound-Assisted Oxidative Desulfurization of Diesel Fuel Using Quaternary Ammonium Fluoride and Portable Unit for Ultrasound-Assisted Oxidative Desulfurization | UNIVERSITY OF SOUTHERN CALIFORNIA | 2008-07-24 | — | — | US | disclosed |
| US-20080173571-A1 | Ultrasound-Assisted Oxidative Desulfurization of Diesel Fuel Using Quaternary Ammonium Fluoride and Portable Unit for Ultrasound-Assisted Oxidative Desulfurization | UNIVERSITY OF SOUTHERN CALIFORNIA | 2008-07-24 | — | — | US | disclosed |
| US-20080153704-A1 | HERBICIDAL COMPOSITION | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2008-06-26 | — | — | US | disclosed |
| US-20080153828-A1 | Imidazopyridazine Compounds | ELI LILLY AND COMPANY | 2008-06-26 | — | — | US | disclosed |
| CN-101208324-A | Benzo [ b ] furan and benzo [ b ] thiophene derivatives | LUNDBECK & CO AS H (DK) | 2008-06-25 | — | — | CN | disclosed |
| US-7387751-B2 | Method of preparing organomagnesium compounds | LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) | 2008-06-17 | — | — | US | disclosed |
| US-7384934-B2 | Piperazine substituted aryl benzodiazepines | ELI LILLY AND COMPANY (US) | 2008-06-10 | — | — | US | disclosed |
| US-7384580-B2 | Method of preparing organomagnesium compounds | LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) | 2008-06-10 | — | — | US | disclosed |
| US-20080114052-A1 | CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL-MYERS SQUIBB COMPANY | 2008-05-15 | — | — | US | disclosed |
| US-7365174-B2 | Azalide and azalactam derivatives and method for producing the same | MEIJI SEIKA KAISHA, LTD. (JP) | 2008-04-29 | — | — | US | disclosed |
| US-20080096949-A1 | Indazolyl-substituted pyrroline compounds as kinase inhibitors | ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC. | 2008-04-24 | — | — | US | disclosed |
| US-20080076795-A1 | 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators | MERCK SHARP & DOHME CORP. | 2008-03-27 | — | — | US | disclosed |
| US-20080076795-A1 | 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators | MERCK SHARP & DOHME CORP. | 2008-03-27 | — | — | US | disclosed |
| US-20080076795-A1 | 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators | MERCK SHARP & DOHME CORP. | 2008-03-27 | — | — | US | disclosed |
| US-20080076935-A1 | ORGANIC SEMICONDUCTOR COMPOUND, ORGANIC SEMICONDUCTOR THIN FILM, ORGANIC SEMICONDUCTOR COATING LIQUID, ORGANIC THIN FILM TRANSISTOR, METHODS FOR PRODUCING BIS(BENZO[4,5] THIENO)[2,3-B:3'2'-E][1,4]DITHIIN AND BIS(BENZO [4,5]THIENO)[2,3-B:2'3'-E][1,4]DITHIIN | SEIKO EPSON CORPORATION (JP) | 2008-03-27 | — | — | US | disclosed |
| US-20080076935-A1 | ORGANIC SEMICONDUCTOR COMPOUND, ORGANIC SEMICONDUCTOR THIN FILM, ORGANIC SEMICONDUCTOR COATING LIQUID, ORGANIC THIN FILM TRANSISTOR, METHODS FOR PRODUCING BIS(BENZO[4,5] THIENO)[2,3-B:3'2'-E][1,4]DITHIIN AND BIS(BENZO [4,5]THIENO)[2,3-B:2'3'-E][1,4]DITHIIN | SEIKO EPSON CORPORATION (JP) | 2008-03-27 | — | — | US | disclosed |
| US-20080076935-A1 | ORGANIC SEMICONDUCTOR COMPOUND, ORGANIC SEMICONDUCTOR THIN FILM, ORGANIC SEMICONDUCTOR COATING LIQUID, ORGANIC THIN FILM TRANSISTOR, METHODS FOR PRODUCING BIS(BENZO[4,5] THIENO)[2,3-B:3'2'-E][1,4]DITHIIN AND BIS(BENZO [4,5]THIENO)[2,3-B:2'3'-E][1,4]DITHIIN | SEIKO EPSON CORPORATION (JP) | 2008-03-27 | — | — | US | disclosed |
| EP-1893596-A2 | BENZOÝB¨FURANE AND BENZOÝB¨THIOPHENE DERIVATIVES | H.Lundbeck A/S (DK) | 2008-03-05 | — | — | EP | disclosed |
| US-7338947-B2 | Cyclic derivatives as modulators of chemokine receptor activity | BRISTOL-MYERS SQUIBB CO. (US) | 2008-03-04 | — | — | US | disclosed |
| US-7335660-B2 | Isochroman compounds for treatment of CNS disorders | ELI LILLY AND COMPANY (US) | 2008-02-26 | — | — | US | disclosed |
| EP-1888559-A2 | PIPERAZINE-PIPERIDINE ANTAGONISTS AND AGONISTS OF THE 5-HT1A RECEPTOR | Wyeth a Corporation of the State of Delaware (US) | 2008-02-20 | — | — | EP | disclosed |
| US-7329657-B2 | Indazolyl-substituted pyrroline compounds as kinase inhibitors | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2008-02-12 | — | — | US | disclosed |
| US-7323608-B2 | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2008-01-29 | — | — | US | disclosed |
| WO-2008011560-A2 | BENZOTHIOPHENE INHIBITORS OF RHO KINASE | KAHRAMAN MEHMET (US) | 2008-01-24 | — | — | WO | disclosed |
| US-20080021026-A1 | BENZOTHIOPHENE INHIBITORS OF RHO KINASE | Kahraman, Mehmet (US) | 2008-01-24 | — | — | US | disclosed |
| US-20080021026-A1 | BENZOTHIOPHENE INHIBITORS OF RHO KINASE | Kahraman, Mehmet (US) | 2008-01-24 | — | — | US | disclosed |
| US-20080021026-A1 | BENZOTHIOPHENE INHIBITORS OF RHO KINASE | Kahraman, Mehmet (US) | 2008-01-24 | — | — | US | disclosed |
| EP-1879896-A1 | IMIDAZOPYRIDAZINE COMPOUNDS | ELI LILLY AND COMPANY (US) | 2008-01-23 | — | — | EP | disclosed |
| EP-1871782-A2 | DIPHOSPHINES AND METAL COMPLEXES | Umicore AG & Co. KG (DE) | 2008-01-02 | — | — | EP | disclosed |
| EP-1492794-B1 | PIPERAZINE SUBSTITUTED ARYL BENZODIAZEPINES AND THEIR USE AS DOPAMINE RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PSYCHOTIC DISORDERS | LILLY CO ELI (US) | 2007-12-12 | — | — | EP | disclosed |
| US-7304060-B2 | Indazolyl-substituted pyrroline compounds as kinase inhibitors | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2007-12-04 | — | — | US | disclosed |
| US-20070270440-A1 | N-benzoyl- and N-benzylpyrrolidin-3-ylamines as histamine-3 antagonists | WYETH (US) | 2007-11-22 | — | — | US | disclosed |
| US-20070270440-A1 | N-benzoyl- and N-benzylpyrrolidin-3-ylamines as histamine-3 antagonists | WYETH (US) | 2007-11-22 | — | — | US | disclosed |
| US-20070270440-A1 | N-benzoyl- and N-benzylpyrrolidin-3-ylamines as histamine-3 antagonists | WYETH (US) | 2007-11-22 | — | — | US | disclosed |
| US-20070259904-A1 | Bi-aryl meta-pyrimidine inhibitors of kinases | TARGEGEN, INC. (US) | 2007-11-08 | — | — | US | disclosed |
| US-7291732-B2 | Isomeric fused pyrrolocarbazoles and isoindolones | CEPHALON, INC. (US) | 2007-11-06 | — | — | US | disclosed |
| US-7291732-B2 | Isomeric fused pyrrolocarbazoles and isoindolones | CEPHALON, INC. (US) | 2007-11-06 | — | — | US | disclosed |
| US-7291732-B2 | Isomeric fused pyrrolocarbazoles and isoindolones | CEPHALON, INC. (US) | 2007-11-06 | — | — | US | disclosed |
| EP-1534671-A4 | COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS | MASSACHUSETTS INST TECHNOLOGY (US) | 2007-10-24 | — | — | EP | disclosed |
| US-7282591-B2 | 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators | MERCK & CO., INC. (US) | 2007-10-16 | — | — | US | disclosed |
| US-7282591-B2 | 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators | MERCK & CO., INC. (US) | 2007-10-16 | — | — | US | disclosed |
| US-7282591-B2 | 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators | MERCK & CO., INC. (US) | 2007-10-16 | — | — | US | disclosed |
| US-7276603-B2 | serotonin receptor antagonists such as 8-{4-[2-(1-benzofuran-3-yl)ethyl]-1-piperazinyl}-6-fluoroquinoline, used for treatment and/or prevention of depression, anxiety and cognitive deficits arising from Alzheimer's disease, neurodegenerative disorders, schizophrenia and prostate cancer | WYETH (US) | 2007-10-02 | — | — | US | disclosed |
| EP-1836166-A2 | GLUCOCORTICOID MIMETICS, METHODS OF MAKING THEM, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) | 2007-09-26 | — | — | EP | disclosed |
| US-20070213364-A1 | Alkoxyphenylpropanoic Acid Derivatives | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-09-13 | — | — | US | disclosed |
| US-20070194468-A1 | Method of preparing organomagnesium compounds | LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) | 2007-08-23 | — | — | US | disclosed |
| US-20070191405-A1 | Bi-aryl meta-pyrimidine inhibitors of kinases | TARGEGEN, INC. (US) | 2007-08-16 | — | — | US | disclosed |
| US-7253165-B2 | Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists | AVENTIS PHARMACEUTICALS INC. (US) | 2007-08-07 | — | — | US | disclosed |
| EP-1390340-A4 | COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS | MASSACHUSETTS INST TECHNOLOGY (US) | 2007-07-25 | — | — | EP | disclosed |
| US-7241773-B2 | 3-quinuclidinyl heteroatom bridged biaryl derivatives | ABBOTT LABORATORIES (US) | 2007-07-10 | — | — | US | disclosed |
| US-20070155795-A1 | MUSCARINIC AGONISTS | ACADIA PHARMACEUTICALS INC. (US) | 2007-07-05 | — | — | US | disclosed |
| US-7238713-B2 | Muscarinic agonists | ACADIA PHARMACEUTICALS, INC. (US) | 2007-07-03 | — | — | US | disclosed |
| US-7214673-B2 | For therapy of psychosis and bipolar disorder | ELI LILLY AND COMPANY (US) | 2007-05-08 | — | — | US | disclosed |
| EP-1546134-B1 | PIPERAZINE SUBSTITUTED ARYL BENZODIAZEPINES | LILLY CO ELI (US) | 2007-05-02 | — | — | EP | disclosed |
| EP-1778639-A2 | ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN | AMR Technology, Inc. (US) | 2007-05-02 | — | — | EP | disclosed |
| WO-2007023395-A2 | BENZO[B]FURANE AND BENZO[B]THIOPHENE DERIVATIVES | H. LUNDBECK A/S (US) | 2007-03-01 | — | — | WO | disclosed |
| EP-1425286-B1 | SUBSTITUTED 7-AZA-[2.2.1]BICYCLOHEPTANES FOR THE TREATMENT OF DISEASES | PHARMACIA & UPJOHN CO LLC (US) | 2007-02-28 | — | — | EP | disclosed |
| US-7183436-B2 | Substituted 4-aminocyclohexanols | GRUENENTHAL GMBH (DE) | 2007-02-27 | — | — | US | disclosed |
| US-7183270-B2 | Cyclic derivatives as modulators of chemokine receptor activity | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-02-27 | — | — | US | disclosed |
| US-20070042974-A1 | Nozel azalide and azalactam derivatives and method for producing the same | MEIJI SEIKA KAISHA, LTD. (JP) | 2007-02-22 | — | — | US | disclosed |
| US-20070032541-A1 | Cyclic derivatives as modulators of chemokine receptor activity | CHERNEY ROBERT J | 2007-02-08 | — | — | US | disclosed |
| EP-1606255-A4 | CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL MYERS SQUIBB CO (US) | 2007-02-07 | — | — | EP | disclosed |
| US-20070027160-A1 | 5-fluoro-8-(4-(4-(6-methoxyquinolin-8-yl)piperazin-1-yl)piperidin-1-yl)quinoline; central nervous system disorders, such as cognition disorders, anxiety disorders, depression and sexual dysfunction | WYETH (US) | 2007-02-01 | — | — | US | disclosed |
| US-20070027160-A1 | 5-fluoro-8-(4-(4-(6-methoxyquinolin-8-yl)piperazin-1-yl)piperidin-1-yl)quinoline; central nervous system disorders, such as cognition disorders, anxiety disorders, depression and sexual dysfunction | WYETH (US) | 2007-02-01 | — | — | US | disclosed |
| US-20070027160-A1 | 5-fluoro-8-(4-(4-(6-methoxyquinolin-8-yl)piperazin-1-yl)piperidin-1-yl)quinoline; central nervous system disorders, such as cognition disorders, anxiety disorders, depression and sexual dysfunction | WYETH (US) | 2007-02-01 | — | — | US | disclosed |
| EP-1735305-A2 | 3-QUINUCLIDINYL HETEROATOM BRIDGED BIARYL DERIVATIVES | ABBOTT LABORATORIES (US) | 2006-12-27 | — | — | EP | disclosed |
| WO-2006135839-A2 | PIPERAZINE-PIPERIDINE ANTAGONISTS AND AGONISTS OF THE 5-HT1A RECEPTOR | WYETH (US) | 2006-12-21 | — | — | WO | disclosed |
| US-20060287386-A1 | Benzo[b]furane and benzo[b]thiophene derivatives | H. LUNDBECK A/S (DK) | 2006-12-21 | — | — | US | disclosed |
| EP-1731505-A1 | ALKOXYPHENYLPROPANOIC ACID DERIVATIVES | Takeda Pharmaceutical Company Limited (JP) | 2006-12-13 | — | — | EP | disclosed |
| US-20060264673-A1 | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2006-11-23 | — | — | US | disclosed |
| US-20060258722-A1 | Condensed ring compound | TAKEDA PHARMACEUTICAL COMPANY., LTD. (JP) | 2006-11-16 | — | — | US | disclosed |
| WO-2006111535-A2 | DIPHOSPHINES AND METAL COMPLEXES | UMICORE AG & CO. KG (DE) | 2006-10-26 | — | — | WO | disclosed |
| US-20060241307-A1 | Bidentate having a heterocyclic ring, especially benzothiophene, 2,3-disubstituted with phosphonate, phosphine, phosphine oxide, dioxyphosphine or diaminophosphine groups; transition metal complexes; hydrogenation, isomerizatioin, hydroformylation, hydroboration, hydrosilylation or hydrocyanation | BERENS ULRICH | 2006-10-26 | — | — | US | disclosed |
| WO-2006107784-A1 | IMIDAZOPYRIDAZINE COMPOUNDS | ELI LILLY AND COMPANY (US) | 2006-10-12 | — | — | WO | disclosed |
| EP-1517977-B1 | PHOTOCHROMIC LIQUID CRYSTALS | QINETIQ LTD (GB) | 2006-10-11 | — | — | EP | disclosed |
| US-7115784-B2 | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2006-10-03 | — | — | US | disclosed |
| US-7115591-B2 | Pyridazinone compounds as cyclooxygenase [COX] 2 inhibitorsfor gastrointestinal disorders | ABBOTT LABORATORIES (US) | 2006-10-03 | — | — | US | disclosed |
| US-20060189646-A1 | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2006-08-24 | — | — | US | disclosed |
| US-7094907-B2 | Ligands for asymmetric reactions | SOLVIAS AG (CH) | 2006-08-22 | — | — | US | disclosed |
| US-7081536-B2 | COMPLEXES; USED FOR CATALYST | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2006-07-25 | — | — | US | disclosed |
| WO-2006071609-A2 | GLUCOCORTICOID MIMETICS, METHODS OF MAKING THEM, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2006-07-06 | — | — | WO | disclosed |
| US-7071180-B2 | Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases | BIOVITRUM AB (SE) | 2006-07-04 | — | — | US | disclosed |
| US-7067515-B2 | Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease | PFIZER INC. (US) | 2006-06-27 | — | — | US | disclosed |
| US-7056348-B2 | 5-aryl-1,3,3-trimethyl-2-methylene-indoline derivatives and salts thereof, methods for the production and use of said compounds for the temporary coloration of fibers | WELLA AG (DE) | 2006-06-06 | — | — | US | disclosed |
| WO-2006058338-A2 | 4 - PIPERIDINECARBOXAMIDE DERIVATIVES AS MODULATORS OF VANILLOID VR1 RECEPTOR | JANSSEN PHARMACEUTICA N.V. (BE) | 2006-06-01 | — | — | WO | disclosed |
| US-20060116368-A1 | 4-Piperidinecarboxamide modulators of vanilloid VR1 receptor | JANSSEN PHARMACEUTICA N.V. (BE) | 2006-06-01 | — | — | US | disclosed |
| EP-1661904-A1 | NOVEL AZALIDE AND AZALACTAM DERIVATIVES AND PROCESS FOR THE PRODUCTION OF THE SAME | MEIJI SEIKA KAISHA LTD. (JP) | 2006-05-31 | — | — | EP | disclosed |
| EP-1362047-B1 | INDAZOLYL-SUBSTITUTED PYRROLINE COMPOUNDS AS KINASE INHIBITORS | ORTHO MCNEIL PHARM INC (US) | 2006-05-17 | — | — | EP | disclosed |
| US-20060084643-A1 | Piperazine substituted aryl benzodiazepines | ELI LILLY AND COMPANY | 2006-04-20 | — | — | US | disclosed |
| US-20060074120-A1 | cyclopent[f]pyrazole derivatives; antiinflammatory agent; autoimmune diseases; side effect reduction, advantages over steroidal glucocorticoid ligands with respect to undesireable side-effects, efficacy, toxicity or metabolism | MERCK SHARP & DOHME CORP. | 2006-04-06 | — | — | US | disclosed |
| EP-1641785-A2 | BENZOFURANYL-AND BENZOTHIENYL-PIPERAZINYL QUINOLINES AS SEROTONIN REUPTAKE INHIBITORS | Wyeth (US) | 2006-04-05 | — | — | EP | disclosed |
| US-20060063766-A1 | Use of aryl- and heteroaryl-substituted tetrahydroisoquinolines to block reuptake of norepinephrine, dopamine, and serotonin | ALBANY MOLECULAR RESEARCH, INC. | 2006-03-23 | — | — | US | disclosed |
| US-20060052378-A1 | Psychological disorders; analgesics; eating disorders; drug abuse; 4-(8-chloro-naphthalen-2-yl)-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-ol; 7-(6-methoxy-pyrazin-2yl)-2-methyl-4-(naphthalene-2-yl)-1,2,3,4-tetrahydroisoquinoline; treating amide intermediates with sodium borohydride | CURIA GLOBAL, INC. | 2006-03-09 | — | — | US | disclosed |
| US-7008958-B2 | 2-substituted 5-oxazolyl indole compounds useful as IMPDH inhibitors and pharmaceutical compositions comprising same | BRISTOL-MYERS SQUIBB COMPANY (US) | 2006-03-07 | — | — | US | disclosed |
| EP-1630152-A1 | CONDENSED RING COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2006-03-01 | — | — | EP | disclosed |
| WO-2006020049-A2 | ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN | AMR TECHNOLOGY, INC. (US) | 2006-02-23 | — | — | WO | disclosed |
| US-7001895-B2 | Prostaglandin endoperoxide H synthase biosynthesis inhibitors | ABBOTT LABORATORIES (US) | 2006-02-21 | — | — | US | disclosed |
| US-20060019984-A1 | Treatment of diseases with alpha-7nACh receptor full agonists | PFIZER INC | 2006-01-26 | — | — | US | disclosed |
| EP-1496892-A4 | 1H-BENZO(F)INDAZOL-5-YL DERIVATIVES AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS | MERCK & CO INC (US) | 2006-01-25 | — | — | EP | disclosed |
| EP-1606255-A2 | CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | Bristol-Myers Squibb Company (US) | 2005-12-21 | — | — | EP | disclosed |
| EP-1178973-B1 | PYRAZINYL-PIPERAZINE- COMPOUNDS, THEIR USE AND PREPARATION | BIOVITRUM AB (SE) | 2005-12-21 | — | — | EP | disclosed |
| US-20050258396-A1 | Potochromic liquid crystals | QINETIQ LIMITED (GB) | 2005-11-24 | — | — | US | disclosed |
| US-20050256315-A1 | 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators | MERCK SHARP & DOHME CORP. | 2005-11-17 | — | — | US | disclosed |
| US-20050250959-A1 | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2005-11-10 | — | — | US | disclosed |
| US-20050245504-A1 | Treatment of diseases with combinations of alpha 7 Nicotinic Acetylcholine Receptor agonists and other compounds | CORBETT JEFFREY W | 2005-11-03 | — | — | US | disclosed |
| EP-1587511-A2 | TREATMENT OF DISEASES WITH ALPHA-7 NACH RECEPTOR FULL AGONISTS | Pharmacia & Upjohn Company LLC (US) | 2005-10-26 | — | — | EP | disclosed |
| US-20050234092-A1 | Azabicyclic-substituted fused heteroaryl compounds for the treatment of disease | PFIZER INC | 2005-10-20 | — | — | US | disclosed |
| CN-1684944-A | method for copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds | MASSACHUSETTS INST TECHNOLOGY (US) | 2005-10-19 | — | — | CN | disclosed |
| US-20050218532-A1 | Method of preparing organomagnesium compounds | LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) | 2005-10-06 | — | — | US | disclosed |
| US-20050222196-A1 | Azabicyclic-substituted fused heteroaryl compounds for the treatment of disease | PFIZER INC. | 2005-10-06 | — | — | US | disclosed |
| EP-1582524-A1 | Method of preparing organomagnesium compounds | Ludwig Maximilians Universität (DE) | 2005-10-05 | — | — | EP | disclosed |
| EP-1582523-A1 | Method of preparing organomagnesium compounds | Ludwig-Maximilians-Universität München (DE) | 2005-10-05 | — | — | EP | disclosed |
| US-20050215794-A1 | Copper-catalyzed formation of carbon heteroatom and carbon-carbon bonds | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2005-09-29 | — | — | US | disclosed |
| US-20050203296-A1 | For therapy of psychosis and bipolar disorder | ELI LILLY AND COMPANY | 2005-09-15 | — | — | US | disclosed |
| EP-1572300-A1 | COMBINATION FOR THE TREATMENT OF ADHD | Pharmacia & Upjohn Company LLC (US) | 2005-09-14 | — | — | EP | disclosed |
| EP-1572205-A2 | TREATMENT OF DISEASES WITH COMBINATIONS OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS AND OTHER COMPOUNDS | Pharmacia & Upjohn Company LLC (US) | 2005-09-14 | — | — | EP | disclosed |
| WO-2004075840-A9 | SELECTIVE NON-STEROIDAL GLUCOCORTICOID RECEPTOR MODULATORS | MERCK & CO INC (US) | 2005-08-04 | — | — | WO | disclosed |
| WO-2005066167-A2 | 3-QUINUCLIDINYL HETEROATOM BRIDGED BIARYL DERIVATIVES | ABBOTT LABORATORIES (US) | 2005-07-21 | — | — | WO | disclosed |
| EP-1546134-A1 | PIPERAZINE SUBSTITUTED ARYL BENZODIAZEPINES | ELI LILLY AND COMPANY (US) | 2005-06-29 | — | — | EP | disclosed |
| US-6911543-B2 | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease | PFIZER INC. (US) | 2005-06-28 | — | — | US | disclosed |
| US-20050137226-A1 | 3-Quinuclidinyl heteroatom bridged biaryl derivatives | ABBOTT LABORATORIES | 2005-06-23 | — | — | US | disclosed |
| US-20050137398-A1 | 3-Quinuclidinyl heteroatom bridged biaryl derivatives | ABBOTT LABORATORIES | 2005-06-23 | — | — | US | disclosed |
| EP-1534671-A2 | COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2005-06-01 | — | — | EP | disclosed |
| EP-1535912-A1 | Muscarinic agonists | Arcadia Pharmaceuticals Inc. (US) | 2005-06-01 | — | — | EP | disclosed |
| US-6900216-B2 | Dihydroimidazo[2,1-b]thiazole and dihydro-5h-thiazolo[3,2-A]pyrimidines as antidepressant agents | KNOLL GMBH (DE) | 2005-05-31 | — | — | US | disclosed |
| US-20050113357-A1 | Muscarinic agonists | ANDERSON CARL-MAGNUS A (DK) | 2005-05-26 | — | — | US | disclosed |
| US-20050107425-A1 | Treatment of attention defecit hyperactivity disorder | PFIZER INC | 2005-05-19 | — | — | US | disclosed |
| WO-2005044008-A2 | 2 -AMINOTHIOPHENE COMPOUNDS AS FUNGICIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2005-05-19 | — | — | WO | disclosed |
| US-20050107377-A1 | Benzisoxazolyl-,pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists | AVENTIS PHARMACEUTIALS INC. (US) | 2005-05-19 | — | — | US | disclosed |
| US-20050107458-A1 | Isomeric fused pyrrolocarbazoles and isoindolones | CEPHALON, INC. (US) | 2005-05-19 | — | — | US | disclosed |
| US-6888032-B2 | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2005-05-03 | — | — | US | disclosed |
| EP-1517977-A1 | PHOTOCHROMIC LIQUID CRYSTALS | Qinetiq Limited (GB) | 2005-03-30 | — | — | EP | disclosed |
| US-6872746-B2 | Isomeric fused pyrrolocarbazoles and isoindolones | CEPHALON, INC. (US) | 2005-03-29 | — | — | US | disclosed |
| US-20050059673-A1 | Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their use | WYETH | 2005-03-17 | — | — | US | disclosed |
| US-6867298-B2 | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2005-03-15 | — | — | US | disclosed |
| US-20050054700-A1 | Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2005-03-10 | — | — | US | disclosed |
| EP-1278741-B1 | MUSCARINIC AGONISTS | ACADIA PHARM INC (US) | 2005-03-02 | — | — | EP | disclosed |
| EP-1105376-B1 | OXINDOLE DERIVATIVES AS GROWTH HORMONE RELEASERS | SUMITOMO PHARMA (JP) | 2005-02-09 | — | — | EP | disclosed |
| US-6849643-B2 | Indazolyl-substituted pyrroline compounds as kinase inhibitors | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2005-02-01 | — | — | US | disclosed |
| EP-1496892-A2 | 1H-BENZO(F)INDAZOL-5-YL DERIVATIVES AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS | Merck & Co., Inc. (US) | 2005-01-19 | — | — | EP | disclosed |
| US-20050004202-A1 | Indazolyl-substituted pyrroline compounds as kinase inhibitors | ZHANG HAN-CHENG (US) | 2005-01-06 | — | — | US | disclosed |
| EP-1492794-A1 | PIPERAZINE SUBSTITUTED ARYL BENZODIAZEPINES AND THEIR USE AS DOPAMINE RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PSYCHOTIC DISORDERS | ELI LILLY AND COMPANY (US) | 2005-01-05 | — | — | EP | disclosed |
| US-20040259928-A1 | Indazolyl-substituted pyrroline compounds as kinase inhibitors | ZHANG HAN-CHENG (US) | 2004-12-23 | — | — | US | disclosed |
| US-20040260091-A1 | Ligands for asymmetric reactions | SOLVIAS AG (CH) | 2004-12-23 | — | — | US | disclosed |
| EP-0863755-B1 | ANTITHROMBOTIC DIAMINES | LILLY CO ELI (US) | 2004-12-15 | — | — | EP | disclosed |
| US-6831093-B2 | For selectively modulating the activation, repression, agonism and antagonism effects of the glucocorticoid receptor in a patient; for therapy and prophylaxis of obesity, diabetes, depression, neurodegeneration or an inflammatory disease | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2004-12-14 | — | — | US | disclosed |
| EP-1483273-A2 | LIGANDS FOR ASYMMETRIC REACTIONS | Solvias AG (CH) | 2004-12-08 | — | — | EP | disclosed |
| US-6828332-B1 | Antagonists and partial agonists of the serotonin receptor, and activity as inhibitors of serotonin reuptake for treatment of depression | ELI LILLY AND COMPANY | 2004-12-07 | — | — | US | disclosed |
| US-20040242554-A1 | CERTAIN ARYLALIPHATIC AND HETEROARYL-ALIPHATIC PIPERAZINYL PYRAZINES AND THEIR USE IN THE TREATMENT OF SEROTONIN-RELATED DISEASES | BIOVITRUM, AB, A STOCKHOLM, SWEDEN CORPORATION | 2004-12-02 | — | — | US | disclosed |
| US-20040236104-A1 | Substituted 4-aminocyclohexanols | GRUENENTHAL GMBH (DE) | 2004-11-25 | — | — | US | disclosed |
| US-20040229910-A1 | Therapeutic compounds | N.V. ORGANON (NL) | 2004-11-18 | — | — | US | disclosed |
| WO-2004099191-A2 | BENZOFURANYL-AND BENZOTHIENYL-PIPERAZINYL QUINOLINES AS SEROTONIN REUPTAKE INHIB ITORS | WYETH (US) | 2004-11-18 | — | — | WO | disclosed |
| US-20040214822-A1 | Substituted 4-aminocyclohexanol compounds | GRUENENTHAL GMBH (DE) | 2004-10-28 | — | — | US | disclosed |
| EP-1467730-A1 | NON-STEROIDAL LIGANDS FOR THE GLUCOCORTICOID RECEPTOR, COMPOSITIONS AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2004-10-20 | — | — | EP | disclosed |
| EP-1206473-B1 | ISOMERIC FUSED PYRROLOCARBAZOLES AND ISOINDOLONES | CEPHALON INC (US) | 2004-10-20 | — | — | EP | disclosed |
| US-20040186140-A1 | Cyclic derivatives as modulators of chemokine receptor activity | BRISTOL-MYERS SQUIBB COMPANY | 2004-09-23 | — | — | US | disclosed |
| US-20040171841-A1 | COMPLEXES; USED FOR CATALYST | CIBA SPECIALTY CHEMICALS CORP. | 2004-09-02 | — | — | US | disclosed |
| WO-2004071460-A2 | CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL-MYERS SQUIBB COMPANY (US) | 2004-08-26 | — | — | WO | disclosed |
| US-20040158064-A1 | Prostaglandin endoperoxide H synthase biosynthesis inhibitors | BLACK LAWRENCE A (US) | 2004-08-12 | — | — | US | disclosed |
| WO-2004064836-A2 | TREATMENT OF DISEASES WITH ALPHA-7 NACH RECEPTOR FULL AGONISTS | PHARMACIA & UPJOHN COMPANY LLC (US) | 2004-08-05 | — | — | WO | disclosed |
| EP-1442028-A1 | SUBSTITUTED ACID DERIVATIVES USEFUL AS ANTIDIABETIC AND ANTIOBESITY AGENTS AND METHOD | Bristol-Myers Squibb Company (US) | 2004-08-04 | — | — | EP | disclosed |
| CN-1518534-A | Copper-catalyzed carbon-heteroatom and carbon-carbon bond formation | 麻省理工学院 | 2004-08-04 | — | — | CN | disclosed |
| US-20040138468-A1 | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-07-15 | — | — | US | disclosed |
| US-6759554-B2 | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2004-07-06 | — | — | US | disclosed |
| EP-1432707-A1 | AZABICYCLIC-SUBSTITUTED FUSED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE | PHARMACIA & UPJOHN COMPANY (US) | 2004-06-30 | — | — | EP | disclosed |
| WO-2004052461-A1 | COMBINATION FOR THE TREATMENT OF ADHD | PHARMACIA & UPJOHN COMPANY LLC (US) | 2004-06-24 | — | — | WO | disclosed |
| WO-2004052348-A2 | TREATMENT OF DISEASES WITH COMBINATIONS OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS AND OTHER COMPOUNDS | PHARMACIA & UPJOHN COMPANY LLC (US) | 2004-06-24 | — | — | WO | disclosed |
| EP-1425286-A1 | SUBSTITUTED 7-AZA[2.2.1]BICYCLOHEPTANES FOR THE TREATMENT OF DISEASES | PHARMACIA & UPJOHN COMPANY (US) | 2004-06-09 | — | — | EP | disclosed |
| WO-2004039366-A1 | NICOTINIC ACETYLCHOLINE AGONISTS IN THE TREATMENT OF GLAUCOMA AND RETINAL NEUROPATHY | PHARMACIA & UPJOHN COMPANY LLC (US) | 2004-05-13 | — | — | WO | disclosed |
| US-20040077654-A1 | Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression | SMITHKLINE BEECHAM CORPORATION | 2004-04-22 | — | — | US | disclosed |
| US-20040063728-A1 | 8-AZA-bicyclo[3.2.1]octan-3-OL derivative of 2,3-dihydro-1,4-benzodioxan as 5-HT 1A antagonists | WYETH | 2004-04-01 | — | — | US | disclosed |
| US-6713505-B2 | SUCH AS N-(2-((3-(AMINOOXOACETYL)-2-ETHYLBENZO(B)THIOPHEN-4-YL)OXY) ACETYL)GLYCINE; SECRETORY PHOSPHOLIPASE A2 (SPLA2) | ELI LILLY AND COMPANY | 2004-03-30 | — | — | US | disclosed |
| EP-1390340-A1 | COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2004-02-25 | — | — | EP | disclosed |
| US-6695978-B2 | FOR USE IN OPTICAL, ELECTROOPTICAL OR ELECTRONIC DEVICE, LIKE FOR EXAMPLE COMPONENTS OF INTEGRATED CIRCUITRY, FIELD EFFECT TRANSISTORS (FET) FOR EXAMPLE AS THIN FILM TRANSISTORS IN FLAT PANEL DISPLAY OR FOR RADIO FREQUENCY IDENTIFICATION TAGS | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 2004-02-24 | — | — | US | disclosed |
| WO-2004014895-A1 | PIPERAZINE SUBSTITUTED ARYL BENZODIAZEPINES | ELI LILLY AND COMPANY (US) | 2004-02-19 | — | — | WO | disclosed |
| WO-2004013094-A2 | COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2004-02-12 | — | — | WO | disclosed |
| EP-0838462-B1 | Benzothiophene compounds, intermediates, compositions, and methods | LILLY CO ELI (US) | 2004-02-11 | — | — | EP | disclosed |
| US-20040019216-A1 | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-01-29 | — | — | US | disclosed |
| WO-2004003107-A1 | POTOCHROMIC LIQUID CRYSTALS | QINETIQ LIMITED (GB) | 2004-01-08 | — | — | WO | disclosed |
| US-6673815-B2 | MODULATE BLOOD GLUCOSE LEVELS, TRIGLYCERIDE LEVELS, INSULIN LEVELS AND NON-ESTERIFIED FATTY ACID LEVELS | BRISTOL-MYERS SQUIBB COMPANY | 2004-01-06 | — | — | US | disclosed |
| US-20030236232-A1 | Novel spla2 inhibitors | ELI LILLY AND COMPANY | 2003-12-25 | — | — | US | disclosed |
| US-20030232866-A1 | 2-Substituted 5-oxazolyl indole compounds useful as IMPDH inhibitors and pharmaceutical compositions comprising same | BRISTOL-MYERS SQUIBB COMPANY | 2003-12-18 | — | — | US | disclosed |
| US-20030225276-A1 | Prostaglandin endoperoxide H synthase biosynthesis inhibitors | BLACK LAWRENCE A (US) | 2003-12-04 | — | — | US | disclosed |
| WO-2003099206-A2 | INDOLE COMPOUNDS USEFUL AS IMPDH INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2003-12-04 | — | — | WO | disclosed |
| EP-0827959-B1 | Benzo[B]thiophene compounds, intermediates, processes, compositions, and methods | LILLY CO ELI (US) | 2003-12-03 | — | — | EP | disclosed |
| US-6656951-B2 | Treating the cognitive deficits due to aging, stroke, head trauma, Alzheimer's disease, or schizophrenia; also anxiety, aggression and stress; controlling appetite, thermoregulation, sleep and sexual behavior | WYETH | 2003-12-02 | — | — | US | disclosed |
| US-20030213071-A1 | 5-Aryl-1.3.3.-trimethyl-2-methylene-indoline derivatives and salts thereof, methods for the production and use of said compounds for the temporary coloration of fibres | Wella GmbH (DE) | 2003-11-20 | — | — | US | disclosed |
| US-20030216419-A1 | Isomeric fused pyrrolocarbazoles and isoindolones | CEPHALON, INC. | 2003-11-20 | — | — | US | disclosed |
| EP-1362047-A2 | INDAZOLYL-SUBSTITUTED PYRROLINE COMPOUNDS AS KINASE INHIBITORS | Ortho-McNeil Pharmaceutical, Inc. (US) | 2003-11-19 | — | — | EP | disclosed |
| WO-2003086294-A2 | 1H-BENZO[F]INDAZOL-5-YL DERIVATIVES AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS | MERCK & CO., INC. (US) | 2003-10-23 | — | — | WO | disclosed |
| US-6635669-B2 | Kinase inhibitor; benign prostatic hyperplasia | CEPHALON, INC. | 2003-10-21 | — | — | US | disclosed |
| WO-2003082877-A1 | PIPERAZINE SUBSTITUTED ARYL BENZODIAZEPINES AND THEIR USE AS DOPAMINE RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PSYCHOTIC DISORDERS | ELI LILLY AND COMPANY (US) | 2003-10-09 | — | — | WO | disclosed |
| US-6627645-B2 | Cholinergic agents | ACADIA PHARMACEUTICALS, INC. | 2003-09-30 | — | — | US | disclosed |
| US-20030176478-A1 | Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof | NIH-DEITR | 2003-09-18 | — | — | US | disclosed |
| US-20030166628-A1 | Dihydroimidazo[2,1-b]thiazole and dihydro-5h-thiazolo[3,2-A]pyrimidines as antidepressant agents | KNOLL GMBH (DE) | 2003-09-04 | — | — | US | disclosed |
| US-20030153604-A1 | Substituted (aminoiminomethyl or aminomethyl) benzoheteroaryl compounds | AVENTIS PHARMACEUTICALS INC. | 2003-08-14 | — | — | US | disclosed |
| US-20030153595-A1 | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease | PHARMACIA & UPJOHN COMPANY | 2003-08-14 | — | — | US | disclosed |
| EP-1216244-B1 | Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as D4 antagonists | AVENTIS PHARMA INC (US) | 2003-08-13 | — | — | EP | disclosed |
| WO-2003061651-A1 | NON-STEROIDAL LIGANDS FOR THE GLUCOCORTICOID RECEPTOR, COMPOSITIONS AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2003-07-31 | — | — | WO | disclosed |
| EP-0832891-B1 | Dihydrobenzo (B) indeno (2,1-D) thiophene compounds, intermediates, processes, compositions, and methods | LILLY CO ELI (US) | 2003-07-30 | — | — | EP | disclosed |
| US-20030130306-A1 | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method | BRISTOL-MYERS SQUIBB COMPANY | 2003-07-10 | — | — | US | disclosed |
| EP-0832890-B1 | Benzo (B) indeno (2,1-D) thiophene compounds, intermediates, processes, compositions, and methods | LILLY CO ELI (US) | 2003-07-02 | — | — | EP | disclosed |
| US-6586357-B1 | Stereospecific catalysts; enantioselective reduction; transition metal complexes | CHEMI S.P.A. (IT) | 2003-07-01 | — | — | US | disclosed |
| US-6576656-B1 | Such as 1-(2-diethylaminoethyl)-4-trifluoromethyl-6-carbamoyl-3-hydroxy-3-(2 -chlorophenyl)oxindole; growth hormone releaser | SUMITOMO PHARMACEUTICALS CO., LTD. (JP) | 2003-06-10 | — | — | US | disclosed |
| US-20030105089-A1 | Substituted 7-aza[2.2.1]bicycloheptanes for the treatment of disease | PHARMACIA & UPJOHN COMPANY | 2003-06-05 | — | — | US | disclosed |
| WO-2003040114-A1 | SUBSTITUTED ACID DERIVATIVES USEFUL AS ANTIDIABETIC AND ANTIOBESITY AGENTS AND METHOD | BRISTOL-MYERS SQUIBB COMPANY (US) | 2003-05-15 | — | — | WO | disclosed |
| US-20030092694-A1 | Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases | BIOVITRUM, AB, A STOCKHOLM, SWEDEN CORPORATION | 2003-05-15 | — | — | US | disclosed |
| US-20030085381-A1 | Mono-, oligo- and polymers of benzo[b]thiophene and 2,2'-bisbenzo[b]thiophene and their use as charge transport materials | MERCK PATENT GMBH (DE) | 2003-05-08 | — | — | US | disclosed |
| US-20030073832-A1 | Novel aminophenyl ketone derivatives | LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) | 2003-04-17 | — | — | US | disclosed |
| WO-2003031456-A2 | LIGANDS FOR ASYMMETRIC REACTIONS | SOLVIAS AG (CH) | 2003-04-17 | — | — | WO | disclosed |
| US-20030073850-A1 | 4-Imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use | ABBOTT LABORATORIES | 2003-04-17 | — | — | US | disclosed |
| WO-2003029252-A1 | AZABICYCLIC-SUBSTITUTED FUSED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE | PHARMACIA & UPJOHN COMPANY (US) | 2003-04-10 | — | — | WO | disclosed |
| EP-1300430-A1 | Mono-, oligo- and polymers of benzo[b]thiophene and 2,2'-bisbenzo[b]thiophene and their use as charge transport materials | MERCK PATENT GmbH (DE) | 2003-04-09 | — | — | EP | disclosed |
| US-20030065187-A1 | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-04-03 | — | — | US | disclosed |
| US-6541505-B1 | Inhibiting the activity of Factor Xa; treating a disease state associated with a physiologically detrimental excess amount of thrombin. | AVENTIS PHARMACEUTICALS INC. | 2003-04-01 | — | — | US | disclosed |
| WO-2003022856-A1 | SUBSTITUTED 7-AZA[2.2.1] BICYCLOHEPTANES FOR THE TREATMENT OF DISEASES | PHARMACIA & UPJOHN COMPANY (US) | 2003-03-20 | — | — | WO | disclosed |
| US-20030055097-A1 | Indazolyl-substituted pyrroline compounds as kinase inhibitors | ORTHO-MCNEIL PHARMACEUTICAL, INC. | 2003-03-20 | — | — | US | disclosed |
| US-20030045540-A1 | Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease | PHARMACIA & UPJOHN COMPANY | 2003-03-06 | — | — | US | disclosed |
| US-20030032648-A1 | 8-Aza-bicyclo[3.2.1]octan-3-ol derivatives of 2,3-dihydro-1,4-benodioxan as 5-HT1A antagonists | WYETH | 2003-02-13 | — | — | US | disclosed |
| EP-1278741-A1 | MUSCARINIC AGONISTS | Acadia Pharmaceuticals Inc. (US) | 2003-01-29 | — | — | EP | disclosed |
| EP-1268489-A1 | DIHYDROIMIDAZO[2,1-B]THIAZOLE AND DIHYDRO-5H-THIAZOLO[3,2-A]PYRIMIDINES AS ANTIDEPRESSANT AGENTS | Knoll GmbH (DE) | 2003-01-02 | — | — | EP | disclosed |
| EP-0997460-B1 | Benzothiophene compounds as antithrombotic agents and intermediates | LILLY CO ELI (US) | 2002-12-11 | — | — | EP | disclosed |
| EP-1077967-B1 | BIPHENYL OXO-ACETIC ACIDS USEFUL IN THE TREATMENT OF INSULIN RESISTANCE AND HYPERGLYCEMIA | WYETH CORP (US) | 2002-12-04 | — | — | EP | disclosed |
| EP-1259491-A1 | 4-IMIDAZOLE DERIVATIVES OF BENZYL AND RESTRICTED BENZYL SULFONAMIDES, SULFAMIDES, UREAS, CARBAMATES AND AMIDES AND THEIR USE AS ALPHA-1A AGONISTS | Abbott Laboratories (US) | 2002-11-27 | — | — | EP | disclosed |
| EP-1077966-B1 | BIPHENYL SULFONYL ARYL CARBOXYLIC ACIDS USEFUL IN THE TREATMENT OF INSULIN RESISTANCE AND HYPERGLYCEMIA | WYETH CORP (US) | 2002-11-20 | — | — | EP | disclosed |
| WO-2002085838-A1 | COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2002-10-31 | — | — | WO | disclosed |
| WO-2002085900-A1 | 8-AZA-BICYCLO[3.2.1]OCTAN-3-OL DERIVATIVES OF 2,3-DIHYDRO-1,4-BENZODIOXAN AS 5-HT1A ANTAGONISTS | WYETH (US) | 2002-10-31 | — | — | WO | disclosed |
| WO-2002083622-A2 | NOVEL AMINOPHENYL KETONE DERIVATIVES | LEO PHARMA A/S (DK) | 2002-10-24 | — | — | WO | disclosed |
| US-6465467-B1 | DISEASES RELATED TO THE 5-HT2C RECEPTOR, ESPECIALLY EATING, MEMORY, MOOD, URINARY AND ANXIETY DISORDERS, SCHIZOPHRENIA, PAIN, SEXUAL DYSFUNCTIONS | BIOVITRUM AB (SE) | 2002-10-15 | — | — | US | disclosed |
| US-20020147341-A1 | Isomeric fused pyrrolocarbazoles and isoindolones | CEPHALON, INC. | 2002-10-10 | — | — | US | disclosed |
| EP-1216244-A1 | Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as D4 antagonists | Aventis Pharmaceuticals Inc. (US) | 2002-06-26 | — | — | EP | disclosed |
| WO-2002046183-A2 | INDAZOLYL-SUBSTITUTED PYRROLINE COMPOUNDS AS KINASE INHIBITORS | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2002-06-13 | — | — | WO | disclosed |
| US-6399780-B1 | KINASE INHIBITORS; ANTICANCER AGENTS | CEPHALON, INC. | 2002-06-04 | — | — | US | disclosed |
| EP-1206473-A1 | ISOMERIC FUSED PYRROLOCARBAZOLES AND ISOINDOLONES | CEPHALON, INC. (US) | 2002-05-22 | — | — | EP | disclosed |
| US-6391897-B2 | (4'-BENZOFURAN-3-YL-BIPHENYL-4-YLOXY)-ACETIC ACID, FOR EXAMPLE; INHIBIT PROTEIN-TYROSINE PHOSPHATASES (PTPASES) | AMERICAN HOME PRODUCTS CORPORATION | 2002-05-21 | — | — | US | disclosed |
| US-6369072-B2 | Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia | AMERICAN HOME PRODUCTS CORPORATION | 2002-04-09 | — | — | US | disclosed |
| US-20020037886-A1 | Muscarinic agonists | ACADIA PHARMACEUTICALS INC. | 2002-03-28 | — | — | US | disclosed |
| US-20020037885-A1 | Therapeutic compounds | DIJCKS FREDERICUS ANTONIUS (NL) | 2002-03-28 | — | — | US | disclosed |
| EP-1187836-A1 | SUBSTITUTED IMIDAZOTHIAZOLES AS ANTIDEPRESSANT AGENTS | Knoll GmbH (DE) | 2002-03-20 | — | — | EP | disclosed |
| US-6358972-B1 | FOR THERAPY OF MIGRAINE | ELI LILLY AND COMPANY | 2002-03-19 | — | — | US | disclosed |
| US-20020028938-A1 | Prostaglandin endoperoxide H synthase biosynthesis inhibitors | BLACK LAWRENCE A (US) | 2002-03-07 | — | — | US | disclosed |
| EP-1178973-A2 | NOVEL COMPOUNDS, THEIR USE AND PREPARATION | Pharmacia AB (SE) | 2002-02-13 | — | — | EP | disclosed |
| EP-1178993-A1 | THIAZOLODERIATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Knoll GmbH (DE) | 2002-02-13 | — | — | EP | disclosed |
| US-20020013318-A1 | Prostaglandin endoperoxide H synthase biosynthesis inhibitors | BLACK LAWRENCE A (US) | 2002-01-31 | — | — | US | disclosed |
| US-20010053785-A1 | Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia | WYETH | 2001-12-20 | — | — | US | disclosed |
| US-20010041715-A1 | Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia | AMERICAN HOME PRODUCTS | 2001-11-15 | — | — | US | disclosed |
| WO-2001083472-A1 | MUSCARINIC AGONISTS | ACADIA PHARMACEUTICALS, INC. (US) | 2001-11-08 | — | — | WO | disclosed |
| US-6313139-B1 | ADMINISTERING BENZYLAMINE DERIVATIVE FOR THERAPY OF PSYCHIATRIC DISORDER IN MAMMALS | AKZO NOBEL N. V. (NL) | 2001-11-06 | — | — | US | disclosed |
| EP-0729956-B1 | Benzothiophene compounds, intermediates, compositions, and methods | LILLY CO ELI (US) | 2001-10-31 | — | — | EP | disclosed |
| US-6310081-B1 | PROTEIN TYROSINE PHOSPHATASE INHIBITORS | AMERICAN HOME PRODUCTS CORPORATION | 2001-10-30 | — | — | US | disclosed |
| US-6307047-B1 | PYRIDAZINONE COMPOUNDS; INHIBITORS OF CYCLOOXYGENASE-2 (COX-2); SELECTIVITY OF THESE COMPOUNDS FOR COX-2 MINIMIZES THE UNWANTED GI AND RENAL SIDE-EFFECTS SEEN WITH CURRENTLY MARKETED NON-STEROIDAL ANTI-INFLAMMATORY DRUGS | ABBOTT LABORATORIES | 2001-10-23 | — | — | US | disclosed |
| EP-1140901-A2 | SUBSTITUTED (AMINOIMINOMETHYL OR AMINOMETHYL)BENZOHETEROARYL COMPOUNDS AS FACTOR XA INHIBITORS | Aventis Pharmaceuticals Products Inc. (US) | 2001-10-10 | — | — | EP | disclosed |
| US-6297387-B1 | AND THEIR USE AS CHIRAL CATALYSTS IN STEREOCONTROLLED REACTIONS, SUCH AS DIASTEREO- AND ENANTIOSELECTIVE REDUCTION REACTIONS, | ITALFARMACO SUD S.P.A. (IT) | 2001-10-02 | — | — | US | disclosed |
| EP-0626968-B1 | PIPERIDINYL THIACYCLIC DERIVATIVES | MERRELL PHARMA INC (US) | 2001-09-26 | — | — | EP | disclosed |
| WO-2001068653-A1 | DIHYDROIMIDAZO[2,1-B]THIAZOLE AND DIHYDRO-5H-THIAZOLO[3,2-A]PYRIMIDINES AS ANTIDEPRESSANT AGENTS | KNOLL GMBH (DE) | 2001-09-20 | — | — | WO | disclosed |
| WO-2001060802-A1 | 4-IMIDAZOLE DERIVATIVES OF BENZYL AND RESTRICTED BENZYL SULFONAMIDES, SULFAMIDES, UREAS, CARBAMATES, AND AMIDES AND THEIR USE AS ALPHA-1A AGONISTS | ABBOTT LABORATORIES (US) | 2001-08-23 | — | — | WO | disclosed |
| EP-1124804-A1 | PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE BIOSYNTHESIS INHIBITORS | ABBOTT LABORATORIES (US) | 2001-08-22 | — | — | EP | disclosed |
| US-6265575-B1 | THROMBIN INHIBITORS | ELI LILLY AND COMPANY | 2001-07-24 | — | — | US | disclosed |
| EP-1113013-A1 | Benzothiophene compounds, intermediates, compositions and methods | Eli Lilly & Company (US) | 2001-07-04 | — | — | EP | disclosed |
| US-6251921-B1 | ADMINISTERING THROMBIN INHIBITING DIAMINE COMPOUND TO MAMMAL | ELI LILLY AND COMPANY | 2001-06-26 | — | — | US | disclosed |
| EP-1105376-A1 | OXINDOLE DERIVATIVES AS GROWTH HORMONE RELEASERS | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 2001-06-13 | — | — | EP | disclosed |
| EP-0888331-A4 | SYNTHESIS OF 3-[4-(2-AMINOETHOXY)-BENZOYL]-2-ARYL-6-HYDROXY-BENZO[b]THIOPHENES | LILLY CO ELI (US) | 2001-05-23 | — | — | EP | disclosed |
| US-6232322-B1 | SUCH AS (4'-BENZOFURAN-3-YL-BIPHENYL-4-YLOXY)-ACETIC ACID OR SALT | AMERICAN HOME PRODUCTS CORPORATION | 2001-05-15 | — | — | US | disclosed |
| US-6221902-B1 | HYPOGLYCEMIC AGENTS; ANTIDIABETIC AGENTS | AMERICAN HOME PRODUCTS CORPORATION | 2001-04-24 | — | — | US | disclosed |
| EP-1089993-A1 | 5-HT1F AGONISTS | ELI LILLY AND COMPANY (US) | 2001-04-11 | — | — | EP | disclosed |
| WO-2001023381-A1 | PIPERIDINE DERIVATIVES AS REUPTAKE INHIBITORS | ELI LILLY AND COMPANY (US) | 2001-04-05 | — | — | WO | disclosed |
| WO-2001019821-A1 | BENZISOXAZOLYL-, PYRIDOISOXAZOLYL- AND BENZTHIENYL-PHENOXY DERIVATIVES USEFUL AS D4 ANTAGONISTS | AVENTIS PHARMACEUTICALS INC. (US) | 2001-03-22 | — | — | WO | disclosed |
| US-6197790-B1 | OSTEOPOROSIS | ELI LILLY AND COMPANY | 2001-03-06 | — | — | US | disclosed |
| WO-2001014380-A1 | ISOMERIC FUSED PYRROLOCARBAZOLES AND ISOINDOLONES | CEPHALON, INC. (US) | 2001-03-01 | — | — | WO | disclosed |
| EP-1077966-A1 | BIPHENYL SULFONYL ARYL CARBOXYLIC ACIDS USEFUL IN THE TREATMENT OF INSULIN RESISTANCE AND HYPERGLYCEMIA | AMERICAN HOME PRODUCTS CORPORATION (US) | 2001-02-28 | — | — | EP | disclosed |
| EP-1077967-A2 | BIPHENYL OXO-ACETIC ACIDS USEFUL IN THE TREATMENT OF INSULIN RESISTANCE AND HYPERGLYCEMIA | AMERICAN HOME PRODUCTS CORPORATION (US) | 2001-02-28 | — | — | EP | disclosed |
| EP-1077213-A2 | Inhibition of serotonin reuptake | ELI LILLY AND COMPANY (US) | 2001-02-21 | — | — | EP | disclosed |
| WO-2001007431-A2 | BENZOTHIOPHENE DERIVATIVES | ELI LILLY AND COMPANY (US) | 2001-02-01 | — | — | WO | disclosed |
| WO-2000076984-A2 | NOVEL COMPOUNDS, THEIR USE AND PREPARATION | BIOVITRUM AB (SE) | 2000-12-21 | — | — | WO | disclosed |
| WO-2000071549-A1 | THIAZOLODERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | KNOLL GMBH (DE) | 2000-11-30 | — | — | WO | disclosed |
| WO-2000071548-A1 | SUBSTITUTED IMIDAZOTHIAZOLES AS ANTIDEPRESSANT AGENTS | KNOLL GMBH (DE) | 2000-11-30 | — | — | WO | disclosed |
| US-6133262-A | 3-AMINOBENZO(B)THIOPHENE DERIVATIVES | ELI LILLY AND COMPANY (US) | 2000-10-17 | — | — | US | disclosed |
| US-6133458-A | FOR INHIBITING BONE LOSS OR BONE RESORPTION, PARTICULARLY OSTEOPOROSIS, CARDIOVASCULAR-RELATED PATHOLOGICAL CONDITIONS INCLUDING HYPERLIPIDEMIA AND RELATED CARDIOVASCULAR PATHOLOGIES, AND ESTROGEN-DEPENDENT CANCER | ELI LILLY AND COMPANY (US) | 2000-10-17 | — | — | US | disclosed |
| US-6133191-A | Heteroaromatic diphosphines as chiral ligands | ITALFARMACO SUD S.P.A. (IT) | 2000-10-17 | — | — | US | disclosed |
| EP-1035843-A2 | I h?-MODULATORS | Akzo Nobel N.V. (NL) | 2000-09-20 | — | — | EP | disclosed |
| US-6107307-A | PSYCHOLOGICAL DISORDERS | ELI LILLY AND COMPANY (US) | 2000-08-22 | — | — | US | disclosed |
| EP-1026179-A1 | Process for preparing polyolefins with a broad molecular weight distribution | Elenac GmbH (DE) | 2000-08-09 | — | — | EP | disclosed |
| WO-2000039087-A2 | SUBSTITUTED (AMINOIMINOMETHYL OR AMINOMETHYL)BENZOHETEROARYL COMPOUNDS AS FACTOR XA INHIBITORS | AVENTIS PHARMACEUTICALS PRODUCTS INC. (US) | 2000-07-06 | — | — | WO | disclosed |
| US-6080773-A | USEFUL FOR TREATMENT OF DEPRESSION, ANXIETY OR PSYCHOSIS | AKZO NOBEL, N.V. (NL) | 2000-06-27 | — | — | US | disclosed |
| US-6077958-A | Heteroaromatic diphosphines as chiral ligands | ITALFARMACO SUD S.P.A. (IT) | 2000-06-20 | — | — | US | disclosed |
| EP-1007515-A1 | ARYLPYRIDAZINONES AS PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE BIOSYNTHESIS INHIBITORS | Abbott Laboratories (US) | 2000-06-14 | — | — | EP | disclosed |
| WO-2000024719-A1 | PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE BIOSYNTHESIS INHIBITORS | ABBOTT LABORATORIES (US) | 2000-05-04 | — | — | WO | disclosed |
| EP-0997460-A1 | Benzothiophene compounds as antithrombotic agents and intermediates | ELI LILLY AND COMPANY (US) | 2000-05-03 | — | — | EP | disclosed |
| US-6046215-A | A PIPERIDINYLBENZOTHIOPHENES USEFUL FOR TRATING BRAIN DISORDERS | ELI LILLY AND COMPANY (US) | 2000-04-04 | — | — | US | disclosed |
| US-6043360-A | Intermediates and a process for preparing benzo[B]thiophenes | ELI LILLY AND COMPANY (US) | 2000-03-28 | — | — | US | disclosed |
| WO-2000010975-A1 | OXINDOLE DERIVATIVES AS GROWTH HORMONE RELEASERS | SUMITOMO PHARMACEUTICALS CO., LTD. (JP) | 2000-03-02 | — | — | WO | disclosed |
| US-6030986-A | POST-MENOPAUSAL SYNDROME, UTERINE FIBROID DISEASE, ENDOMETRIOSIS, AND AORTAL SMOOTH MUSCLE CELL PROLIFERATION; ESTROGEN INDUCED UTERINE CANCER; OSTEOPOROSIS; RESTENOSIS; CARDIOVASCULAR DISORDERS | ELI LILLY AND COMPANY (US) | 2000-02-29 | — | — | US | disclosed |
| US-6025382-A | Antithrombotic diamines | ELI LILLY AND COMPANY (US) | 2000-02-15 | — | — | US | disclosed |
| WO-2000000487-A1 | 5-HT1F AGONISTS | ELI LILLY AND COMPANY (US) | 2000-01-06 | — | — | WO | disclosed |
| WO-2000000490-A2 | 5-HT1F AGONISTS | ELI LILLY AND COMPANY (US) | 2000-01-06 | — | — | WO | disclosed |
| EP-0969005-A1 | Azabicyclic inhibitors of serotonin reuptake | ELI LILLY AND COMPANY (US) | 2000-01-05 | — | — | EP | disclosed |
| US-6008377-A | ACYLATING A N-DISUBSTITUED-PHENYLOXYETHYLAMINE CHLORO OR BROMO SALT WITH A BENZOTHIOPHENE DERIVATIVE IN PRESENCE OF TRIBOROCHLORIDE OR BROMIDE, DEALKYLATING ONE OR MORE PHENOLIC GROUP OF THE PRODUCT WITH ADDITIONAL BOROHALIDE | ELI LILLY AND COMPANY (US) | 1999-12-28 | — | — | US | disclosed |
| WO-1999065492-A1 | INHIBITION OF SEROTONIN REUPTAKE | ELI LILLY AND COMPANY (US) | 1999-12-23 | — | — | WO | disclosed |
| US-5998441-A | ANTICHOLESTEROL AGENT; MIXTURE WITH ESTROGEN | ELI LILLY AND COMPANY (US) | 1999-12-07 | — | — | US | disclosed |
| WO-1999058520-A1 | BIPHENYL SULFONYL ARYL CARBOXYLIC ACIDS USEFUL IN THE TREATMENT OF INSULIN RESISTANCE AND HYPERGLYCEMIA | AMERICAN HOME PRODUCTS CORPORATION (US) | 1999-11-18 | — | — | WO | disclosed |
| WO-1999058518-A2 | BIPHENYL OXO-ACETIC ACIDS USEFUL IN THE TREATMENT OF INSULIN RESISTANCE AND HYPERGLYCEMIA | AMERICAN HOME PRODUCTS CORPORATION (US) | 1999-11-18 | — | — | WO | disclosed |
| US-5985897-A | METHODS OF INHIBITING BONE LOSS OR BONE RESORPTION, PARTICULARLY OSTEOPOROSIS, AND CARDIOVASCULAR-RELATED PATHOLOGICAL CONDITIONS, INCLUDING HYPERLIPIDEMIA, AND ESTROGEN-DEPENDENT CANCER | ELI LILLY AND COMPANY | 1999-11-16 | — | — | US | disclosed |
| US-5986109-A | UROGENITAL DISORDERS, CARDIOVASCULAR DISORDERS AND ANTICARCINOGENIC AGENTS | ELI LILLY AND COMPANY (US) | 1999-11-16 | — | — | US | disclosed |
| US-5985898-A | INHIBITING HYPERLIPIDEMIA RESULTED FROM ESTROGEN DEFICIENCY DISEASE, REDUCING SERUM CHOLESTEROL, | ELI LILLY AND COMPANY (US) | 1999-11-16 | — | — | US | disclosed |
| US-5981765-A | FOR TREATMENT OF POST-MENOPAUSAL SYNDROME INCLUDING OSTEOPOROSIS, CARDIOVASCULAR EFFECTS SUCH AS HYPERLIPIDEMIA, AND ESTROGEN-DEPENDENT CANCER, PARTICULARLY BREAST AND UTERINE CANCER | ELI LILLY AND COMPANY (US) | 1999-11-09 | — | — | US | disclosed |
| US-5977382-A | Benzo[b]thiophene compounds, intermediates, processes, compositions, and methods | ELI LILLY AND COMPANY (US) | 1999-11-02 | — | — | US | disclosed |
| US-5977093-A | INHIBITING ESTROGEN-DEPENDENT CANCER | ELI LILLY AND COMPANY (US) | 1999-11-02 | — | — | US | disclosed |
| US-5977098-A | Benzo[B]thiophene compounds, intermediates, processes, compositions, and methods | ELI LILLY AND COMPANY (US) | 1999-11-02 | — | — | US | disclosed |
| US-5969142-A | OXIDIZING SULFUR ATOM OF SUBSTITUTED BENZOTHIOPHENE, REACTING PRODUCT WITH NUCLEOPHILIC GROUP, REDUCING PRODUCT TO DESIRED COMPOUND | ELI LILLY AND COMPANY (US) | 1999-10-19 | — | — | US | disclosed |
| EP-0770085-B1 | HETEROAROMATIC DIPHOSPHINES AS CHIRAL LIGANDS | CHEMI SPA (IT) | 1999-09-22 | — | — | EP | disclosed |
| US-5952513-A | TREATING POSTMENOPAUSAL SYNDROME SUCH AS OSTEOPOROSIS | ELI LILLY AND COMPANY (US) | 1999-09-14 | — | — | US | disclosed |
| US-RE36256-E | ADMINISTERING ARYL-SUBSTITUTED QUINOXALINE DERIVATIVES AS ANTIPROLIFERATIVE, ANTICARCINOGENIC AND ANTITUMOR AGENTS | RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) | 1999-07-20 | — | — | US | disclosed |
| US-5919800-A | INHIBITING ENDOMETRIOSIS BY ADMISTERING (6-HYDROXY-3-(4-(2-(1-PIPERIDINYL)ETHOXY)PHENOXY)-2-(4-METHOXYPHENYL))BENZO B)THIOPHENE OR THE HYDROCHLORIDE SALT THEREOF | ELI LILLY AND COMPANY (US) | 1999-07-06 | — | — | US | disclosed |
| US-5907045-A | Heteroaromatic diphosphines as chiral ligands | ITALFARMACO SUD S.P.A. (IT) | 1999-05-25 | — | — | US | disclosed |
| WO-1999018941-A2 | Ih-MODULATORS | AKZO NOBEL N.V. (NL) | 1999-04-22 | — | — | WO | disclosed |
| WO-1999010331-A1 | ARYLPYRIDAZINONES AS PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE BIOSYNTHESIS INHIBITORS | ABBOTT LABORATORIES (US) | 1999-03-04 | — | — | WO | disclosed |
| US-5874427-A | MIGRAINE | ELI LILLY AND COMPANY (US) | 1999-02-23 | — | — | US | disclosed |
| EP-0888331-A1 | SYNTHESIS OF 3-[4-(2-AMINOETHOXY)-BENZOYL]-2-ARYL-6-HYDROXY-BENZO[b]THIOPHENES | ELI LILLY AND COMPANY (US) | 1999-01-07 | — | — | EP | disclosed |
| US-5856339-A | POST-MENOPAUSAL SYNDROME, AND UTERINE FIBROID DISEASE, ENDOMETRIOSIS, AND AORTAL SMOOTH MUSCLE CELL PROLIFERATION. | ELI LILLY AND COMPANY (US) | 1999-01-05 | — | — | US | disclosed |
| US-5856341-A | INHIBITING BONE LOSS OR BONE RESORPTION, PARTICULARLY OSTEOPOROSIS, CARDIOVASCULAR-RELATED PATHOLOGICAL CONDITIONS INCLUDING HYPERLIPIDEMIA, ESTROGEN-DEPENDENT CANCER | ELI LILLY AND COMPANY (US) | 1999-01-05 | — | — | US | disclosed |
| US-5856340-A | 2-PHENYL-3-/ALKOXYPHENOXY OR PHENYLTHIO/BENZOTHIOPHENES | ELI LILLY AND COMPANY (US) | 1999-01-05 | — | — | US | disclosed |
| US-5846982-A | Inhibition of serotonin reuptake | ELI LILLY AND COMPANY (US) | 1998-12-08 | — | — | US | disclosed |
| US-5843965-A | Benzo B! thiophene compounds, intermediates, processes, compositions, and methods | ELI LILLY AND COMPANY (US) | 1998-12-01 | — | — | US | disclosed |
| EP-0878474-A2 | Intermediates and a process for preparing benzo[b]thiophenes | ELI LILLY AND COMPANY (US) | 1998-11-18 | — | — | EP | disclosed |
| US-5834488-A | INHIBIT BONE LOSS OR BONE RESORPTION, LOWER SERUM CHOLESTEROL LEVELS, INHIBIT ESTROGEN-DEPENDENT CANCER | ELI LILLY AND COMPANY (US) | 1998-11-10 | — | — | US | disclosed |
| EP-0875513-A1 | Substituted heteroaromatic 5-HT 1F agonists | ELI LILLY AND COMPANY (US) | 1998-11-04 | — | — | EP | disclosed |
| WO-1998046570-A1 | SUBSTITUTED HETEROAROMATIC 5-HT1F AGONISTS | ELI LILLY AND COMPANY (US) | 1998-10-22 | — | — | WO | disclosed |
| US-5795889-A | INHIBITING CELL GROWTH WITH ENZYME INHIBITORS FOR SKIN DISORDERS | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1998-08-18 | — | — | US | disclosed |
| EP-0838462-A1 | Benzothiophene compounds, intermediates, compositions, and methods | ELI LILLY AND COMPANY (US) | 1998-04-29 | — | — | EP | disclosed |
| US-5739150-A | Piperidinyl thiacyclic derivatives | MERRELL PHARMACEUTICALS INC. (US) | 1998-04-14 | — | — | US | disclosed |
| EP-0832891-A1 | Dihydrobenzo (B) indeno (2,1-D) thiophene compounds, intermediates, processes, compositions, and methods | ELI LILLY AND COMPANY (US) | 1998-04-01 | — | — | EP | disclosed |
| EP-0832890-A1 | Benzo (B) indeno (2,1-D) thiophene compounds, intermediates, processes, compositions, and methods | ELI LILLY AND COMPANY (US) | 1998-04-01 | — | — | EP | disclosed |
| EP-0827959-A2 | Benzo[B]thiophene compounds, intermediates, processes, compositions, and methods | ELI LILLY AND COMPANY (US) | 1998-03-11 | — | — | EP | disclosed |
| US-5723474-A | TREATING POST-MENOPAUSAL SYNDROME, UTERINE FIBROID DISEASE, ENDOMETRIOSIS, AND AORTAL SMOOTH MUSCLE CELL PROLIFERATION; ANTIESTROGENS | ELI LILLY AND COMPANY (US) | 1998-03-03 | — | — | US | disclosed |
| WO-1997047302-A1 | INHIBITION OF SEROTONIN REUPTAKE | ELI LILLY AND COMPANY (US) | 1997-12-18 | — | — | WO | disclosed |
| EP-0812826-A1 | 1H-indole and benzo(b)thiophene derivatives with 4-(1,2,3,6-tetra:hydro:pyridinyl)- and 4-piperidinyl-groups bound to the heterocyclic ring as inhibitors of serotonin reuptake | ELI LILLY AND COMPANY (US) | 1997-12-17 | — | — | EP | disclosed |
| WO-1997034888-A1 | SYNTHESIS OF 3-[4-(2-AMINOETHOXY)-BENZOYL]-2-ARYL-6-HYDROXY-BENZO[b]THIOPHENES | ELI LILLY AND COMPANY (US) | 1997-09-25 | — | — | WO | disclosed |
| US-5656643-A | QUINOLIN PYRIDINE DERIVATIVES; USEFUL FOR TREATING CANCER, LEKEMIA, PSORIASIS, INFLAMMATORY DISODERS, BONE DISORDERS, ATHEROSCLEROSIS AND RESTENOSIS; CONTROLLS CELLULAR REPRODUCTION | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1997-08-12 | — | — | US | disclosed |
| US-5650416-A | Piperidinyl thiacyclic derivatives | MERRELL PHARMACEUTICALS INC. (US) | 1997-07-22 | — | — | US | disclosed |
| US-5646153-A | INHIBITING ABNORMAL CELL PROLIFERATION | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1997-07-08 | — | — | US | disclosed |
| US-5631268-A | ANTIALLERGENS, 5HT2 RECEPTOR ANTAGONISTS | MERRELL PHARMACEUTICALS INC. (US) | 1997-05-20 | — | — | US | disclosed |
| EP-0771796-A1 | Substituted S-triazines and process for their preparation | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-05-07 | — | — | EP | disclosed |
| EP-0770085-A1 | HETEROAROMATIC DIPHOSPHINES AS CHIRAL LIGANDS | ITALFARMACO SUD S.p.A. (IT) | 1997-05-02 | — | — | EP | disclosed |
| US-5602147-A | Piperidinyl thiacyclic derivatives | MERRELL PHARMACEUTICALS INC. (US) | 1997-02-11 | — | — | US | disclosed |
| US-5599937-A | Heteroaromatic quinuclidinenes, their use and preparation | PHARMACIA AB (SE) | 1997-02-04 | — | — | US | disclosed |
| US-5596003-A | Piperidinyl thiacyclic derivatives | MERRELL PHARMACEUTICALS INC. (US) | 1997-01-21 | — | — | US | disclosed |
| EP-0729956-A1 | Benzothiophene compounds, intermediates, compositions, and methods | ELI LILLY AND COMPANY (US) | 1996-09-04 | — | — | EP | disclosed |
| US-5541200-A | Piperidinyl thiacyclic derivatives | MERRELL PHARMACEUTICALS INC. (US) | 1996-07-30 | — | — | US | disclosed |
| US-5510357-A | POST-MENOPAUSAL SYNDROME, ENDOMETRIOSIS | ELI LILLY AND COMPANY (US) | 1996-04-23 | — | — | US | disclosed |
| US-5510498-A | Benzothiophene compounds, intermediates, compositions, and methods | ELI LILLY AND COMPANY (US) | 1996-04-23 | — | — | US | disclosed |
| US-5510358-A | OSTEOPOROSIS | ELI LILLY AND COMPANY (US) | 1996-04-23 | — | — | US | disclosed |
| US-5492922-A | PREVENTING RESTENOSIS | ELI LILLY AND COMPANY (US) | 1996-02-20 | — | — | US | disclosed |
| US-5488058-A | UROGENITAL DISORDERS OR OSTEOPOROSIS | ELI LILLY AND COMPANY (US) | 1996-01-30 | — | — | US | disclosed |
| WO-1996001831-A1 | HETEROAROMATIC DIPHOSPHINES AS CHIRAL LIGANDS | ITALFARMACO SUD S.P.A. (IT) | 1996-01-25 | — | — | WO | disclosed |
| US-5480883-A | Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1996-01-02 | — | — | US | disclosed |
| US-5476861-A | Piperidinyl thiacyclic derivatives | MERRELL DOW PHARMACEURICALS INC. (US) | 1995-12-19 | — | — | US | disclosed |
| US-5409930-A | Inhibits abnoramal cell proliferation; dimethoxyquinoline/ dimethylquinoline/ quinolineoxide/ and quinoxaline derivatives | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1995-04-25 | — | — | US | disclosed |
| EP-0640082-A1 | HETEROAROMATIC QUINUCLIDINENES, THEIR USE AND PREPARATION | Pharmacia & Upjohn Aktiebolag (SE) | 1995-03-01 | — | — | EP | disclosed |
| EP-0626968-A4 | — | — | 1995-01-04 | — | — | EP | disclosed |
| EP-0626968-A1 | PIPERIDINYL THIACYCLIC DERIVATIVES | MERRELL PHARMACEUTICALS INC. (US) | 1994-12-07 | — | — | EP | disclosed |
| US-5371093-A | Piperidinyl thiacyclic derivatives | MERRELL DOW PHARMACEUTICALS INC. (US) | 1994-12-06 | — | — | US | disclosed |
| US-5340833-A | Antiarthritic, antiinflammatory, antitumor agents | EISAI CO., LTD. (JP) | 1994-08-23 | — | — | US | disclosed |
| US-5276024-A | 3-substituted cephalosporins, and their use as medicaments | BAYER AKTIENGESELLSCHAFT (DE) | 1994-01-04 | — | — | US | disclosed |
| WO-1993023395-A1 | HETEROAROMATIC QUINUCLIDINENES, THEIR USE AND PREPARATION | KABI PHARMACIA AB (SE) | 1993-11-25 | — | — | WO | disclosed |
| US-5260294-A | Treatment of diseases caused by oxidative metabolism of arachidonic acid; antiinflammatory, antiallergins, antiarthriric | HOFFMAN-LA ROCHE INC. (US) | 1993-11-09 | — | — | US | disclosed |
| EP-0568289-A2 | Benzothiophenes and thienothiophenes and related compounds useful, for example, as urokinase inhibitors | Eisai Co., Ltd. (JP) | 1993-11-03 | — | — | EP | disclosed |
| US-5252574-A | Hypotensive agents, vision disorder | MERCK & CO., INC. (US) | 1993-10-12 | — | — | US | disclosed |
| WO-1993016081-A1 | PIPERIDINYL THIACYCLIC DERIVATIVES | MERRELL DOW PHARMACEUTICALS INC. (US) | 1993-08-19 | — | — | WO | disclosed |
| US-5198438-A | ANGIOTENSIN II ANTAGONISTS INCORPORATING A SUBSTITUTED THIOPHENE OR FURAN | MERCK & CO., INC. (US) | 1993-03-30 | — | — | US | disclosed |
| US-5177074-A | Heterocyclic nitrogen compounds used to treat hypertension, cognitive dysfunction, anxiety or depression | MERCK & CO., INC. (US) | 1993-01-05 | — | — | US | disclosed |
| WO-1992020642-A1 | BIS MONO-AND BICYCLIC ARYL AND HETEROARYL COMPOUNDS WHICH INHIBIT EGF AND/OR PDGF RECEPTOR TYROSINE KINASE | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1992-11-26 | — | — | WO | disclosed |
| EP-0513979-A1 | Angiotensin II antagonists incorporating a substituted thiophene or furan | MERCK & CO. INC. (US) | 1992-11-19 | — | — | EP | disclosed |
| EP-0512675-A1 | Angiotensin II antagonists incorporating a substituted thiophene or furan | MERCK & CO. INC. (US) | 1992-11-11 | — | — | EP | disclosed |
| EP-0510812-A1 | Angiotensin II antagonists incorporating a substituted thiophene or furan | MERCK & CO. INC. (US) | 1992-10-28 | — | — | EP | disclosed |
| US-5132310-A | Benzochroman compounds, lipoxygenase inhibitors | HOFFMANN-LA ROCHE INC. (US) | 1992-07-21 | — | — | US | disclosed |
| EP-0487996-A2 | Cephalosporins substituted in position 3, process for their preparation and their use as medicine | BAYER AG (DE) | 1992-06-03 | — | — | EP | disclosed |
| EP-0485290-A1 | Antioxydant and/or anticorrosive agents for use as additives in lubricating compositions, especially for turbines | NYCO S.A. (FR) | 1992-05-13 | — | — | EP | disclosed |
| US-5015661-A | Lipoxygenase inhibitors | HOFFMANN-LA ROCHE INC. (US) | 1991-05-14 | — | — | US | disclosed |
| EP-0217530-B1 | DIHYDROPYRIDINES | ELI LILLY AND COMPANY (US) | 1990-10-31 | — | — | EP | disclosed |
| EP-0354508-A2 | Benzopyranol derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1990-02-14 | — | — | EP | disclosed |
| US-4659717-A | CAUSING VASODILATION | ELI LILLY AND COMPANY (US) | 1987-04-21 | — | — | US | disclosed |
| EP-0217530-A1 | Dihydropyridines | ELI LILLY AND COMPANY (US) | 1987-04-08 | — | — | EP | disclosed |
| US-4654352-A | AMINO SUBSTITUTED | PFIZER INC. (US) | 1987-03-31 | — | — | US | disclosed |
| EP-0117675-B1 | BENZOFURAN AND BENZOTHIOPHENE-CARBOXYLIC-ACID DERIVATIVES | BEECHAM GROUP PLC (GB) | 1986-07-23 | — | — | EP | disclosed |
| EP-0073663-B1 | THROMBOXANE SYNTHETASE INHIBITORS, PROCESSES FOR THEIR PRODUCTION, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | Pfizer Limited (GB) | 1986-06-18 | — | — | EP | disclosed |
| US-4590200-A | NON-INHIBITION OF PROSTACYCLIN SYNTHETASE OR CYCLO-OXYGENASE | PFIZER INC. (US) | 1986-05-20 | — | — | US | disclosed |
| EP-0169012-A1 | Benzothiophene anti-diarrhoeal agents | Pfizer Limited (GB) | 1986-01-22 | — | — | EP | disclosed |
| US-4548948-A | Anti-inflammatory and analgesic benzothiophene and benzafuran derivatives, compositions, and method of use therefor | BEECHAM GROUP P.L.C. (GB) | 1985-10-22 | — | — | US | disclosed |
| US-4496572-A | Benzo-fused thromboxane synthetase inhibitors | PFIZER INC. (US) | 1985-01-29 | — | — | US | disclosed |
| EP-0117675-A1 | Benzofuran and benzothiophene-carboxylic-acid derivatives | BEECHAM GROUP PLC (GB) | 1984-09-05 | — | — | EP | disclosed |
| EP-0073663-A2 | Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them | Pfizer Limited (GB) | 1983-03-09 | — | — | EP | disclosed |
| US-4185108-A | INDOLE OR CARBAZOLE CARBOXYLIC ACIDS | WESTWOOD PHARMACEUTICALS INC. (US) | 1980-01-22 | — | — | US | disclosed |
| US-4125621-A | THIOXANTHENE-9-ONES | BRISTOL-MYERS COMPANY (US) | 1978-11-14 | — | — | US | disclosed |
| US-4101668-A | BENZOTHIOPHENE AND DIBENZOTHIOPHENE CARBOXYLIC ACIDS | BRISTOL-MYERS COMPANY (US) | 1978-07-18 | — | — | US | disclosed |
| US-3974280-A | Benzothiophenes | CIBA-GEIGY CORPORATION (US) | 1976-08-10 | — | — | US | disclosed |
| US-3974280-A | Benzothiophenes | CIBA-GEIGY CORPORATION (US) | 1976-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (50 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10150109-B2 | Palladium(II)-silica supported catalyst | PDK2, SIK2, SIK1 | CYP2A6 2399/4885MAPT 4094/4885HDAC3 855/4885 |
| US-20210184121-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CCNL2, CRY1, CCNA1 | CYP2A6 188/4885MAPT 3623/4885HDAC3 1537/4885 |
| US-10882856-B2 | 5 or 8-substituted imidazo [1,5-a] pyridines as selective inhibitors of indoleamine and/or tryptophane 2,3-dioxygenases | IDO1, TPH1, IDO2 | CYP2A6 211/4885MAPT 1488/4885HDAC3 1454/4885 |
| US-20230287010-A1 | POLYCYCLIC AROMATIC DERIVATIVE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | DDT, TYR, DDC | CYP2A6 2080/4885MAPT 219/4885HDAC3 1467/4885 |
| US-20060063766-A1 | Use of aryl- and heteroaryl-substituted tetrahydroisoquinolines to block reuptake of norepinephrine, dopamine, and serotonin | SLC6A3, SLC6A4, SLC6A2 | CYP2A6 742/4885MAPT 2119/4885HDAC3 1196/4885 |
| US-20060264673-A1 | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds | ADH5, CBR3, ALDH3A1 | CYP2A6 90/4885MAPT 2654/4885HDAC3 456/4885 |
| US-20040063728-A1 | 8-AZA-bicyclo[3.2.1]octan-3-OL derivative of 2,3-dihydro-1,4-benzodioxan as 5-HT 1A antagonists | HTR5A, HTR1A, HTR1D | CYP2A6 578/4885MAPT 1516/4885HDAC3 1115/4885 |
| US-20250163078-A1 | IMIDAZOPYRIDAZINE DERIVATIVE, AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | CYP4A11, CYP4F11, SLC6A11 | CYP2A6 87/4885MAPT 229/4885HDAC3 2535/4885 |
| US-20150238498-A1 | COMPOUNDS FOR THE TREATMENT OF PARAMOXYVIRUS VIRAL INFECTIONS | SARS1, MAVS, ZC3HAV1 | CYP2A6 4205/4885MAPT 4529/4885HDAC3 1922/4885 |
| US-20220085298-A1 | COMPOUND, ORGANIC OPTOELECTRONIC DIODE, AND DISPLAY DEVICE | ALDH1A2, OXER1, AOX1 | CYP2A6 577/4885MAPT 2645/4885HDAC3 4084/4885 |
| US-20030236232-A1 | Novel spla2 inhibitors | PLA2G2E, PLA2G4B, PLA2G12A | CYP2A6 1690/4885MAPT 4758/4885HDAC3 3965/4885 |
| US-20050107377-A1 | Benzisoxazolyl-,pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists | DRD4, DRD2, DRD1 | CYP2A6 818/4885MAPT 347/4885HDAC3 1132/4885 |
| US-20130175507-A1 | Novel Heterocyclic Host Materials | OCIAD2, OCIAD1, ORC3 | CYP2A6 2881/4885MAPT 2309/4885HDAC3 1320/4885 |
| US-20050215794-A1 | Copper-catalyzed formation of carbon heteroatom and carbon-carbon bonds | CBR3, ADH5, IDH1 | CYP2A6 84/4885MAPT 2527/4885HDAC3 449/4885 |
| US-20040214822-A1 | Substituted 4-aminocyclohexanol compounds | ADRA2C, OPRD1, OPRK1 | CYP2A6 170/4885MAPT 1212/4885HDAC3 2080/4885 |
| US-11161824-B2 | Heterocyclic lipoxin analogs and uses thereof | LTB4R2, ALOX12, ALOX15B | CYP2A6 973/4885MAPT 4885/4885HDAC3 1444/4885 |
| US-20050245504-A1 | Treatment of diseases with combinations of alpha 7 Nicotinic Acetylcholine Receptor agonists and other compounds | CHRNA7, CHRNG, CHRNE | CYP2A6 2378/4885MAPT 322/4885HDAC3 528/4885 |
| US-20050234092-A1 | Azabicyclic-substituted fused heteroaryl compounds for the treatment of disease | UGT2B7, CYP3A7, UGT1A7 | CYP2A6 159/4885MAPT 3351/4885HDAC3 255/4885 |
| US-20080114052-A1 | CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | CCL11, CCL2, CCR1 | CYP2A6 3209/4885MAPT 4604/4885HDAC3 2194/4885 |
| US-10294212-B2 | Inhibitors of the kynurenine pathway | IDO1, IDO2, KYNU | CYP2A6 132/4885MAPT 3460/4885HDAC3 1003/4885 |
| US-20030153595-A1 | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease | MALT1, TPMT, ABCB1 | CYP2A6 102/4885MAPT 3838/4885HDAC3 505/4885 |
| US-20230135152-A1 | PIKFYVE KINASE INHIBITORS | PIKFYVE, PIP5K1B, PIP5K1C | CYP2A6 4456/4885MAPT 1501/4885HDAC3 1511/4885 |
| US-20030092694-A1 | Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases | HTR2C, HTR3C, HTR2A | CYP2A6 77/4885MAPT 4036/4885HDAC3 332/4885 |
| US-20180099987-A1 | FUNCTIONALIZED MAGNETIC NANOPARTICLE, A CATALYST, A METHOD FOR FORMING C-C BONDS | MSN, COIL, NSFL1C | CYP2A6 2757/4885MAPT 919/4885HDAC3 1769/4885 |
| US-20050054700-A1 | Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof | NR3C1, NR3C2, GCGR | CYP2A6 2059/4885MAPT 1624/4885HDAC3 939/4885 |
| US-20180326409-A1 | METHOD FOR MAKING AND USING A SOLID-SUPPORTED CATALYST | AOC1, SOD1, PDK2 | CYP2A6 905/4885MAPT 4176/4885HDAC3 1969/4885 |
| US-20040242554-A1 | CERTAIN ARYLALIPHATIC AND HETEROARYL-ALIPHATIC PIPERAZINYL PYRAZINES AND THEIR USE IN THE TREATMENT OF SEROTONIN-RELATED DISEASES | HTR2C, HTR3C, HTR2A | CYP2A6 78/4885MAPT 3969/4885HDAC3 313/4885 |
| US-20220396581-A1 | COMPOUNDS FOR THE TREATMENT OF PARAMYXOVIRUS VIRAL INFECTIONS | MAVS, SARS1, ZC3HAV1 | CYP2A6 4442/4885MAPT 4377/4885HDAC3 1633/4885 |
| US-10858334-B2 | Method for aerobic oxidative coupling of thiophenes with a ligand-supported palladium catalyst | PPOX, TST, COX6C | CYP2A6 396/4885MAPT 4271/4885HDAC3 4535/4885 |
| US-20030105089-A1 | Substituted 7-aza[2.2.1]bicycloheptanes for the treatment of disease | CHRNA7, CHRNA1, CHRNA6 | CYP2A6 118/4885MAPT 2155/4885HDAC3 238/4885 |
| US-20130292653-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING THE SAME | CRY1, CRY2, CCNT1 | CYP2A6 1894/4885MAPT 1082/4885HDAC3 1980/4885 |
| US-20050250959-A1 | Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds | CBR3, TST, CBS | CYP2A6 106/4885MAPT 3914/4885HDAC3 1518/4885 |
| US-11014935-B2 | Compounds for the treatment of paramyxovirus viral infections | MAVS, SARS1, ZC3HAV1 | CYP2A6 4442/4885MAPT 4377/4885HDAC3 1633/4885 |
| US-20250289817-A1 | SEROTONIN RECEPTOR MODULATORS AND METHODS OF MAKING AND USING THE SAME | HTR5A, HTR1A, HTR3A | CYP2A6 720/4885MAPT 3587/4885HDAC3 3778/4885 |
| US-20200152890-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, LMNB2, RUVBL2 | CYP2A6 3727/4885MAPT 983/4885HDAC3 2679/4885 |
| US-11773074-B2 | Method for aerobic oxidative coupling of thiophenes with a ligand-supported palladium catalyst | PPOX, TST, COX6C | CYP2A6 396/4885MAPT 4271/4885HDAC3 4535/4885 |
| US-20090286789-A1 | Bi-Aryl Meta-Pyrimidine Inhibitors of Kinases | JAK2, TYK2, LTK | CYP2A6 2691/4885MAPT 4206/4885HDAC3 2712/4885 |
| US-20070191405-A1 | Bi-aryl meta-pyrimidine inhibitors of kinases | JAK2, TYK2, JAK3 | CYP2A6 1775/4885MAPT 3127/4885HDAC3 3040/4885 |
| US-20040158064-A1 | Prostaglandin endoperoxide H synthase biosynthesis inhibitors | PTGS1, PTGIS, PTGS2 | CYP2A6 108/4885MAPT 4845/4885HDAC3 4195/4885 |
| US-20060019984-A1 | Treatment of diseases with alpha-7nACh receptor full agonists | CHRNA7, CHRNA1, CHRNG | CYP2A6 3477/4885MAPT 2082/4885HDAC3 1374/4885 |
| US-11945836-B2 | Compositions and methods for treating CNS disorders | GRIN2B, ADRA2B, ADRA1B | CYP2A6 242/4885MAPT 693/4885HDAC3 384/4885 |
| US-20100331326-A1 | Inhibitors of CYP 17 | CYP17A1, CYP21A2, CYP4A22 | CYP2A6 51/4885MAPT 3491/4885HDAC3 1159/4885 |
| US-20160136629-A1 | SPIRO-1,1'-BINDANE-7,7-BISPHOSPHINE OXIDES AS HIGHLY ACTIVE SUPPORTING LIGANDS FOR PALADIUM-CATALYZED ASYMMETRIC HECK REACTION | SBK1, SIK1, PDPK1 | CYP2A6 2159/4885MAPT 4690/4885HDAC3 1515/4885 |
| US-20080076795-A1 | 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators | NR3C1, NR3C2, GRK5 | CYP2A6 624/4885MAPT 3518/4885HDAC3 408/4885 |
| US-20040186140-A1 | Cyclic derivatives as modulators of chemokine receptor activity | CCL11, CCR1, CCL2 | CYP2A6 3265/4885MAPT 4636/4885HDAC3 2157/4885 |
| US-20180179186-A1 | ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS | CFD, TFPI, CFH | CYP2A6 907/4885MAPT 4523/4885HDAC3 1175/4885 |
| US-20060287386-A1 | Benzo[b]furane and benzo[b]thiophene derivatives | CYP1B1, TBCB, CYP4B1 | CYP2A6 401/4885MAPT 3465/4885HDAC3 2994/4885 |
| US-20230279043-A1 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | GRIN2B, ADRA2B, ADRA1B | CYP2A6 242/4885MAPT 693/4885HDAC3 384/4885 |
| US-20080021026-A1 | BENZOTHIOPHENE INHIBITORS OF RHO KINASE | RHOT2, ROCK2, ROCK1 | CYP2A6 4122/4885MAPT 551/4885HDAC3 1840/4885 |
| US-20140228394-A1 | INHIBITORS OF CYP 17 | CYP17A1, CYP21A2, CYP4A22 | CYP2A6 51/4885MAPT 3491/4885HDAC3 1159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.